XIX Colloquium Programa 20110914

PROGRAMME BOOK | PROGRAMA

19TH COCHRANE COLLOQUIUMScientific evidence for healtcare quality and patient safety

19º COLLOQUIUM COCHRANEEvidencia científica para la calidad asistencial y la seguridad del paciente

Programme at a glance

Wednesday 1907:30 h15:00 h Meetings

Thursday 20 Friday 21 Saturday 22

09:00 h13:30 h

16:00 h17:30 h

Workshop

Official Opening17:30 h18:00 h

18:00 h19:30 h

Meetings

20:30 h

Joint Plenary

Coffee breakPoster session

SafetyConference

Plenary

Oral sessions

07:30 h08:55 h

09:00 h10:30 h

10:30 h11:15 h

11:00 h12:30 h

Lunch


Lunch


Lunch12:30 h14:00 h

07:30 h08:55 h

09:00 h10:30 h

10:30 h11:15 h

11:15 h12:45 h

12:45 h14:00 h

07:30 h08:55 h

09:00 h10:30 h

10:30 h11:15 h

11:15 h12:45 h

12:45 h14:00 h

Workshops14:00 h15:30 h

14:00 h15:30 h

14:00 h15:30 h

16:00 h17:30 h

Social event21:00 h

Meetings

Colloquium Plenary Session

Oralsessions

Coffee Break15:30 h16:00 h Coffee Break15:30 h

16:00 h


Workshops16:00 h17:30 h

Free evening

Meetings


Workshops


Cochrane Closing Session

Meetings

Gala Dinner and Farewell Party

15:45 h17:00 h

17:00 h17:45 h

18:00 h19:30 h

21:00 h

From08:30 h Registration

11:15 h12:45 h

Workshops

PAHO meeting

Meetings

SafetyConference

Plenary12:45 h14:00 h

CochraneAnnualGeneralMeeting

SafetyConference

PlenaryREDIBAM-GPCWorkshops

Meetings

Safety ConferenceClosing Plenary Session

17:30 h18:30 h

17:45 h19:30 h Meetings Special

Workshops

Satelliteworkshops

15:00 h16:00 h Colloquium Plenary Session

Joint PlenaryCochrane Colloquium-Safety Conference

SafetyConference

PlenaryMeetings Workshops

Welcome reception

Workshops

17:45 h19:30 h WorkshopsMeetings

Workshops

Oralsessions Workshops

October

14:00 h14:45 h Newcomers’ Session

COLLOQUIUM

Xavier BonfillOn behalf of the Organizing Committee / en nombre del Comité Organizador

19th Colloquium Cochrane / 19º Colloquium Cochrane

Estimado/as amigo/as y colegas,

Tras el privilegio de organizar en 2003 el 11º Colloquium Cochrane en Barcelona, ahora asumimos nuevamente el reto de organizar otro Colloquium aunque esta vez en Madrid. Este Colloquium tiene como lema “Evidencia científica para la calidad asistencial y la seguridad del paciente”. Se trata de una elección estratégica que nos brinda la oportunidad de celebrar el Colloquium conjuntamente con la VI Conferencia Internacional de Seguridad del Paciente que organiza anualmente la Agencia Nacional de Calidad del Ministerio español de Sanidad, Política Social e Igualdad.

Contribuir a mejorar la calidad asistencial y la seguridad de los pacientes supone un atractivo reto para la Colaboración Cochrane, además de prioridades bien establecidas por la Organización Mundial de la Salud, gobiernos, instituciones sanitarias y profesionales de todo el mundo. Como siempre, durante el Colloquium habrá numerosas oportunidades de aprender juntos y de discutir acerca de una gran variedad de aspectos metodológicos y temas de gran interés, dirigidos tanto a quienes acuden regularmente a estas reuniones como a los menos habituales.

Además, junto a la ya mencionada Conferencia de Seguridad, la LatinCLEN (Red Latinoamericana de Epidemiología Clínica) y la REDIBAM-GPC (Red Iberoamericana de Guías) coincidirán también en este evento celebrando sus propias reuniones periódicas. Y por si fuera poco, Madrid ofrece múltiples opciones para gozar de la cultura, la música, la comida… de la vida en todas sus expresiones!

Por todo ello, estamos seguros de que con la participación de todos vamos a conseguir que el Colloquium sea realmente muy fructífero y que además lo pasemos estupendamente.

Cordiales saludos,

Dear friends and colleagues:

In 2003, we had the privilege of organising the 11th Cochrane Colloquium in Barcelona. We embark again on this exciting enterprise, this time in Madrid, for the 19th Cochrane Colloquium. The theme for this Colloquium is “Scientific evidence for healthcare quality and patient safety”, a strategic choice that will allow us to celebrate the Colloquium in conjunction with the VI International Conference on Patient Safety, organised by the National Agency for Health Care Quality at the Spanish Ministry of Health.

Improving quality of care and patient safety is an appealing challenge for the Cochrane Collaboration, in line with priorities set by the World Health Organization, governments, health care facilities, and health professionals all around the world. As always, during the Colloquium there will also be plenty of opportunities to learn and discuss a variety of methodological issues and topics of great interest, directed to the usual participants and to newcomers.

In addition, LatinCLEN (the Latin American Network of Clinical Epidemiology) and REDIBAM-GPC (The Iberoamerican Network of Clinical Guidelines) will hold their periodic meetings during this event. And as if that were not enough, we will have the opportunity of experiencing the culture, music, and gastronomy that Madrid has to offer…life in all its forms and expressions!

With your participation, this Colloquium will surely be a great success and all of us will enjoy a great time!

Best wishes,

WELCOMEBIENVENIDA

19th COCHRANE COLLOQUIUM19º COLLOQUIUM COCHRANE

COLLOQUIUM COMMITEESCOMITÉS DEL COLLOQUIUM

Local Organizing CommitteeComité Organizador Local

Executive CommitteeComité EjecutivoXavier Bonfill, Spain(Chair / Moderador)

Margarita García Mas, SpainSara Sentís, SpainIvan Solà, Spain

Committee MembersMiembros del ComitéMarta Gorgues, SpainMarta Roqué, SpainLaura Martínez, SpainIgnasi Bolíbar, SpainJesús López Alcalde, SpainM José Martínez, SpainSalomé Planas, SpainDavid Rigau, SpainMaroussia Tzanova, SpainGerard Urrútia, SpainHector Pardo, Spain

Web TeamEquipo WebChris Mavergames, Germany Martin Janczyk, GermanyJuliane Ried, Germany

Abstract CommitteeComité de AbstractsMaria José Martínez, Spain(Chair / Moderadora)Alain Mayhew, Canada(Chair / Moderador)

Adrienne Stevens, CanadaAgustín Ciapponi, ArgentinaChantelle Garritty, CanadaClaire Glenton, NorwayDenise O’Connor, AustraliaElizabeth Pienaar, South AfricaGabriel Rada, ChileGeorgia Salanti, GreeceGuido Schwarzer, GermanyIan Shrier, CanadaJavier Gisbert, SpainMegan Prictor, AustraliaMichelle Fiander, CanadaPablo Alonso, SpainPhil Wiffen, UKPrathap Tharyan, IndiaRachel Churchill, UKRob Scholten, NetherlandsRobert Wolff, UKRoberto D’Amico, ItalySera Tort, Spain

Susan Norris, USAVivian Welch, Canada

Workshop CommitteeComité de TalleresMarta Roqué, Spain(Chair / Moderadora)Miranda Cumpston, Australia (Chair / Moderadora)

Erin Ueffing, CanadaGail Higgins, AustraliaJavier Zamora, SpainJesús López Alcalde, SpainJimmy Volmink, South Africa Joseph Beyene, CanadaJulian Higgins, UKLiliana Coco, ItalyLudovic Reveiz, USARob Scholten, NetherlandsSally Hopewell, UKSophie Hill, USASreekumaran Nair, IndiaToby Lasserson, UK

Thomas C Chalmers Award CommitteComité del Premio Thomas C Chalmers

Georgia Salanti, Greece (Chair)Bernadette Coles, UKHelen Worthington, UKJill Hayden, CanadaSally Hopewell, UKJulian Higgins, UKJonathan Stern, UKBarney Reeves, UKJoanne E McKenzie, AustraliaPetra Macaskill, AustraliaYemisi Takwoingi, UK

Scientific CommitteeComité CientíficoJordi Pardo, Canada(Chair / Moderador)

Xavier Bonfill, SpainVictor Abraira, SpainMónica Ausejo, SpainCarlos Aibar, SpainElena Andradas, SpainJosé Asua, SpainAmanda Burls, UKJuan Cabello, SpainClaudia Cattivera, ArgentinaMarisa López García, SpainMike Clarke, UKLuís Gabriel Cuervo, USAJosé Ignacio Emparanza, SpainJames Fitzgerald, USA

Agustín Gómez de la Cámara, SpainJeremy Grimshaw, CanadaPedro Gutiérrez, MexicoFrancisco Kovacs, SpainPablo Lázaro, SpainAlessandro Liberati, ItalyJesús López Arrieta, SpainArturo Louro, SpainEsteban de Manuel, SpainIgnacio Marín, SpainArturo Martí, VenezuelaSteve McDonald, AustraliaSergio Minué, SpainMaite Moreno, SpainJoaquín Morís de la Tassa, SpainSergio Muñoz, ChileZulma Ortiz, ArgentinaPhilippe Ravaud, FranceJosé Luís Rodríguez, SpainCristina Sampaio, PortugalAntonio Sarria, SpainKarla Soares, IsraelOriol de Solà-Morales, SpainJoaquim Bañeres, SpainDavid Tovey, UKMario Tristán, Costa RicaAntonio Vaz Carneiro, Portugal

Stipend Committee (Developing Countries)Comité de Estipendios (Países en Desarrollo)Caroline Rouse, UK (Chair / Moderadora)Ivan Solà, Spain (Chair / Moderador)

Joy Oliver, South AfricaMario Tristán, Costa Rica

Stipend Committee (Consumers)Comité de Estipendios (Consumidores)Catherine McIlwain, UK (Chair / Moderadora)Caroline Rouse, UK (Chair / Moderadora)

David Rigau, SpainLiz Whamond, CanadaMingming Zhang, China

Stipend SecretariatSecretaría de Estipendios

Juliane Ried, GermanyCaroline Rouse, UKJini Hetherington, UK

INDEXÍNDICE

PROgRAMME AT A gLANCE

WELCOME / BIENvENIDA

COLLOQUIUM COMMITTEES / COMITéS DEL COLLOQUIUM

INfORMATION ON LOgISTICS / INfORMACIóN LOgíSTICA

Colloquium venue / Sede del Colloquium

Palacio’s floorplan / Distribución de salas del Palacio

General information / Información general

DAy-TO-DAy PROgRAMME / EL PROgRAMA DíA A DíA

Wednesday, October 19 / Miércoles, 19 de Octubre

Thursday, October 20 / Jueves, 20 de Octubre

Friday, October 21 / Viernes, 21 de Octubre

Saturday, October 22 / Sábado, 22 de Octubre

WORkSHOPS / TALLERES

PÓSTERES / PóSTERS

MORE… / MáS...

Pre- and post-Colloquium events / Actos pre- y post-Colloquium

Social events / Actos sociales

Prizes and awards / Premios y reconocimientos

MADRID: THE bASICS / MADRID: LO BáSICO

About Madrid / Acerca de Madrid

Visitor Tips / Consejos para el visitante

PARTNERSHIPS AND SPONSORSHIPS / COLABORACIONES y PATROCINIOS

fUTURE COLLOQUIA / fUTUROS COLLOQUIA

EL PROgRAMA DE UN vISTAzO

1

2

3

4

6

7

10

15

16

22

32

40

48

78

104

106

111

120

126

128

131

142

147

149

PUER

TA D

E A

LCA

Lá

LOGISTICSLOGÍSTICA

COLLOQUIUM VENUESEDE DEL COLLOQUIUM

PALACIO´S fLOORPLANSDISTRIBUCIóN DE LAS SALAS DEL PALACIO

gENERAL INfORMATIONINfORMACIóN gENERAL

LOg

ISTI

CS

LOg

íSTI

CA

6 | logistics • logística

COLLOQUIUM VENUESEDE DEL COLLOQUIUM

PALACIO DE CONgRESOS DE MADRID

Palacio de Congresos de Madrid | Paseo de la Castellana, 99 | 28046 Madrid, España www.palaciocongresosmadrid.com

Access to Palacio de Congresos de Madrid:

Metro: The nearest Metro station is Santiago Bernabeu (line 10). Alternatively you can walk 3 minutes to Nuevos Ministerios station (line 8) which is connected by train to Barajas Airport T1, T2 & T3 (15 minutes ride).

buses: Lines 14, 27, 40, 43, 120, 126, 147, 150.

Acceso al Palacio de Congresos de Madrid:

Metro: La estación del metro más cercana es Santiago Bernabeu (línea 10). Alternativamente, usted puede caminar 3 minutos hasta la estación de Nuevos Ministerios (línea 8), que está conectada por tren al aeropuerto de Barajas T1, T2 y T3 (trayecto 15 minutos).

Autobuses: Líneas 14, 27, 40, 43, 120, 126, 147, 150.

C. d

e O

rens

e

Pase

o de

la C

aste

llana

Pase

o de

la C

aste

llana

Av.

del

Bra

si

Plaza de Joan Miró

C. de Rafael Salgado

Av. general Perón

Palacio deCongresosde Madrid

Jardinesdel mundial

Plaza de Lima

C. d

el C

apitá

n H

aya

EstadioSantiagoBernabéu

TorreEuropa

Plaza deManolete

C. S

an J

uan

de la

Sal

le

Av. Concha Espina

logistics • logística | 7

ROOMS DISTRIBUTIONDISTRIBUCIÓN DE SALAS

Information & registration deskSecretaría de información e inscripciones

CafeteriaCafetería

Computer rooms 2A, 2BSalas de informática 2A, 2B

Cochrane ExchangeIntercambio Cochrane

FUERTEVENTURA • GRAN CANARIA LA PALMA • LANZAROTE • TENERIFE

Main Entrance (Plaza Joan Miró) Entrada Principal (Plaza Joan Miró)

gROUND fLOORPLANTA BAJA

MEzzAINE ENTREPLANTA BAJA

UNESCO

Hall / Vestíbulo

Bar Miró

AUDITORIUM

Stands

gOyA

Main Hall Vestíbulo pral


fIRST fLOOR PRIMERA PLANTA

SECOND fLOORSEgUNDA PLANTA

BoardroomS, Offices, Secretaries Salas de juntas, Despachos, SecretaríasDENMARK • GERMANY • ITALYPORTUGAL • UNITED KINGDOM

AMERICA

OCEANIA

AUDITORIUM

HallVestíbulo

HallVestíbulo

RoomsSalas

Posters area 1Área de pósters 1

Posters area 2Área de pósters 2

Dinning roomComedor

Room 9Sala 9

ASIA vIPS

AfRICA

EUROPE

ANTICIS

AUDITORIUMRoom 7 Sala 7

Room 8 Sala 8

ANTARCTICA

MENINA

12

13

14

15


LOCATION / LOCALIzACIóN ROOMS / SALAS

GROUND FLOOR / PLANTA BAJA

UNESCOFUENTEVENTURAGRAN CANARIALA PALMALANZAROTETENERIFE

MEZZAINE / ENTREPLANTA

AUDITORIUM (entrance / entrada 1)GOYA2A (COMPUTER ROOM)(SALA DE INFORMÁTICA)2B (COMPUTER ROOM )(SALA DE INFORMÁTICA)AUDITORIUM (entrance / entrada 2)

FIRST FLOOR / PRIMERA PLANTA

COCHRANE EXCHANGEAMERICA9 ROOM / SALADENMARK SECRETARY (PREVIEW ROOM / SALA VISUALIZACIÓN)DENMARK OFFICEDENMARK BOARDROOM SALA DE REUNIONESGERMANY/ ALEMANIA OFFICEGERMANY/ ALEMANIA BOARDROOM/ SALA DE REUNIONESITALY OFFICEITALY BOARDROOMSALA DE REUNIONESPORTUGAL OFFICEPORTUGAL BOARDROOM SALA DE REUNIONESUNITED KINGDOM /REINO UNIDO OFFICEUNITED KINGDOM /REINO UNIDO BOARDROOM / SALA DE REUNIONESOCEANIAAUDITORIUM (entrance / entrada 3)

SECOND FLOOR / SEGUNDA PLANTA

7 ROOM / SALA8 ROOM / SALAANTICIS12 ROOM / SALA13 ROOM / SALA14 ROOM / SALA15 ROOM / SALAVIPSAFRICAEUROPEASIAMENINAANTARCTICA


GENERAL INfORMATIONINfORMACIÓN GENERAL

Registration and Information desk • The Registration and Information desk is located

at the Ground Floor and will be open from 8 AM to 7 PM

• Full registration includes access to all sessions, coffee breaks (refreshments), and meals. The Welcome Reception and the Gala Dinner and Farewell Party are also included, though subject to availability and to having signed up for each event in advance.

• Day registration includes access to all sessions, coffee breaks, and meals held on the day for which they are purchased. They also grant access to the possible free social events of that day (subject to availability).

• Delegates who register on the same day will receive a Colloquium bag with a copy of the Program and the Abstract Book. There are also local maps, information on public transportation, and other information of interest on Madrid and its surroundings, as well as some inserts.

• Please complete the evaluation form that you will findinthewelcomepackageandreturnittostaffatthe Registration desk. This will allow us to improve the quality of next Colloquia.

• If you need any information, please contact any member of the organization, who will carry a badge labelled “ORGANIZATION”, or go directly to the Information desk.

• Contact details of the Registration desk:

Información e inscripciones • La secretaría está ubicada en la Planta Baja y

estará abierta de 8 h a 19 h.

• La inscripción completa da derecho a asistir a todas las sesiones, pausa-cafés y comidas. La Recepción de Bienvenida y la Cena/ Fiesta de Despedida también están incluidas, aunque sujetas a disponibilidad puesto que hay que inscribirse previamente a tales eventos.

• La inscripción de un día da derecho a asistir a todas las sesiones, pausa-cafés y comidas del día registrado. Los tickets de día incluyen el acceso a los posibles eventos gratuitos de ese día (sujeto a disponibilidad).

• A los delegados registrados el mismo día se les dará una bolsa del Colloquium con el Programa y el libro de Resúmenes. La bolsa del Colloquium contiene mapas locales, guías de transporte y otra información de Madrid y alrededores, así como algunos materiales de difusión.

• Les pedimos rellenen el formulario de evaluación que encontrarán en la bolsa para así poder mejorar la calidad de los siguientes Colloquium. Rogamos entreguen el formulario en la Secretaría del Colloquium.

• Para cualquier información que necesite, contacte con algún miembro de la organización, los cuales seidentificanconlapalabra“ORGANIZACIÓN”ensutarjetadeidentificación,ovayadirectamenteala Secretaría.

• Datos de contacto de la Secretaría del Colloquium:

Tel.: +34 - 671077682 e-mail: [email protected]

badgeEach participant will receive a badge with his or her name. It is mandatory to carry this badge in a visible place in order to access all of the Colloquium’s sessions and events. If the badge is lost or forgotten, please contact the Registration desk.

Audiovisuals • The use of audiovisual equipment is restricted to

people who have requested them in advance.

Tarjeta de identificación Cada participante y acompañante recibirá una tarjeta de identificación con su nombre. Es obligatorio llevar visible la tarjeta de identificación para acceder a todos los eventos y sesiones del Colloquium. En caso de pérdida u olvido de la tarjeta de identificación, deberán contactar con la Secretaría del Colloquium.

Audiovisuales• El uso de equipos audiovisuales está restringido a

las personas que los han solicitado previamente.


• Todas las sesiones plenaries del Colloquium serán grabadas y divulgadas posteriormente a través de la web de la Colaboración Cochrane.

Ordenadores-Internet • Existen dos salas informáticas habilitadas en las salas2ay2b.Tieneninstaladaunaconfiguraciónestándar de Windows/Office con conexión aInternet y teclado Inglés/Español. Los talleres programados tienen preferencia para usar estas salas.

• Existe conexión WiFi accesible desde distintos puntos de las instalaciones.

Esta conexión será gestionada a través de un portal cautivoquecontrolaráeltráfico,conlassiguientesaplicaciones:

•Detenerelspam •Controldeanchodebanda •Controldelasredessociales •Bloqueodejuegosenlínea •BloquearAdware

Intercambio Cochrane: el CRS para ayudar a los clínicosEl Cochrane Exchange, que será el espacio de exhibición de la Colaboración, tendrá sesiones prácticas durante el Colloquium para proporcionar apoyo técnico a los usuarios del Cochrane Register of Studies (CRS). Los temas de estas sesiones incluirán cómo importar y exportar, buscar, rastreo y reportes. Los usuarios también pueden pedir una cita o pasarse por el Exchange para obtener ayuda por parte de los equipos de apoyo de Metaxis y el CRS.

ReunionesEn el horario del programa encontrará los nombres y salas de cada reunión. Si necesita un sala para una reunión de última hora, por favor diríjase a la Secretaría lo más pronto posible. Si hay disponibilidad, se le asignará una sala.

TalleresEn el horario del programa encontrará los nombres y aulas de cada taller. Los asistentes que se inscribieron en talleres antes del Colloquium pueden revisar su selección en las listas de talleres de los tableros de la Entreplanta. Si desea inscribirse en algún taller después de comenzado el Colloquium, lo puede hacer siempre y cuando hayan plazas disponibles.

• All the Colloquium plenary sessions will be recorded and posted in the Cochrane Collaboration webpage afterwards.

Computers-Internet• There are two computer rooms available at

Room 2a and 2b. Computers have a standard copy of Microsoft Office/Windows with Internetconnection and an English/Spanish keyboard. The programmed workshops have preference for using these rooms.

• There is WiFi connection at different points of the venue.

This connection will be managed through a captive portalthatwillhandlethetraffic,withthefollowingapplications:

•StopSpam •BandwidthUsageControl •SocialNetworksControl •OnlineGamblingBlock •AdwareBlock Cochrane Exchange: CRS help clinics The Collaboration’s dedicated exhibition spaces, the Cochrane Exchange, will be home to daily help clinics during the Colloquium aimed at supporting users of the Cochrane Register of Studies (CRS). Topics covered in help sessions will include importing and exporting, searching, tracking and reporting. Users can also make an appointment or drop in to the Exchange to get help and support from the Metaxis and CRS User Support teams on any question or problem.

MeetingsPlease refer to the relevant daily schedule in the Programme book for the titles and locations of meetings. If you need a room for an impromptu meeting, please present yourself at the Registration desk as early as possible. We will then allocate a room for you, if available.

WorkshopsPlease refer to the relevant daily schedule in the Programme book for the titles and locations of workshops. Delegates who signed up for workshops before the Colloquium can check their selection on the workshop lists on the boards on the Mezzanine Floor. If you didn’t sign up for workshops before the Colloquium, you can add your name to the participant lists, subject to availability.


Languages The official languages of the Colloquium will be English and Spanish. In the plenary sessions, there will be simultaneous translation. Sessions with simultaneous translation are marked with a T

Translation receivers It is necessary to leave a form of identification in order to receive a receiver of simultaneous translation. The form of identification will be returned once the receiver is given back.

Message boardThere will be two announcement boards, one for official announcements of the organization for Colloquium participants and another for general messages which will of free use.

Mobile phones Please turn off your cell phone during all sessions and meetings.

Presentation preview roomsIt is highly recommended that all presenters visit this room on the day before their presentation to ensure that their presentations can be viewed and displayed correctly.

Meals Each day there will be a lunch menu. In exceptional cases, you can request a change of menu by filling a form at the Registration desk one day in advance.

• Vegetarian menus will be available only to those who requested them during registration. You will find all information on the menus with theColloquium’s registration documents.

• All meals will be served in the dining room except those prepared for scheduled meetings.

• Please note that refreshments will not be available during early morning meetings. The cafeteria located at the Ground Floor opens a bit earlier than 7:30 AM.

SmokingPlease remember that smoking is not allowed at the Colloquium venue.

IdiomasLas lenguas oficiales del congreso son el inglés y español. En las sesiones plenarias se dispondrá de traducción simultánea. Las sesiones con traducción simultánea están marcadas con una T

Receptores de traducciónEs necesario entregar un documento de identificación para obtener un receptor de traducción simultánea. El documento será retornado una vez finalizada la utilización del receptor.

Tablón de anuncios Habrá dos tablones de anuncios, el de avisos de la organización para anuncios oficiales a los participantes del Colloquium y el de mensajes generales de uso libre.

Teléfonos móvilesSe ruega a todos los participantes que desconecten los teléfonos móviles durante las sesiones.

Sala de previsualizacionesSe recomienda a todos los ponentes asistir a esta sala para comprobar que su presentación pueda visualizarse en óptimas condiciones. Por favor, acudan a esta sala un día antes de su presentación.

ComidasHay un menú diario para almorzar. En casos excepcionales, se podrá solicitar un cambio de menú rellenando la solicitud y entregándola a la Secretaría del Colloquium con un día de antelación.

• Los menús vegetarianos serán servidos sólo en aquellos casos que han sido solicitados en el momento de la inscripción. Junto con la documentación del Colloquium, encontrará los listados de los menús diarios.

• Todas las comidas serán servidas en el comedor excepto aquellas preparadas para quienes tengan reuniones programadas.

• No se servirán refrigerios durante las reuniones tempranas en la mañana. La cafeteria ubicada en la Planta Baja abre un poco antes de las 7:30 h.

fumarRecordamos que no está permitido fumar en la sede del Colloquium


WardrobeThere will be a wardrobe room located at the Mezzanine Floor.

Disabled people The Palacio de Congresos and the venues where the social events will take place are accessible for disabled people.

Child care The Colloquium organization does not offer child care. If you need these services, please contact the Registration desk.

Attendance certificatesAttendance certificates will be handed to those who request them at the Registration desk.

MerchandisingThere are some Colloquium-related handmade souvenirs that can be bought at the Information Desk: brooches, handkerchiefs and foulards.

guardarropíaHay una sala asignada a tal efecto en la Entreplanta.

Personas con discapacidadesTanto la sede del Congreso como las de los eventos sociales están adaptadas para sillas de ruedas.

guarderíaLa organización del Colloquium no ofrece servicio de guardería. No obstante, es posible contratar esta prestación de forma particular contactando con la Secretaría del Colloquium.

Certificados de asistenciaLos certificados de asistencia serán entregados a demanda en la Secretaría del Colloquium.

MerchandisingExisten algunos souvenirs relacionados con el Colloquium y hechos a mano que están a la venta en la Secretaría: broches, pañuelos y fulares.

hand painted handkerchiefs pañuelos pintados a mano

hand painted foulardsfulares hechos a mano

handmade broochesbroches hechos a mano


Cancellations Registrations to the Colloquium and to the social events are binding. After September 15, 2011, the registration and social events fees will not be returned.

DisclaimerThe Organization Committee is not liable for any lost or damaged items belonging to participants or their companions during the official activities or the tours. Participants and their companions attend all official activities and tours at their own risk. Participants and their companions are encouraged to purchase insurance for items that can be lost, as well as for accidents and injuries before, during, and after the Colloquium. Verbal agreements are nonbinding until they are confirmed in writing. All events will take place under the jurisdiction of the courts of the city of Madrid. The Spanish law will be applied.

CancelacionesTodas las inscripciones al Colloquium y a los eventos sociales son vinculantes. Después del 15 de septiembre de 2011 ni las cuotas de inscripción ni las de los eventos sociales serán reembolsadas.

Responsabilidades El Comité Organizador Local no acepta ninguna responsabilidad por daños y/o pérdidas de cualquier tipo que les pueda ocurrir a los participantes o a sus acompañantes, tanto durante las actividades oficiales como durante las excursiones. Los asistentes participan en todos los eventos y tours bajo su cuenta y riesgo. Se aconseja a los participantes contratar su propio seguro contra pérdidas, accidentes o daños que les puedan ocurrir antes, durante o después del Colloquium. Los acuerdos verbales no serán vinculantes hasta que no sean confirmados por escrito. El ámbito de jurisdicción corresponderá a los juzgados y tribunales de Madrid ciudad. Se aplicará la ley española.

15

MONDAyLUNES 17

Pre- Colloquium meetings & satellite workshops Reuniones y talleres satélite pre-Colloquium

TUESDAy MARTES 18

WEDNESDAyMIéRCOLES 19

Colloquium Conference / ConferenciaTHURSDAyJUEvES 20 Closing session / Clausura

fRIDAy vIERNES 21

SATURDAy SáBADO 22 Closing session / Clausura

SUNDAy DOMINgO 23

Post- Colloquium meetingsReuniones post-Colloquium

DAy-TO-DAy pROGRAMME EL pROGRAMA DÍA A DÍA

“I am Don Quixote, and my profession is Knight-Errantry. My laws—to un-blind the blind, spread goodness and avoid evil. I flee from the easy life, ambition and hypocrisy and look for the narrowest and most difficult path

towards my own glory. Is that silly or unrealistic?”

“DonQuijotesoy,ymiprofesiónladeandantecaballería.Sonmisleyes,eldeshacerentuertos,prodigarelbieny evitar el mal. Huyo de la vida regalada, de la ambición y la hipocresía, y busco para mi propia gloria la senda

másangostaydifícil.¿Eseso,detontoymentecato?”

Miguel de Cervantes Saavedra.

Oficial opening / Inauguración Oficial

© E

:M: P

rom

oció

n de

Mad

rid, S

.A. |

PLA

zA M

AyO

R

WEDNESDAyMIÉRCOLES

19 OCT.

DAY AT A GLANCE • EL DíA DE UN vISTAzO

7:30 MeetingsReuniones

8:30 RegistrationInscripciones

9:00 Workshops & Satellite workshopsTalleres y talleres satélite

15:00 Cochrane Plenary sessionSesión Plenaria Cochrane

16:00Joint Plenary session (with the VI Int. Conference on Patient Safety)Sesión Plenaria conjunta (con la VI Conferencia Int. de Seguridad del Paciente)

17:30 Official openingInauguración Oficial

18:00

MeetingsReunionesPlenary session of the VI Int. Conference on Patient SafetySesión Plenaria de la VI Conferencia Int. de Seguridad del PacienteWorkshopsTalleres

20:30 Welcome receptionRecepción de bienvenida

WED

NES

DAy

MIÉ

RC

OLE

S 19

OC

T.

18 | Wednesday Oct. 19 • Miércoles 19 Oct.

WEDNESDAy, OCTOBER 19MIÉRCOLES, 19 DE OCTUBRE

VI INTERNATIONAL CONfERENCE ON PATIENT SAfETyvI CONfERENCIA INTERNACIONAL DE SEgURIDAD DEL PACIENTE(19-20 OCT. 2011)

19th COCHRANE COLLOQUIUM / 19º COLLOQUIUM COCHRANEREDIBAM-GPC VIII Annual Meeting / VIII Reunión Annual REDIBAM-GPCLatinCLEN XII Congress / XII Congreso LatinCLEN

From / Desde 08:30 Registration Inscripciones

07:30 - 15:00 MEETINgS / REUNIONES

07:30 - 08:55 Centre Directors’ Executive (Closed, gERMANy Boardroom)08:00 - 14:55 Co-ordinating Editors (Closed, gOyA)

Managing Editors (Closed, Room 8)Trials Search Co-ordinators, (Closed, Room 7)

08:30 - 11:30 Methods Board (Closed, AMERICA)08:30 - 12:30 Cochrane Sexually Transmitted Diseases Group (DENMARK Boardroom)09:00 - 11:00 Fields Executive - 1st meeting (Closed, PORTUgAL Boardroom)09:00 - 12:30 Cochrane event manager training (Closed, 09:00 - 10:30h OCEANIA Room; 10:30 - 12:30h Room 2a)09:00 - 13:30 Centre Directors (Closed, EUROPE)11:30 - 14:55 Cochrane Fields (AMERICA)12:00 - 13:30 Methods Executive (Closed, UNITED KINgDOM Boardroom)13:00 - 14:55 Alliance for Health Policy and Systems Research (Closed, gERMANy

Boardroom)13:30 - 14:55 Centre Staff (Closed, UNESCO)14:00 -14:55 Campbell International Development Coordinating Group (Closed,

ANTARCTICA)14:00 – 14:50 Newcomers to the Cochrane Collaboration Introducción a la Colaboración Cochrane. (ANTICIS)

09:00 – 13:30 SATELLITE WORkSHOPS / TALLERES SATéLITE

•AprendizajeBasadoenlosProblemas(ABP):Unsaltodecalidadeneducación médica (SAT08. vIPS)

•FromNovicetoExperttoMentor:IncreasingParticipationintheCochraneCollaboration in Low and Middle Income Countries (SAT09. MENINA)

•Herramienta“Pritectools”enlaobservacióndetecnologíassanitariastrassuintroducción en la práctica clínica (SAT07. AfRICA)

•MakingSenseofScientificEvidenceandCommentingonaCochraneReview: A Dual Language Workshop for Consumers (WS52. Room 9)

•OdontologíaBasadaenlaEvidencia (SAT05. ANTICIS)•TallerdeMetanálisisconSTATA (SAT06. Room 2b)

SCIENTIfIC EVIDENCE fOR HEALTHCARE QUALITy AND PATIENT SAfETyEvIDENCIA CIENTífICA PARA LA CALIDAD ASISTENCIAL

y LA SEgURIDAD DEL PACIENTE(Rooms: in brackets) / (Salas: entre paréntesis)

Wednesday Oct. 19 • Miércoles 19 Oct. | 19

15:00 – 16:00 PLENARy SESSION / SESIóN PLENARIA COCHRANE Auditorium. T

global collaborations and health alliances (PCol01) Colaboraciones y alianzas globales de salud.

Globalization brings new challenges as well as new opportunities. We will explore how different collaborations and health alliances deal with the numerous challenges and opportunities and investigate the possibilities of new interactions.

La globalización trae consigo nuevos retos, así como nuevas oportunidades. Vamos a explorar cómo las diferentes colaboraciones y alianzas en el campo de la salud hacen frente a los numerosos retos y oportunidades y exploran las posibilidades de nuevas interacciones.

Chairs / Moderadores: Jordi Pardo, Iberoamerican Cochrane Centre, Spain; ghada Bawazeer, King Saud University, Yemen.

Speakers / Ponentes: •Mirta Roses, Director of the Pan American Health Organization (PAHO)

Organización Panamericana de Salud (OPS). •Jonathan Craig, Co-Chair of the Cochrane Collaboration. •Sergio Muñoz, Presidente de LatinCLEN. •Ignacio Marín, Presidente de la REDIBAM-GPC

16:00 – 17:30 JOINT PLENARy SESSION / SESIóN PLENARIA CONJUNTA COCHRANE

CONfERENCE / CONfERENCIAAuditorium. T Interventions to reduce adverse events impact on health care (I)Las intervenciones para reducir el impacto de eventos adversos en la atención sanitaria (I) (PCC01)

This session aims to highlight the highly relevant work on patient safety. Challenges will be presented and contributions made from Cochrane and more general Evidence-based healthcare perspectives will be highlighted as well as directions for future developments. Esta sesión tiene como objetivo destacar la gran relevancia de los trabajos sobre la seguridad del paciente. Se van a presentar los desafíos existentes y las aportaciones realizadas desde la Colaboración Cochrane y más en general, la perspectiva de la atención sanitaria basada en la evidencia. También se destacarán los futuros desarrollos en este campo.

Chairs / Moderadores: Carmen Moya, Agencia de Calidad del Sistema Nacional de Salud. MSPSI; gerard Urrútia, Iberoamerican Cochrane Centre, Spain

Speakers / Ponentes: •Adverseevents innursinghomesandpatient-assistedcentres (EARCAS)

Estudio EARCAS: Seguridad del paciente en los centros sociosanitarios de España. Carlos Aibar, MSPSI-Hospital Clínico Lozano Blesa, Spain.

20 | Wednesday Oct. 19 • Miércoles 19 Oct.

•MethodologicalchallengesforpatientsafetyRetos metodológicos para la seguridad del paciente. Jeremy grimshaw, EPOC Group, Canada.

•Nationalsystemofadverseeventsnotification(SINAPS)Sistema nacional de notificación de eventos adversos (SINAPS). Paula vallejo, Fundación Avedis Donabedian, Spain.

•ApplyingtheGRADEapproachtoreduceadverseoutcomesUtilización del sistema GRADE para reducir los desenlaces adversos. gordon guyatt, Applicability and Recommendation Cochrane Methods Group, Canada.

17:30 – 18:00 OffICIAL OPENINg / INAUgURACIóN OfICIAL: COCHRANE

CONfERENCE / CONfERENCIA Auditorium. T (PCC01)

•Dña. Leire Pajín, Ministra de Sanidad, Política Social e Igualdad (MSPSI), Gobierno de España.

•D. José Martínez Olmos, Secretario General del MSPSI. •Dra. Carmen Moya, Directora General de la Agencia de Calidad del Sistema

Nacional de Salud. MSPSI. •Dra. Mirta Roses, Director of PAHO/OPS •Dr. Jonathan Craig, Co-chair of the Cochrane Collaboration. •Dr. Xavier Bonfill, Director del Centro Cochrane Iberoamericano.

18:00 - 19:30 WORkSHOPS / TALLERES

•NavigatingTheCochraneLibrary (WS58. Room 2b)

TALLERES REDIBAM-gPC

• REDIBAM-GPC: ¿Cómo incorporar la seguridad de los pacientes en laelaboración de GPC? (R01. vIPS)

MEETINgS / REUNIONES

•ApplicabilityandRecommendationsMethodGroup (gOyA)•CochraneDevelopingCountriesField (Closed, gERMANy Boardroom)•Developmental,PsychosocialandLearningProblemsReviewGroupeditorialboard (Closed, OCEANIA)•GermanspeakingContributors(ANTICIS)•ManagingEditors’Executive (Closed, ITALy Boardroom)•MusculoskeletalReviewGroupeditorialstaff(Closed, MENINA)•OccupationalSafetyandHealthReviewGroup (DENMARK Boardroom)•PrognosisMethodsGroup (Room 8)•Promotingevidence-basedrecommendationstomembersofthepublic:the

DECIDE project (AfRICA)•REDIBAM-GPCExecutive (Closed, UNITED KINgDOM Boardroom)•StatisticalMethodsGroup (Room 7)•TheCochraneEmptyReviewsProject:reportoffindingsandconsensus

group feedback (Room 9)•TrialsSearchCo-ordinators’Executive (Closed, PORTUgAL Boardroom)

Wednesday Oct. 19 • Miércoles 19 Oct. | 21

PLENARy SESSION / SESIóN PLENARIACONfERENCE / CONfERENCIA Auditorium.

“Experiencias de los profesionales sanitarios en la aplicación de prácticas seguras” (PCon01)

20:30 WELCOME RECEPTION RECEPCIóN DE BIENvENIDA.

PALACIO DE CIBELES Cuarteto Pagagnini entertainment showEspectáculo de entretenimiento a cargo del Cuarteto Pagagnini. Refreshment / RefrigerioSee Social Events section / Ver sección Actos sociales

© E

:M: P

rom

oció

n de

Mad

rid, S

.A. |

PLA

zA C

IBEL

ES

THURSDAyJUEVES20 OCT.

DAy AT A gLANCE • EL DíA DE UN vISTAzO


9:00Joint Plenary session (with the VI Int. Conference on Patient Safety)Sesión Plenaria conjunta (con la VI Conferencia Int. de Seguridad del Paciente)

10:30 Coffee break & Poster sessionCafé y sesión de pósteres

11:00 Plenary session of the VI Int. Conference on Patient SafetySesión Plenaria de la VI Conferencia Int. de Seguridad del Paciente

11:15

Oral sessionsSesiones orales WorkshopsTalleresPAHO meetingReunión OPS

12:45

LunchAlmuerzoMeetingsReuniones

14:00 WorkshopsTalleres

15:30 Coffee break Café

16:00

Cochrane Annual General MeetingReunión Anual General de la Colaboración Cochrane Plenary session of the VI Int. Conference on Patient SafetySesión Plenaria de la VI Conferencia Int. de Seguridad del Paciente Talleres REDIBAM-GPC WorkshopsMeetingsReuniones

17:30Closing Plenary session : VI Int. Conference on Patient SafetySesión Plenaria de Clausura: VI Conferencia Internacional de Seguridad del Paciente


21:00 Social eventActo social

THU

RSD

AyJU

EVES

20 O

CT.

24 | Thursday Oct. 20 • Jueves 20 Oct.

THURSDAy, OCTOBER 20 JUEVES, 20 DE OCTUBRE

VI INTERNATIONAL CONfERENCE ON PATIENT SAfETyvI CONfERENCIA INTERNACIONAL DE SEgURIDAD DEL PACIENTE(19-20 OCT. 2011)



•ChildHealthField (gOyA)•CochraneConsumerNetwork (AfRICA)•ColloquiumPolicyAdvisoryCommittee (Closed, MENINA)•ComplementaryandAlternativeMedicineField(Room 8)•CONSORTe-assistfocusgroup (UNITED KINgDOM Boardroom)•ConsumersandCommunicationReviewGroupEditors-1stmeeting (Closed, gERMANy Boardroom)

•Ear,NoseandThroatDisordersReviewGroup (Closed, DENMARK Boardroom)

•HaematologicalMalignanciesGroup-Editors (Closed, vIPS)•InternationalSocietyofEvidenceBasedHealthcare (Closed, Room 9)•JointeditorialmeetingoftheAirwaysandAcuteRespiratoryInfectionsReview

Groups (Closed, OCEANIA)•MenstrualDisordersandSubfertilityGroup (Closed, ITALy Boardroom)• Neonatal Review Group (ASIA)• Primary Care Field: Updates, Discussions & More (Room 7)•ProposedCochraneagendasettingandprioritysettingmethodsgroup

(ANTICIS)•PublicHealthReviewGroup (AMERICA)•TrialsSearchCo-ordinators’Executive (Closed, PORTUgAL Boardroom)

09:00 – 10:30 JOINT PLENARy SESSION / SESIóN PLENARIA CONJUNTA COCHRANE

CONfERENCE / CONfERENCIAAuditorium. T

Interventions to reduce adverse events impact on health care (II)Las intervenciones para reducir el impacto de eventos adversos en la atención sanitaria (II) (PCC03)

As the former one, this session also aims to highlight the highly relevant work on patient safety. Challenges will be presented and contributions made from Cochrane, and more general Evidence-based healthcare, perspectives will be highlighted as well as directions for future developments. Como la anterior, esta sesión también tiene como objetivo destacar la gran



Thursday Oct. 20 • Jueves 20 Oct. | 25

relevancia de los trabajos sobre la seguridad del paciente. Se van a presentar los desafíos existentes y las aportaciones realizadas desde la Colaboración Cochrane y más en general, la perspectiva de la atención sanitaria basada en la evidencia. También se destacarán los futuros desarrollos en este campo.

Chairs / Moderadores: yolanda Agra, Agencia de Calidad del Sistema Nacional de Salud. MSPSI, Spain; Amanda Burls, Department of Primary Health Care-Oxford University, UK.

Speakers / Ponentes: •Integrationofasafetyprogrambasedoncontrollinghealth-carerelated

infeccions in Spanish ICUs / Integración de la seguridad del paciente en las UCI españolas mediante programas de control y prevención de infección nosocomial. Mercedes Palomar.Technical Committee of SEMICYUC, Spain.

• How to incorporate non-randomized studies in Cochrane Reviews of patient safety / Cómo incorporar estudios no aleatorizados en revisiones sistemáticas de seguridad del paciente. george Wells. Non-randomized Studies Cochrane Methods Group, Canada.

• Handwashing in Primary Health Care. Collaborative project WHO-MSPSI Higiene de manos en Atención Primaria. Proyecto colaborativo OMS–MSPSI. Benedetta Allegranzi. WHO Patient Safety Programme, Switzerland.

•Knowledgetranslationinpatientsafety / Transferencia del conocimiento en seguridad del paciente. Ivan Solà, Iberoamerican Cochrane Centre, Spain.

10:30 – 11:15 Coffee break Café

POSTER SESSION / SESIONES DE PóSTERES

•Searchingandinformationretrieval (P1A1- P1A55. 1st floor Hall / vestíbulo 1er piso)

•Editorialprocessesandsupportingreviewauthors (P1A56- P1A68. 1st floor Hall / vestíbulo 1er piso; P1B69- P1B80. 2nd floor Hall / vestíbulo 2º piso)

•Globalhealthandequity (P1B81- P1B102. 2nd floor Hall / vestíbulo 2º piso)

•Knowledgetranslationinpatientsafety (P1B103- P1B117. 2nd floor Hall / vestíbulo 2º piso)

•Educationandtraining (P1B118- P1B132. 2nd floor Hall / vestíbulo 2º piso)

•Informationandcommunicationtechnology (P1B133- P1B134. 2nd floor Hall / vestíbulo 2º piso)

11:00 – 12:30 PLENARy SESSION / SESIóN PLENARIACONfERENCE / CONfERENCIAAuditorium. T

“Acciones para la seguridad del paciente en la Unión Europea” “Actions for the patient safety in the European Union”

(PCon02)


12:30 – 14:00 SESIóN PLENARIA / PLENARy SESSION CONfERENCIA / CONfERENCE Auditorium. T

“Los pacientes y ciudadanos ante los retos de la calidad y la seguridad asistencial”“Patients and citizens facing the challenges of care quality and safety” (PCon03)

Moderadores / Chairs: Adoración Carpintero. Red Ciudadana de Formadores en Seguridad del Paciente, MSPSI; Claudia Cattivera. Pacientes Online, Argentina.

Ponentes / Speakers • La Estrategia de Seguridad y Calidad en la Ciudadanía del Sistema Nacional de Salud / The Strategy on Safety and Quality for Citizens of the Spanish Health National System. Jesús Casal, Agencia de Calidad del Sistema Nacional de Salud. MSPSI, España.•Evaluacióndeunaestrategiaformativasobreseguridaddelpacienterealizadapor pacientes / Evaluation of a training strategy for patient safety by patients. Joan Carles March. MSPSI. Escuela Andaluza de Salud Pública, España. • Red Cochrane de Pacientes y Ciudadanos / The Cochrane Consumer Network. Silvana Simi. Grupo Cochrane de Pacientes con Esclerosis Múltiple, Italia.

• La participación de los pacientes en la priorización de la investigación / The involvement of patients in the prioritization of research. Sally Crowe James Lind Alliance, UK.

11:15 – 12:45 ORAL SESSIONS / SESIONES ORALES

• Knowledge translation and communicating evidence (A1) (UNESCO) Chairs / Moderadores: Jose Asua; João Costa Speakers / Ponentes:

•A1O1| Presenting the results of a Cochrane review to policy makers in a video format. Sarah Rosenbaum

•A1O2| Using evidence to stop ineffective practice: The UK Cochrane Centre (UKCC) and the National Institute of Health and Clinical Excellence (NICE) work together. Mary Docherty

•A1O3| Wording GRADEd evidence statements and recommendations. Ilkka Kunnamo

•A1O4| Scientific evidence and practice: bridging the gap. A European Monitoring Center for Drugs and Drug Addiction (EMCDDA) project to promote Best Practice in Drug Addiction field. Marica ferri

• Knowledge translation and communicating evidence (A2) (gOyA) Chairs / Moderadores: José I. Emparanza; Nancy Santesso Speakers / Ponentes:

•A2O1| Impact of reporting the number treated needlessly on perceived effectiveness and decision to adopt an intervention. Ashraf Nabhan

•A2O2| The Use of Synthesis Methods in Support of Developing a New Surveillance Initiative. Lisa Waddell

•A2O3 | Grading evidence and recommendations: randomised experimental evaluation of four grading systems. Carlos Cuello

•A2O4| Understanding subjectivity in the meta-analytic process: Meta-analysts’ variation in managing variability. Ian Shrier


•Education and training (C1) (AMERICA)Chairs / Moderadores: Miranda Cumpston; Pisake LumbiganonSpeakers / Ponentes: •C1O1| Expanding the Cochrane collaboration in low and middle

income countries: a Caribbean experience. Damian francis •C1O2 | Feasibility of recruitment and training of carers of people

with dementia as a route to Cochrane-NHS engagement. Caroline Struthers

•C1O3| A pilot study of an evidence-based practice training program for Filipino physiotherapists: emerging evidence on outcomes and acceptability. Janine Margarita Dizon

•C1O4| Evidence-based medicine training: reaching the front line clinician in an integrated medical care system. Karen Chin

• Global health and equity (C2) (Room 7) Chairs / Moderadores: Elizabeth Waters; Ludovic ReveizSpeakers / Ponentes:

•C2O1| Lack of equity reporting in Cochrane reviews of effectiveness in chronic obstructive pulmonary disease. María Ospina

•C2O2| Synthesizing health systems evidence: the contribution of a network based on North-South collaboration. Tracey Perez

•C2O3| Do we need a PRISMA-Equity extension for systematic reviews? vivian Welch

•C2O4| What’s the story? : The Cochrane Library publicity, global media coverage and author experience. gavin Stewart

• Consumer issues and shared decision making (C3) (ANTICIS) Chairs / Moderadores: Cristina Sampaio; Ruth Stewart

Speakers / Ponentes: •C3O1| Consumer participation in The Cochrane Collaboration –

comparison of two models. gill gyte•C3O2| Spreading Cochrane press releases to lay people and Italian

journalists. Cinzia Colombo•C3O3| Involving young people in all stages of a systematic review.

Kristin Liabo•C3O4| Do Cochrane systematic reviews report patient-important

outcomes? Allison Tong

• Diagnostic test accuracy review methods (B1) (Room 9) Chairs / Moderadores: Rob Scholten; Javier zamora Speakers / Ponentes: •B1O1| QUADAS-2: an updated quality assessment tool for diagnostic

accuracy studies. Penny Whiting •B1O2 | Updating QUADAS: User experience informs the development

of QUADAS-2. Marie Westwood•B1O3| Forecasting Yesterday’s Weather: The Risk of Spectrum Bias

from the Inclusion of Already Diagnosed/Treated Patients in Studies of Depression Screening Tools. Brett Thombs

•B1O4| A novel approach to evaluate the diagnostic accuracy of a sequence of tests. Nicola Cooper


PAHO MEETINg / REUNIóN OPS

•Mirta Roses. PAHO/OPS Director. Developing research systems for public health and global and regional policies. / Desarrollo de sistemas de investigación para la salud pública y las políticas globales y regionales (EUROPE). T


•Developingsearchstrategiesforsystematicreviewsofdiagnostictestaccuracy (WS19, Restricted. Room 2a)

•Structuredpeerreviewofsearchstrategiesforsystematicreviews:PRESSforum and the PRESS checklist (WS71, Restricted. Room 2b)

TALLER DEL JOANNA BRIggS INSTITUTE

•TallerJBICOnNECT+ (The Joanna Briggs Institute Clinical Online Network of Evidence for Care and Therapeutics) (SAT10. Room 8). Workshop in Spanish. No es necesario inscribirse previamente.

12:45 – 14:30 Lunch Almuerzo

Meet the Cochrane entities (1): the Review groupsEncuentro con las entidades Cochrane (1): los grupos de Revisión


•CochraneEpilepsyGroup(Closed, UNITED KINgDOM Boardroom)•CochraneLibraryOversightCommittee (Closed, ITALy Boardroom)•CochraneOfficialBlog (Closed, DENMARK Boardroom)•HealthcareofOlderPeopleField (ASIA)•JointmeetingofConvenorsofthe3CochraneReviewGroupExecutives

(Closed, gERMANy Boardroom)•PrognosisMethodsGroupconvenors (Closed, PORTUgAL Boardroom)

14:00 – 15:30 WORkSHOPS / TALLERES

•An introduction to systematic reviewsof prognosis andprognostic factors(WS4. Room 12)

•Cochranepatientdecisionaids: translatingCochraneevidence forshareddecision making (WS8. ASIA)

•Comparingmultipletreatments1:Overviewsvsstandardinterventionreviews (WS11. Room 7)

•Create‘Summaryoffindings’tables(WS15. fUERTEvENTURA)•DebatingCochrane’sroleinacoldfinancialclimate:experience,problems

and solutions (WS17. AMERICA)•Developingastrategyforassessingtheextentofselectivereportinginprimary

studies when including non-randomised studies (NRS) in a systematic review (WS18. Room 13)

• Diagnostic test accuracy reviews 1: What is a Cochrane diagnostic testaccuracy review? (WS21. Room 8)

•Diagnostic test accuracy reviews 4: Introduction tometa-analysis (WS24. gRAN CANARIA)


•Evidenceforlow-andmiddle-incomecountries:guidanceforCampbellandCochrane reviews (WS31.gOyA)

•Howtoaskananswerablequestionforhealthcareandhealthresearch(WS36. OCEANIA)

•Implementationofcopy-editingstandardsforCochranereviewsandprotocols(WS39, Restricted. ANTARCTICA)

•Introductiontometa-analysis1:Basicideasfornovices (WS42. EUROPE)•Introductiontometa-analysis4:Dealingwithheterogeneity (WS45. MENINA)•Investigatinganddealingwithbiasinsystematicreviews (WS47. ANTICIS)•Makingresultsofpatient-reportedoutcomesinterpretable (WS51, LANzAROTE)•MeasuresofpainandfunctioninSummaryofFindingTables (WS54, vIPS)•Plainlanguagesummaries:themostvaluablepartofaCochranereview

(WS60. LA PALMA)•SearchingforstudiesforinclusioninCochraneReviews (WS65. Room 2a)•Selectingandinterpretingdatafromrelevantstudiesofadverseeffects

(WS68. ITALy Boardroom)•Statisticalissuesformanagingandco-ordinatingeditors:commonerrorsin

reviews, what to look for and how to spot them (WS69. AfRICA)•SystematicreviewsofClinicalStudyReports(CSRs)–aspecialformof

unpublished data (WS73. UNESCO)• Taking workflows to new heights: an advanced workshop for Managing

Editors (WS74, Restricted. Room 2b)•Translatingcriticalappraisalofasystematicreviewtomeaningfulpeer

review (WS79. gERMANy Boardroom)•Usinghealthsystemsevidencetodevelopguidanceforpolicymakerson

health systems strengthening (WS83. Room 9)•WorkshopAGREEII–Appraisalinstrumenttoassessclinicalguidelines

(WS86. TENERIfE)•HowtocompleteaCochraneprotocolforqualitativeevidencesynthesis

(WS37. DENMARK Boardroom) (14:00 – 16:00)• Includingdatafromprotocolsonqualitativeresearchfindings inRevMan-

current version and a wish list (WS40. DENMARK Boardroom) (14:00 – 16:00)


16:00 – 17:30 COCHRANE ANNUAL gENERAL MEETINg REUNIóN ANUAL gENERAL DE LA COLABORACIóN COCHRANE

UNESCO

16:00 – 17:30 PLENARy SESSION / SESIóN PLENARIACONfERENCE / CONfERENCIAAuditorium. T

”Experiencias de las Comunidades Autónomas en la mejora de la seguridad del paciente”“Experiences of the Spanish Autonomous Communities in improving patient safety” (PCon04)

16:00 – 19:30 TALLERES REDIBAM-gPC

•ElaboracãodeindicadoresdesegurançaapartirdasGPCbaseadasemevidência (R02. Room 9) (16:00 – 17:30)


•Evidênciadebaseparaasguiasdesegurançadospacientes:umaanálisemetodológica (R03. Room 9) (18:00 – 19:30)

MEETINgS/ REUNIONES

•ReuniónPlenariaLatinCLEN (AfRICA). •WHOTaskForceonHealthSystemsGuidance(Closed, DENMARK

Boardroom) (16:00 – 19:30)

17:30 – 18:30 SESIóN PLENARIA DE CLAUSURA CLOSINg PLENARy SESSION

CONfERENCIA / CONfERENCE Auditorium. T (PCon05)

• Moderadora / Chair: Dra. Carmen Moya. Directora General de la Agencia de Calidad del Sistema Nacional de Salud. MSPSI.

• Conclusiones de la Conferencia / Conference conclusions.

17:45 – 19:30 SPECIAL WORkSHOPS / TALLERES ESPECIALES

future directions for Cochrane data•UsingtheCochraneRegisterofStudiestodevelopastudy-based

Specialised Register (SWS88. Room 2a)•DevelopingyourSpecialisedRegisterintheCochraneRegisterofStudies

(SWS89. Room 2b)


•EvidenceAid–progresstodate (UNESCO)•ReuniónplenariaRedCochraneIberoamericana (EUROPE)•Thebarriersandfacilitatorstoupdatingsystematicreviews (Closed,

OCEANIA)

21:00 DINNER AND fLAMENCO SHOW CENA y ESPECTáCULO fLAMENCO

florida Park Restaurant (Parque del Retiro)See Social Events section / Ver sección Actos sociales


© E

:M: P

rom

oció

n de

Mad

rid, S

.A.

Flamenco is an artistic expression fusing song (cante), dance (baile) and musicianship (toque), born in Andalusia (a southern region in Spain).

Cante is the vocal expression of flamenco, sung both by men or women, preferably seated, with no backing singers. The gamut of feelings and states of mind (grief, joy, tragedy, rejoicing, fear) are expressed through simple, sincere, and expressive lyrics.

Flamenco baile is a dance of passion and courtship, and also expresses a wide range of situations. The technique is complex, differing depending on whether the performer is male (heavier use of the feet) or female (more sensual movements).

Toque or the art of guitar playing has long surpassed its original role as accompaniment to cante. This instrument can be accompanied by other instruments and is the responsible of the fusion with other musical genres. The fusion of flamenco guitar with genres such as jazz music has contributed to spread its language worldwide thanks to Paco de Lucía, Camarón de la Isla’s cante, or the choreography of Antonio Gades or Carmen Amaya.

Flamenco is the badge of identity of numerous communities, in particular the Gitano (Roma) ethnic community, which has played an essential role in its transmission, preservation, and dissemination. These popular roots deserved the declaration in 2010 of one of the UNESCO’s Masterpieces of the Oral and Intangible Heritage of Humanity.

SOURCE: UNESCO – Intangible Heritage Lists

El flamenco es una expresión artística de origen andaluz resultante de la fusión de la música vocal, danza y acompañamiento musical (denominados cante, baile y toque).

El cante flamenco lo interpretan tanto hombres como mujeres, generalmente en solitario. A partir de letras sencillas, generalmente de raíz popular, expresa toda una gama de sentimientos y estados de ánimo (pena, alegría, tragedia, regocijo, temor).

El baile flamenco es apasionado y seductor, y también expresa toda una serie de emociones. Su técnica es compleja y su interpretación diferente dependiendo de si lo baila un hombre (con un estilo más contundente) o una mujer (con movimientos más sensuales).

El toque de la guitarra flamenca ha evolucionado desde su primitiva función de acompañamiento del cante a una voz propia dentro de este género. Este instrumento se acompaña con otros instrumentos y es el que ha contribuido en mayor medida a la fusión del flamenco con todo tipo de estilos musicales. Esta fusión de la guitarra flamenca con estilos como el jazz contribuyó a que el género se internacionalizara gracias a maestros como Paco de Lucía, voces como las de Camarón de la Isla, o estilos coreográficos como los de Antonio Gades o Carmen Amaya.

El flamenco es un signo de identidad para numerosos grupos populares, encabezados por la comunidad étnica gitana que ha desempeñado un papel esencial en su evolución, transmitiendo a través de generaciones el respeto por este arte, y la determinación para preservarlo y difundirlo. Este carácter popular le mereció en el año 2010 la proclamación de Patrimonio Cultural Inmaterial de la UNESCO.

Fuente: Listado de Patrimonios Culturales Inmateriales de la UNESCO

© E

:M: P

rom

oció

n de

Mad

rid, S

.A. |

ED

IfIC

IO A

BC

fRIDAyVIERNES

21 OCT.

DAy AT A gLANCE • EL DíA DE UN vISTAzO

7:30

MeetingsReunionesWorkshopsTalleres

9:00 Plenary sessionSesión Plenaria


11:15 Oral sessions Sesiones orales

12:45 LunchAlmuerzo


15:30 Coffee breakCafé

15:45 Special parallel sessionSesión paralela especial


17:45

MeetingsReuniones

WorkshopsTalleresFree EveningNoche libre

fRID

AyVI

ERN

ES21

OC

T.

34 | Friday Oct. 21 • Viernes 21 Oct.

fRIDAy, OCTOBER 21VIERNES, 21 DE OCTUBRE

07:30 – 08:55 MEETINgS / REUNIONES

•AnaesthesiaReviewGroup (OCEANIA)•CampbellandCochraneEquityMethodsGroup (gOyA)•CochraneAdverseEffectsMethodsGroup(Room 7)•ConsumersandCommunicationReviewGroupEditors-2ndmeeting

(Closed, ITALy Boardroom)•EditorialResourcesCommittee (Closed, gERMANy Boardroom)•EffectivePracticeandOrganisationofCareGroup (Room 8)•EROS:isittheweb-basedsoftwaredevelopedtofacilitatetheinitialphases

of a Cochrane systematic review? (Room 9)•InformationRetrievalMethodsGroup(AMERICA)•MonitoringandRegistrationCommittee (Closed, DENMARK Boardroom)•PregnancyandChildbirthReviewGroup (ANTICIS)•PROSPEROadvisorygroup (Closed, PORTUgAL Boardroom)•QualitativeResearchMethodsGroup (vIPS)•UScontributors (Closed, AfRICA)


•Entitywebsitebuilder:Makingthemostofyourentity’sonlinepresence(WS28. Room 2b)

09:00 – 10:30 PLENARy SESSION / SESIóN PLENARIACOCHRANEAuditorium. T

Using evidence to improve health systems El uso de la evidencia para mejorar los sistemas de salud (PCol02)

Research evidence on system-level interventions for health will be presented as clear guidance to inform health policy. While the methods and approaches to produce and implement clinical guidelines are well established, the development of the actual recommendations poses several conceptual and methodological challenges. Se presentarán los resultados de intervenciones a distintos niveles para informar las políticas de salud. Si bien los métodos y enfoques para producir y poner en práctica las directrices clínicas están bien establecidos, el desarrollo de las recomendaciones actuales plantea varios desafíos conceptuales y metodológicos.




Friday Oct. 21 • Viernes 21 Oct. | 35

Chairs / Moderadores: zulma Ortiz, UNICEF, Argentina; Karla Soares-Weiser, Enhanced Reviews Ltd., Speakers / Ponentes:• What types of evidence are needed to inform decisions about health systems?

Andy Haines •Developingevidence-informedguidanceonhealthsystems:thechallengesof

complexity and context. Xavier Bosch-Capblanch • Using evidence to inform decision making on health systems in LMICs: what evidence do policymakers need? Harriet Nabudere


POSTER SESSION / SESIóN DE PóSTERES

•Methodsforpreparingreviews (P2A135-P2A196. 1st floor Hall / vestíbulo 1er piso)

• Investigatingbias (P2A197-P2A202. 1st floor Hall / vestíbulo 1er piso; P2B203-P2B260. 2nd floor Hall / vestíbulo 2º piso)

•Diagnostictestaccuracyreviewmethods (P2B261- P2B271. 2nd floor Hall vestíbulo 2º piso)

SESIóN DE PóSTERES LATINCLEN

• Sesión 1: L1-L10. (vestíbulo 2º piso / 2nd floor Hall)Moderadores: Adolfo Rubinstein; Pamela Serón.

11:15 – 12: 45 ORAL SESSIONS / SESIONES ORALES

• Knowledge translation and communicating evidence (A3) (UNESCO)Chairs / Moderadores: Claire glenton; gunn E. vistSpeakers / Ponentes:

•A3O1| Cross-sectional study of abstract quality. Sandra Bierling•A3O2| Reporting of effect direction and size in abstracts of systematic

reviews. Ellaine Beller• A3O3 | Investigating and improving the understanding of Cochrane

Diagnostic Test Accuracy Reviews (DTARs). zhelev zhivko•A3O4| To what extent is the clinical context considered in diagnostic

test accuracy (DTA) reviews?: A methodological review. Clave Davenport

• Knowledge translation and Education (A4) (ANTICIS)Chairs / Moderadores: Ricardo Hidalgo; M. Regina TorloniSpeakers / Ponentes:

•A4O1| Epidemiology, Quality and Reporting Characteristics of Systematic Reviews of Acupuncture Interventions Published in Chinese Journals. yaolong Chen

•A4O2| Credence: creation of reliable evidence in developing countries by continuous enabling. Manu Easow Mathew

•A4O3 | Turning knowledge into action: Translating Cochrane reviews in the healthcare setting. Marguerite Koster

•A4O4| Understanding how meta-analysts interpret meta-analyses. Ian Shrier


• Knowledge translation in patient safety (A6) (AMERICA) Chairs / Moderadores: Hernando gaitán; Megan PrictorSpeakers / Ponentes:

•A6O1| Implementation and evaluation of an international standardized operating protocol for the prevention of wrong site surgery in Germany. Liat fishman•A6O2| Warnings for serious adverse events in drug labelling: are same-class drugs treated the same? Evangelia Ntzani•A6O3| An investigation into the assessment and reporting of harms in clinical studies. Jamie Kirkham•A6O4| What is a rapid review? Julie Harker

• Searching and information retrieval (B2) (Room 7)Chairs / Moderadores: gabriel Rada; Deirdre BeecherSpeakers / Ponentes:

•B2O1| Study selection by means of a web-based Trial Selection DataBase (webTSDB). Elke Hausner•B2O2| Assessing the completeness of systematic reviews via the “related articles” function and/or a simple structured Boolean search in PubMed – a pilot study. Siw Waffenschmidt•B2O3| Primary outcomes reported in abstracts and ClinicalTrials.gov – do they agree? Lynn Huynh•B2O4| PRISMA in practice: keeping track of the literature search documentation. What are the problems? Mala Mann

• Methods for preparing reviews (B4) (Room 8)Chairs / Moderadores: Philippe Ravaud; Arturo MartíSpeakers / Ponentes:

•B4O1| The proposed Cochrane agenda setting and priority setting methods group: Establishing a research program. Mona Nasser•B4O2| Evaluating priority-setting approaches: tools for a Cochrane Methodology Review. Mona Nasser•B4O3| Modifications to the Risk of Bias tool: a case study of 204 trials. Lisa Hartling•B4O4 | Consensus-based recommendations for investigating clinical heterogeneity in systematic reviews. Joell gagnier

• Investigating bias (B7) (Room 9)Chairs / Moderadores: Peter gøtzsche; Pablo PerelSpeakers / Ponentes:

•B7O1 | A descriptive analysis of risk of bias in neonatal trials and the association with effect estimates. Lisa Bialy•B7O2| Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiological study. Isabelle Boutron•B7O3| PROSPERO: An international prospective register of systematic review protocols. Alison Booth•B7O4| Characteristics of physicians who receive large payments from industry and the accuracy of their disclosures in concurrent publications. Susan Norris


• SPECIAL SESSION: future directions for Cochrane data (S1) (gOyA)Chairs / Moderadores: David Tovey; Ruth foxleeSpeakers / Ponentes:

•S1O1| Opening presentation: an exploration of where we are and where we could be in five to ten years. An introduction to the work of the CENTRAL Development Committee, the development of the CRS, and the possibilities for doing more with our data (David Tovey, Editor in Chief of The Cochrane Library)•S1O2| Value-adding with the CRS (Ruth foxlee, Cochrane Editorial

Unit; and gordon Dooley, Managing Director of Metaxis, UK)•S1O3| Examining the potential value of the Systematic Review Data

Repository (SRDR) to Cochrane (Stanley Ip, Tufts Medical Center, USA)

•S1O4| Data linking: the next dimension. A report from the Star Trek Crew (Chris Mavergames, Manager of the Cochrane Web Team)

OTRAS SESIONES ORALES

•REDIBAM-gPC (1):“guías, evidencias y seguridad del paciente”. (vIPS)Moderadores: Airton Stein; Dolors Montserrat

• LatinCLEN (1):“Investigación primaria en Iberoamérica” (EUROPA)Moderadores: Ana Mª Alarcón; Agustín Ciapponi.Ponentes:

•SíntomasdepresivosycargasubjetivadelCuidadorPrimarioinformaldel Paciente con EVC. Laura Torres

•Diferencias en la frecuencia de la morbilidad cuando se aplica unprotocolo de aspiración endotraqueal a necesidad comparado con uno de aspiración rutinaria en la unidad de cuidado intensivo pediátrica del Hospital Pablo Tobón Uribe: un ensayo clínico controlado al azar. gloria Lema

• Estudio de detección y seguimiento de riesgo cardiovascular en elCono Sur (CESCAS I): Resultados preliminares sobre prevalencia y distribución de factores de riesgo cardiovascular (FRCV). Adolfo Rubinstein.

•Característicasclínicasyepidemiológicasdeunapoblacióncondolorlumbar subagudo en la ciudad de Medellín: sus índices de dolor, depresión, discapacidad y su calidad de vida relacionada con la salud y la concordancia de la Escala análoga visual y el componente de dolor corporal de la SF36. Jesús Plata

•Análisisdeladoblelecturamamográficaenelcribadopoblacionaldecáncer de mama del Hospital de la Santa Creu i Sant Pau de Barcelona, España. Margarita Posso

• Prevención del sangrado postoperatorio: Ensayo clínico unicéntrico,aleatorizado, paralelo de cuatro brazos de tratamiento, que evalúa la eficacia de la cola de fibrina y el ácido tranexámico versus el tratamiento de hemostasia habitual en pacientes intervenidos de artroplastia total de rodilla. Mª José Martínez

12:45 – 14:00 Lunch Almuerzo

Meet the Cochrane entities (2): the Centres, fields and Methods groups Encuentro con las entidades Cochrane (2): los Centros, ámbitos y grupos de Métodos



Implementing the evidence into the systemLa incorporación de la evidencia en el sistema (PCol03) There are several barriers to implementing evidence based practice into the healthcare system. These barriers are multifaceted; they can be methodological (i.e. how evidence is presented), organizational (i.e. how the system is oriented to implement evidence), or socio-cultural (i.e., whether the results are culturally acceptable). Existen varias barreras para la incorporación de la práctica basada en la evidencia en el sistema sanitario. Estas barreras son múltiples, ya que pueden ser metodológicas (por ejemplo, cómo se presenta la evidencia), organizativas (es decir, cómo el sistema está configurado para aplicar las evidencias), o socio-culturales (ej. si los resultados son culturalmente aceptables).

Chairs / Moderadores: vivian Welch, Campbell & Cochrane Equity Methods Group; Pablo Alonso-Coello, Centro Cochrane Iberoamericano

Speakers / Ponentes:•HowGRADEcouldhelptoimplementtheevidence.Holger Schünemann •ImplementingNICEClinicalPracticeGuidelines. fergus Macbeth •Usingtheevidencetoinformpractice. francisco Kovacs. •EvidenceinLMIC.Susan Munabi-Babigumira



•AConversationonStandardsfortheConductofSystematicReviews (WS1. gOyA)

•AdvancedSearchinginTheCochraneLibrary (WS3. Room 2a)•Classifyingnon-randomisedstudies(NRS)andtheassessingtheriskofbias

for a systematic review (WS7. ASIA)•CochraneReviewGroupCollaborationWithUKClinicalGuidelineDevelopers:

A Win-Win Situation (WS9. gRAN CANARIA)•Comparingmultipletreatments2:anintroductiontonetworkmeta-analysis

(WS12. UNESCO)• Core outcome measures for randomised controlled trials and Cochrane

reviews (WS14. OCEANIA)•Diagnostic testaccuracy reviews3:Assessmentofmethodologicalquality

(WS23. Room 7)•Diagnostic testaccuracy reviews5:Advancedmeta-analysis:dealingwith

heterogeneity and test comparisons (WS25. Room 8)•EstablishingasuccessfulCochraneReviewGroupsatellite(WS30,

Restricted. ANTICIS) •Extrapolation:applyingtheresultsfromsystematicreviewstowhom,when,

and how? (WS32. AMERICA)•Goingfromevidencetocoveragedecisions(WS33. Room 12)•Gradingthequalityofevidenceandpreparing‘Summaryoffindings’tables

for diagnostic test accuracy reviews (WS34, EUROPE)•Howshouldwewriteupthestatisticalresultsofmeta-analysesinthetextand

abstract of a Cochrane systematic review? (WS35. Room 9)


• How to develop brief economic commentaries for Cochrane interventionreviews (WS38. Room 13)

•Introductiontometa-analysis2:Effectmeasuresfordichotomousoutcomes(WS43. LA PALMA)

• Introduction tometa-analysis 5: Including non-standard studies and non-standard data (WS46. LANzAROTE)

•MakingapodcastforaCochranereview (WS50. ANTARCTICA)•Maximisingtheimpactofsystematicreviewsinhealthpolicy-making:methods

and challenges (WS53. vIPS)•Methodsforinvolvingconsumersinsystematicreviews (WS57,

fUERTEvENTURA)•PeerreviewingthesearchstrategyforaCochranediagnostictestaccuracy

systematic review (WS59, Restricted. DENMARK Boardroom)• Search strategies and data sources for adverse effects reviews (WS64.

gERMANy Boardroom)•Searchingtrialsregistersandtrialsresultsregisters (WS66. ITALy Boardroom)•Searching,samplingandselectingforqualitativeevidencesynthesis (WS67.

TENERIfE)•Statisticalmethodsforindividualparticipantdatameta-analysis (WS70. MENINA)•TheupdatedCochraneRiskofBiastool (WS78. AfRICA)•UsingGRADEprotocreate‘Summaryoffindings’tables (WS82. Room 2b)

17:45-19:15 SPECIAL WORkSHOPS / TALLERES ESPECIALES

future directions for Cochrane data• CENTRAL & the CRS: a discussion and policy-setting session (SWS90.

gOyA)Chairs / Moderadores: Ruth foxlee; David Tovey. Cochrane Editorial Unit


•BasicsofusingtheworkflowsysteminArchie(WS6. Room 2a)•Referencemanagementforsystematicreviews (WS62, Restricted. Room 2b)


•CochraneInjuriesGroup (ANTICIS)•Consumers’Executive (Closed, PORTUgAL Boardroom)•DiagnosticTestAccuracyWorkingGroup (Closed, Room 8)•Evidence-InformedPolicyNetworkAmericas (Closed, UNITED KINgDOM

Boardroom)•EyesandVisionGroup (Closed, gERMANy Boardroom)•FieldsExecutive-2ndmeeting (Closed, ANTARCTICA)•Fromevidencetopoint-of-careguidelinesincollaboration (vIPS)•IndividualPatientDataMethodsGroup (ITALy Boardroom)•IsitworthincludingNon-RCTsinCochraneReviews? (OCEANIA)•MethodsApplicationandReviewStandardsWorkingGroup (Closed,

DENMARK Boardroom)•NursingCareField (Room 7)•OralHealthGroup(Room 9)•Patient-ReportedOutcomesMethodsGroup(AMERICA)•ReuniónPlenariaREDIBAM-GPC (AfRICA)•RiskofBiasToolExtension (Closed, MENINA)

fREE EVENINg / NOCHE LIBRESee our recommendations in Visitor tips sectionConsulte nuestras recomendaciones en la sección Consejos para el visitante

© E

:M: P

rom

oció

n de

Mad

rid, S

.A. !

MER

CA

DO

DE

SAN

MIg

UEL

SATURDAySÁBADO22 OCT.

DAy AT A gLANCE • EL DÍA DE UN VISTAZO

7:30

MeetingsReuniones

WorkshopsTalleres



11:15

Oral sessionsSesiones orales

WorkshopsTalleres

12:45 LunchAlmuerzo



16:45 Closing sessionSesión de Clausura


21:00 Gala dinner and farewell party Cena de gala y fiesta de despedida

SATU

RD

AySÁ

bA

DO

22 O

CT.

42 | Saturday Oct. 22 • Sábado 22 Oct.

SATURDAy, OCTOBER 22SÁBADO, OCTUBRE 22


•Canadiancontributors (vIPS)•CochraneEngagementAwardrecipients-2ndmeeting (Closed, DENMARK

Boardroom)•ComparingMultipleInterventionsMethodsGroup (AfRICA)•LungCancerGroup(Closed, gERMANy Boardroom)•ManagingEditors’Executive (Closed, ITALy Boardroom)•ScreeningandDiagnosticTestsMethodsGroup (Room 9)•TrainingWorkingGroup (Closed, OCEANIA)•ItalianCochraneNetwork (ANTICIS)


•EffectivesearchingofLILACSdatabaseforsystematicreviews (WS27. Room 2b)

• InformationManagementSystemworkshopfor theCochraneTrialSearchCo-ordinators (WS41, Restricted. Room 2a)


The challenges of reviewing science in the XXI century Los retos de revisar la ciencia en el siglo XXI. (PCol04)

Systematic reviews are critical for advancing knowledge from what is currently known and practiced. However, methods of reviewing are constantly evolving. There is a requirement to improve our understanding as methods develop and also to consider and explore alternative sources of evidence. Are we ready for reviewing the science of the XXI century? Las revisiones sistemáticas son fundamentales para avanzar en el conocimiento de lo que actualmente se conoce y se practica. Sin embargo, los métodos de revisión están en constante evolución. Debemos mejorar nuestra comprensión de los métodos en desarrollo y también estudiar y explorar fuentes alternativas de evidencias. ¿Estamos listos para revisar la ciencia del siglo XXI?

Chairs / Moderadores: Sophie Hill, Consumer and Communication Cochrane Review Group; graziella filipini, Multiple Sclerosis Cochrane Review Group.

Speakers / Ponentes:•Geometryoftheevidence:retrospectiveandprospectiveagenda-wideviews

of research. John Ioannidis, Stanford University




Saturday Oct. 22 • Sábado 22 Oct. | 43

• MECIR: new quality standards for Cochrane reviews. Julian Higgins, Cochrane Methods Board.

•Patientcenteredprioritizationofresearch. Sally Crowe, James Lind Alliance. •IncorporatingeconomicperspectivesintoCochranereviews. Dawn Craig,

Economic Methods Group.


POSTER SESSION / SESIóN DE PóSTERES

• Knowledge translation and communicating evidence (P3A272- P3A332. 1st floor Hall / vestíbulo 1er piso; P3B333- P3B345. 2nd floor Hall / vestíbulo 2º piso)

•Statisticalmethods (P3B346- P3B381. Hall 2st floor / vestíbulo 2º piso)•Consumerissuesandshareddecisionmaking (P3B382- P3B400. 2nd floor

Hall / vestíbulo 2º piso)

SESIóN DE PóSTERES LATINCLEN

• Sesión 2: L11-L19. (vestíbulo 2º piso / 2nd floor Hall) Moderadores: Ignasi Bolíbar; Carlos vallejos

11:15 – 12:45 ORAL SESSIONS / SESIONES ORALES

• Knowledge translation and communicating evidence (A5) (UNESCO)Chairs / Moderadores: gerd Antes; Marcelo garcía DiéguezSpeakers / Ponentes:

•A5O1 | What do we know about interpretation and application of test accuracy measures? Clave Davenport

•A5O2| The challenge of assessing quality of evidence generated from mixed treatment comparisons and a potential solution. Jo Dunville

•A5O3|Communicating Cochrane: An update on the Collaboration’s communications initiative. Lori Tarbett

•A5O4| Approaches to Estimate and Present Baseline Risks: Recommendations for Cochrane Review Summary of Findings (SoF) Tables. Jill Hayden

• Methods for preparing reviews (B5) (gOyA)Chairs / Moderadores: Rachel Churchill; Marie-Pierre gagnonSpeakers / Ponentes:

•B5O1| Intensity of a public health intervention in a systematic review: Assessing it. Philip Baker

•B5O2| The implications of different intervention definitions on a network meta-analysis of acupuncture and other physical therapies for the relief of chronic pain due to osteoarthritis of the knee. Stephen Rice

•B5O3| Latent class bivariate model for the meta-analysis of diagnostic test accuracy studies. Paolo Eusebi

•B5O4 | A new strategy for meta-analysis of continuous covariates in observational studies. Willi Sauerbrei


• Investigating bias (B8) (AMERICA)Chairs / Moderadores: Lorenzo Moja; Dario SambunjakSpeakers / Ponentes:

•B8O1 | Can trial quality be reliably assessed from a trial publication? Claire vale

•B8O2| Inter-rater reliability of a new instrument for assessing potential for bias in prognosis studies. Kim Peterson

• B8O3 | Risk of Bias Assessment tool for Non-randomized Studies (RoBANS): Development and Validation of a New Instrument. Soo young

•B8O4| Initial experience with a pilot Cochrane tool for assessing risk of bias for non-randomized studies applying a web-based survey of content experts to derive criteria for imbalance. Philip Dahm

• Searching and information retrieval (B3) (Room 7)Chairs / Moderadores: Robert Wolff; veronica AbdalaSpeakers / Ponentes:

•B3O1| Screen2Go : a pilot smartphone app for citation screening. Kit Huckvale

•B3O2| Could a search for a diagnostic test accuracy review be restricted to MEDLINE? Annefloor vanenst

•B3O3| Endorsement of the ICMJE’s clinical trial registration policy by biomedical journals: A survey of instructions for authors. Lotty Hooft

•B3O4| A systematic review of studies that develop or evaluate search filters for the retrieval of diagnostic studies in MEDLINE. Mariska Leeflang

• Editorial processes and supporting review authors (C4) (Room 8)Chairs / Moderadores: Ian Roberts; Sera TortSpeakers / Ponentes:

•C4O1 | National Institute of Health Research (NIHR) CC Programme Grant Scheme - Gynaecological Cancer Review Group. gail Quinn

•C4O2| Testing selective responses of Cochrane groups to the request of conducting a Cochrane systematic review: A Crossover Randomized Controlled Trial. Agustín Ciapponi

• C4O3 | Impact, Accountability, and Sustainability of the Cochrane Prioritization Project – Eyes and Vision Group Experience. Tiajing Li

•C4O4| Capacity building in systematic review in South Asia: a South-North collaboration to expand the production and translation of synthesized evidence. Tracey Pérez

• Statistical methods in meta-analysis (B6) (Room 9)Chairs / Moderadores: Regina Kunz; Marta Roqué Speakers / Ponentes:

•B6O1 | Graphical augmentations to the funnel plot for assessing the impact of additional evidence on a meta-analysis. Alex Sutton

• B6O2 | Bayesian approach to meta-analysis. What can you gain? Mateusz Nikodem

•B6O3| A Bayesian selection model for incorporating prior information for publication bias in meta-analysis. Dimitris Mavridis

• B6O4 | The implications for meta-analysis of different methods of analysing count data. Peter Herbison


OTHER ORAL SESSIONS / OTRAS SESIONES ORALES

• REDIBAM-GPC (2): “Gestión de catálogos institucionales de experiencias de gPC basadas en la evidencia. (ASIA)

Moderadores: Mario Tristán; Cesar Cárcamo.

• LatinCLEN (2): “Investigación secundaria para la toma de decisiones en salud”. (vIPS)

Moderadores: Eddy Rios; Lucieni Conterno Ponentes: •EvaluacióndelacalidaddelasGuíasdePrácticaClínicasobreRehabilitaciónCardiaca. Pamela Serón•EsquemasecuencialVpi/Vpocontra lapoliomielitis: revisiónsistemáticaymeta-análisis. Agustín Ciapponi• Revisión sistemática sobre la eficacia y seguridad de la acupuntura conagujas en el tratamiento de los trastornos gineco-obstétricos. Revisión global (overview). Anna Selva •Análisiscosto-efectividadsectorialde45intervencionessanitariasenChile.Carlos vallejos•Factoressociodemográficos,económicos,conductualesydesaludpercibidacomo determinantes de acceso y utilización de servicios de salud en la Argentina: un análisis de la primera Encuesta Nacional de Factores de Riesgo (ENFR). Adolfo Rubinstein.•Estudio de cumplimiento de las intervenciones diagnósticas, terapéuticasy de seguimiento de 15 guias clínicas por parte de los equipos de salud chilenos. Pedro Lorca

SPECIAL WORkSHOPS / TALLERES ESPECIALES

•Clarifyingmethodsandprotocoldesignissuesforsystematicreviewsthatincorporate evidence from econometric analyses (SWS91. EUROPE)


• A measurement tool to assess the methodological quality of systematicreviews of non-randomized studies (AMSTAR NRS) (WS2. UNESCO)

•Assessing theriskofoutcomereportingbias insystematicreviews (WS5. AfRICA)

•CommentingonaCochraneplainlanguagesummary (WS10. Room 13)• Comparing multiple treatments 3: statistical methods for network meta-

analysis (WS13. gRAN CANARIA)•CrossCheck(plagiarism)surgery (WS16.LA PALMA)• Development of a CONSORT extension for randomised controlled trials

evaluating complex behavioural change and psychological interventions (WS20. LANzAROTE)

•Diagnostictestaccuracyreviews2:Searchingfordiagnostictestaccuracystudies – review authors and information specialists working in partnership (WS22, Restricted. Room 2a)

•Diagnostictestaccuracyreviews6:PresentingandinterpretingresultsofDTAmeta-analysis (WS26. TENERIfE)

•Equity101:whatequitycandoforyou! (WS29. EUROPE )• Introduction to meta-analysis 3: Meta-analysis of continuous outcomes

(WS44. MENINA)•Investigatingclinicalheterogeneityinsystematicreviews (WS48. ANTICIS)•Meta-analysisofcontinuousoutcomes:helpingreviewauthorsnegotiatethe

change score versus final value debate (WS55. Room 9)


•MethodologicalExpectationsofCochraneInterventionReviews(MECIR)–Searching for Studies (WS56, Restricted. Room 7)

•Preparingmaterialstohelprunajournalclub (WS61. Room8)•RevMan5.1forCochraneInterventionreviewauthors–learntouseallthe

features hands-on (WS63. Room 2b)•Testingforexcessstatisticalsignificance(WS75. AMERICA)•Textanalysistoolsforinformationretrieval(WS76. ANTARCTICA)•ThecomplexandchallengingmandateofCochraneFields:a trainingand

support workshop (WS77. OCEANIA)•UpdatingCochraneReviews:findingsofanNHSengagementprojectand

future updating options (WS80. vIPS)•UsingGRADEtoassessthequalityofevidenceforpublichealthsystematic

reviews (WS81. Room 12)• Using systematic reviews to inform policymaking: the experience of

Evidence-Informed Policy networks (EVIPNet) in the Americas (WS84. fUERTEvENTURA)

• Using the Cochrane Event Manager for Colloquia, Symposia and otherCochrane meetings (WS85, Restricted. DENMARK Boardroom)

•WorkshopforManagingEditorsandAssistantManagingEditors:ourpursuitsaren’t trivial (WS87, Restricted. gOyA)

•‘Summaryoffindings’tables:Discussionofpracticalissues (WS72. ASIA)

15:45 – 17:00 PLENARy SESSION / SESIóN PLENARIACOCHRANE Auditorium. T

Designing a sustainable evidence-based health care in times of crisis Diseño de una atención sanitaria sostenible y basada en la evidencia en tiempos de crisis. (PCol05)

There is a continuous threat of social crises, economic downturns, or natural disasters. Any talk about the future seems to lead to the ongoing concerns for health systems in the world. Are we ready to deal with this perspective of crisis more or less permanent? Is research designed and prepared to survive in health care systems in crisis? Different perspectives from economists to politicians and researchers will provide some insight into how evidence could be obtained and used to help sustain a health care system in a crisis context.Existe una amenaza constante de crisis sociales, económicas o desastres naturales. Cualquier conversación sobre el futuro parece mediatizada por las preocupaciones que persisten para los sistemas de salud de todo el mundo. ¿Estamos preparados para hacer frente a esta perspectiva de crisis más o menos permanente? ¿Está diseñada la investigación para sobrevivir en unos sistemas de salud en crisis? Diferentes perspectivas, desde las de los economistas a los políticos e investigadores, apuntarán cómo podría obtenerse y usarse la evidencia para ayudar a hacer sostenible el sistema de salud en un contexto de crisis.

Chairs / Moderadores: Mark Petticrew, UK; Isabelle Boutron, France.

Speakers / Ponentes: •Comparativeeffectivenessresearch. Kay Dickersin, Director, US Cochrane Center.• Rafael Bengoa, Health Minister, Basque Country Government. Spain.•vicente Ortún, Dean, Faculty of Economic Science and Business. Universitat Pompeu Fabra, Spain.


17:00 – 17:45 CLOSINg SESSION / SESIóN DE CLAUSURA:COCHRANE (PCol06)Auditorium. T

•Jeremy grimshaw, Co-Chair of the Cochrane Collaboration•Xavier Bonfill, Director of the Iberoamerican Cochrane Centre • See you at Nanning Colloquium 2012• Thomas Chalmers Award• PAHO-Cochrane award “Strengthening health systems in the Americas”


•BiasMethodsGroup (vIPS)•CochraneWebStrategy (Closed, DENMARK Boardroom)•MusculoskeletalReviewGroup (AfRICA)•OPENProject (Closed, Room 9)

21:00 gALA DINNER AND fAREWELL PARTy CENA DE gALA y fIESTA DE DESPEDIDA

Palacio de CongresosMusic and Dance Festival. See Social Events section. Festival de música y baile. Ver sección Actos sociales.

© E

:M: P

rom

oció

n de

Mad

rid, S

.A. |

MU

SEO

DEL

PR

AD

O

WORKSHOpSTALLERES

WORkSHOPSTALLERES

OTHEROTROS

SPECIAL WORkSHOP

SATELLITE WORkSHOPSTALLERES SATéLITE

TALLERES REDIBAM-gPC

WO

Rk

SHO

PSTA

LLA

RES

50 | workshops • talleres

WORKSHOpSTALLERES

WS1| A CONVERSATION ON STANDARDS fOR THE CONDUCT Of SySTEMATIC REVIEWS

Date/ Time/ Place: Friday 21 / 16:00 / gOyACategory: Other methods for preparing systematic reviewsMethods group: Not applicableType: DiscussionLevel: Anyfacilitators: Christopher Schmid, Tufts University, USA; Jeremy Grimshaw, Ottawa Hospital Research Institute, Canada; Mark Helfand, Oregon Health and Science University, USA; David Tovey, Cochrane Collaboration, UK; Rachel Churchill, Cochrane Collaboration, UKOther contributors: Kay Dickersin, Johns Hopkins University, USA; Sally Morton, University of Pittsburgh, USA; Jesse Berlin, Johnson and Johnson, USATarget audience: Co-ordinating Editors, Managing Editors, Trials Search Co-ordinators, Consumers, review authors, knowledge users

WS2 | A MEASUREMENT TOOL TO ASSESS THE METHODOLOgICAL QUALITy Of SySTEMATIC REVIEWS Of NON-RANDOMISED STUDIES (AMSTAR NRS)

Date/ Time/ Place: Saturday 22 / 14:00 / UNESCOCategory: Investigating biasMethods group: Non-Randomised Studies Methods GroupType: TrainingLevel: Anyfacilitators: Beverley Shea, CIET, Canada; George Wells, University of Ottawa, CanadaOther contributors: David Moher, University of Ottawa, Canada; Barney Reeves, Non-Randomised Studies Methods Group, UK; David Henry, Institute for Clinical Evaluative Science (ICES), Canada; Peter Tugwell, University of Ottawa, Canada; Neil Andersson, CIET, CanadaTarget audience: Review authors

(All the workshops abstracts are available in the Colloquium abstracts book Todos los resúmenes de los talleres están disponibles en el libro de resúmenes del Colloquium)

• Workshops marked with the symbol “ J” provide a basic suite of trainings likely to be relevant to anyone conducting a Cochrane intervention review.

• Lostalleresmarcadosconelsímbolo“J”ofrecenunentrenamientoquepuedeseratractivoacualquiera que lleve a cabo una revisión de intervención Cochrane.

• Workshops marked with the symbol “ ” include hands-on training in the computer lab.

• Los talleres marcados con el símbolo “ ” incluyen prrácticas en la sala de ordenadores.

workshops • talleres | 51

WS3 | ADVANCED SEARCHINg IN THE COCHRANE LIbRARy

Date/ Time/ Place: Friday 21 / 16:00 / Room 2aCategory: Knowledge translation and communicating evidenceMethods group: Not applicableType: TrainingLevel: Intermediatefacilitators: Colleen Finley, John Wiley & Sons, USATarget audience: Review authors, Consumers, researchers

WS4 | AN INTRODUCTION TO SySTEMATIC REVIEWS Of PROgNOSIS AND PROgNOSTIC fACTORS

Date/ Time/ Place: Thursday 20 / 14:00 / Room 12Category: Other methods for preparing systematic reviews Methods group: Prognosis Methods Group Type: TrainingLevel: Basicfacilitators: Jill Hayden, Dalhousie University, Canada; Karel Moons, UMC Utrecht, the Netherlands; Katrina Williams, The Royal Children’s Hospital, AustraliaOther contributors: Riekie de Vet, VU University Medical Center, the Netherlands; Richard Riley, University of Birmingham, UK; Douglas Altman, University of Oxford, UK; Susan Woolfenden, Liverpool Health Service, AustraliaTarget audience: Review authors with an interest in learning about prognosis systematic reviews

WS5 | ASSESSINg THE RISk Of OUTCOME REPORTINg bIAS IN SySTEMATIC REVIEWS

Date/ Time/ Place: Saturday 22 / 14:00 / AfRICACategory: Investigating biasMethods group: Bias Methods GroupType: TrainingLevel: Intermediatefacilitators: Kerry Dwan, University of Liverpool, UK; Jamie Kirkham, University of Liverpool, UK; Paula Williamson, University of Liverpool, UKContributors: Doug Altman, Centre for Statistics in Medicine, UKTarget audience: Review authors, trialists, Consumers, and researchers with a particular interest

WS6 | bASICS Of USINg THE WORkfLOW SySTEM IN ARCHIE

Date/ Time/ Place: Friday 21 / 17:45 / Room 2aCategory: Information and Communication Technology Methods group: Not applicableType: TrainingLevel: Basicfacilitators: Becky Gray, IMS Support, USA; Liz Dooley, IMS Support, Australia; Sonja Henderson, IMS Support, UK; Jacob Riis, IMS Development, Denmark; Karen Hovhannisyan, IMS Support, Denmark Other contributors: Rasmus Moustgaard, IMS Development, Denmark; Paolo Rosati, IMS Development, Denmark; Olga Ahtirschi, IMS Development, DenmarkTarget audience: Restricted; Managing Editors and other Cochrane Review Group (CRG) staff who are or will be directly involved in using the workflow system in Archie


WS7 | CLASSIfyINg NON-RANDOMISED STUDIES (NRS) AND THE ASSESSINg THE RISk Of bIAS fOR A SySTEMATIC REVIEW

Date/ Time/ Place: Friday 21 / 16:00 / ASIACategory: Investigating bias Methods group: Non-Randomised Studies Methods Group Type: TrainingLevel: Intermediatefacilitators: Barnaby Reeves, Non-Randomized Studies Methods Group Other contributors: Bev Shea, University of Ottawa; George Wells, University of Ottawa Target audience: Review authors and Editors considering whether or not to include non-randomised studies in Cochrane systematic reviews

WS8 | COCHRANE PATIENT DECISION AIDS: TRANSLATINg COCHRANE EVIDENCE fOR SHARED DECISION MAkINg

Date/ Time/ Place: Thursday 20 / 14:00 / ASIACategory: Consumer issues and shared decision makingMethods group: Not applicableType: TrainingLevel: Intermediatefacilitators: Tamara Rader, Cochrane Musculoskeletal Group, Canada; Jordi Pardo, Campbell and Cochrane Equity Methods Group, CanadaOther contributors: Annette O’Connor, University of Ottawa, Canada; Dawn Stacey, Ottawa Hospital Research Institute, Canada; Elizabeth Ghogomu, Cochrane Musculoskeletal Group, CanadaTarget audience: Co-ordinating Editors, Managing Editors, Centre Staff, Consumers

WS9 | COCHRANE REVIEW gROUP COLLAbORATION WITH Uk CLINICAL gUIDELINE DEVELOPERS: A WIN-WIN SITUATION

Date/ Time/ Place: Friday 21 / 16:00 / gRAN CANARIACategory: Knowledge translation and communicating evidenceMethods group: Not applicableType: DiscussionLevel: Anyfacilitators: June Cody, Cochrane Incontinence Group, UK; Ella Fields, National Collaborating Centre for Women’s and Children’s Health (NCC-WCH), UK; Sonja Henderson, Cochrane Pregnancy and Childbirth Group, UK; Hugh McGuire, NCC-WCH, UK; Roz Ullman, NCC-WCH, UKTarget audience: Managing Editors, Co-ordinating Editors, Review authors

WS10 | COMMENTINg ON A COCHRANE PLAIN LANgUAgE SUMMARy

Date/ Time/ Place: Saturday 22 / 14:00 / Room 13Category: Knowledge translation and communicating evidenceMethods Group: Not applicableType: TrainingLevel: Anyfacilitators: Gill Gyte, Consumer Editor, UK; Shirley Manknell, Consumer, UK; Dell Horey, Editor, AustraliaOther contributors: Liz Wager, Freelance medical writer, UKTarget audience: Consumers and other referees


WS11 | COMPARINg MULTIPLE TREATMENTS 1: OVERVIEWS VS STANDARD INTERVENTION REVIEWS

Date/ Time/ Place: Thursday 20 / 14:00 / Room 7Category: Other methods for preparing systematic reviews Methods group: Comparing Multiple Interventions Methods Group Type: DiscussionLevel: Anyfacilitators: Lorne Becker, USA Target audience: Review authors, Managing Editors, Editors

WS12 | COMPARINg MULTIPLE TREATMENTS 2: AN INTRODUCTION TO NETWORk META-ANALySIS

Date/ Time/ Place: Friday 21 / 16:00 / UNESCOCategory: Statistical methods and meta-analysis Methods group: Comparing Multiple Interventions Methods Group Type: TrainingLevel: Intermediatefacilitators: Deborah Caldwell, University of Bristol Target audience: Statisticians, Review authors, Editorial teams

WS13 | COMPARINg MULTIPLE TREATMENTS 3: STATISTICAL METHODS fOR NET-WORk META-ANALySIS

Date/ Time/ Place: Saturday 22 / 14:00 / gRAN CANARIACategory: Statistical methods and meta-analysis Methods group: Comparing Multiple Interventions Methods Group Type: DiscussionLevel: Advancedfacilitators: Georgia Salanti, University of Ioannina School of Medicine; Julian Higgins, MRC Biostatistics Unit, UKTarget audience: Statisticians and methodologists

WS14 | CORE OUTCOME MEASURES fOR RANDOMISED CONTROLLED TRIALS AND COCHRANE REVIEWS

Date/ Time/ Place: Friday 21 / 16:00 / OCEANIACategory: Other topicsMethods group: Not applicableType: DiscussionLevel: Anyfacilitators: Paula Williamson, University of Liverpool, UK; Elizabeth Gargon, University of Liverpool, UKOther contributors: Rosalind Smyth, University of Liverpool, UK; Ian Sinha, University of Liverpool, UK; Jane Blazeby, University of Bristol, UK; Doug Altman, University of Oxford, UKTarget audience: Review authors, Editors, Consumers, statisticians, methodologists, trialists


WS15 | CREATE ‘SUMMARy Of fINDINgS’ TAbLES

Date/ Time/ Place: Thursday 20 / 14:00 / fUERTEvENTURACategory: Knowledge translation and communicating evidence Methods group: Applicability and Recommendations Methods Group Type: TrainingLevel: Basicfacilitators: Holger Schünemann, McMaster University, Canada; Nancy Santesso, McMaster University, Canada; Jan Brozek, McMaster University, Canada Target audience: Review authors, Editors, and Entity and Centre staff

WS16 | CROSSCHECk (PLAgIARISM) SURgERy

Date/ Time/ Place: Saturday 22 / 14:00 / LA PALMACategory: Editorial processes and supporting review authorsMethods group: Not applicableType: TrainingLevel: Anyfacilitators: Gavin Stewart, Wiley-Blackwell, UKTarget audience: Managing Editors, Editors, Trials Search Co-ordinators, and Review authors

WS17 | DEbATINg COCHRANE’S ROLE IN A COLD fINANCIAL CLIMATE: EXPERIENCE, PRObLEMS AND SOLUTIONS

Date/ Time/ Place: Thursday 20 / 14:00 / AMERICACategory: Knowledge translation and communicating evidenceMethods group: Not applicableType: DiscussionLevel: Anyfacilitators: Mary Docherty, National Institute for Health and Clinical Excellence (NICE), UK; Peter Littlejohns, NICE, UK; Tarang Sharma, NICE, UKOther contributors: Mike Clarke, UK Cochrane Centre, UK; Sarah Garner, NICE, UKTarget audience: Review authors, Consumers, researchers

WS18 | DEVELOPINg A STRATEgy fOR ASSESSINg THE EXTENT Of SELECTIVE REPORTINg IN PRIMARy STUDIES WHEN INCLUDINg NON-RANDOMISED STUDIES (NRS) IN A SySTEMATIC REVIEW

Date/ Time/ Place: Thursday 20 / 14:00 / Room 13Category: Investigating biasMethods group: Non-Randomised Studies Methods GroupType: DiscussionLevel: Advancedfacilitators: Barnaby Reeves, Non-Randomised Studies Methods Group, UKOther contributors: Susan Norris, Oregon Health & Science University, USA; Bev Shea, University of Ottawa, Canada; George Wells, University of Ottawa, CanadaTarget audience: Review authors, Co-ordinating Editors, methodologists

J


WS19 | DEVELOPINg SEARCH STRATEgIES fOR SySTEMATIC REVIEWS Of DIAgNOSTIC TEST ACCURACy

Date/ Time/ Place: Thursday 20 / 11:15 / Room 2aCategory: Searching and information retrieval Methods group: Information Retrieval Methods Group Type: TrainingLevel: Advancedfacilitators: Ruth Mitchell, Cochrane Renal Group, Australia; Anne Eisinga, UK Support Unit for Cochrane Systematic Reviews of Diagnostic Test Accuracy, UKOther contributors: Julie Glanville, York Economic Consortium Ltd., UKTarget audience: Restricted; Trials Search Co-ordinators, Information Specialists

WS20 | DEVELOPMENT Of A CONSORT EXTENSION fOR RANDOMISED CONTROLLED TRIALS EVALUATINg COMPLEX bEHAVIOURAL CHANgE AND PSyCHOLOgICAL INTERVENTIONS

Date/ Time/ Place: Saturday 22 / 14:00 / LANzAROTECategory: Other topicsMethods group: Not applicableType: DiscussionLevel: Intermediatefacilitators: Paul Montgomery, University of Oxford, UK; Evan Mayo-Wilson, University of Oxford, UK; Sean Grant, University of Oxford, UKTarget audience: Editors, Review authors, methodologists, trialists, Consumers, those with experience with reporting guidelines

WS21 | DIAgNOSTIC TEST ACCURACy REVIEWS 1: WHAT IS A COCHRANE DIAgNOSTIC TEST ACCURACy REVIEW?

Date/ Time/ Place: Thursday 20 / 14:00 / Room 8Category: Diagnostic test accuracy review methods Methods group: Screening and Diagnostic Tests Methods Group Type: TrainingLevel: Anyfacilitators: Chris Hyde, University of Exeter, UK; Jon Deeks, University of Birmingham, UK Target audience: Any attendee who has not already had training in doing Cochrane diagnostic test accuracy reviews or has been to a similar introductory session at the Colloquium

WS22 | DIAgNOSTIC TEST ACCURACy REVIEWS 2: SEARCHINg fOR DIAgNOSTIC TEST ACCURACy STUDIES – REVIEW AUTHORS AND INfORMATION SPECIALISTS WORkINg IN PARTNERSHIP

Date/ Time/ Place: Saturday 22 / 14:00 / Room 2aCategory: Diagnostic test accuracy review methods Methods group: Screening and Diagnostic Tests Methods Group Type: TrainingLevel: Intermediatefacilitators: Anne Eisinga, UK Support Unit for Cochrane Systematic Reviews of Diagnostic Test Accuracy, UK; Ruth Mitchell, Trials Search Coordinator, Cochrane Renal Group, Australia Target audience: Restricted; Review authors, Trials Search Co-ordinators, Information Specialists


WS23 | DIAgNOSTIC TEST ACCURACy REVIEWS 3: ASSESSMENT Of METHODOLOgICAL QUALITy

Date/ Time/ Place: Friday 21 / 16:00 / Room 7Category: Diagnostic test accuracy review methods Methods group: Screening and Diagnostic Tests Methods Group Type: TrainingLevel: Basicfacilitators: Penny Whiting, University of Bristol, UK; Anne Rutjes, University of Bern, Switzerland; Hans Reitsma, Utrecht University; The Netherlands; Mariska Leeflang, University of Amsterdam, The Netherlands; Marie Westwood, Kleijnen Systematic Reviews Ltd, UKTarget audience: Review authors interested in conducting diagnostic test accuracy reviews

WS24 | DIAgNOSTIC TEST ACCURACy REVIEWS 4: INTRODUCTION TO META-ANALySIS

Date/ Time/ Place: Thursday 20 / 14:00 / gRAN CANARIACategory: Diagnostic test accuracy review methods Methods group: Screening and Diagnostic Tests Methods Group Type: TrainingLevel: Intermediatefacilitators: Jon Deeks, DTA Working Group, UK; Yemisi Takwoingi, DTA Working Group, UK Target audience: Review authors conducting diagnostic test accuracy reviews

WS25 | DIAgNOSTIC TEST ACCURACy REVIEWS 5: ADVANCED META-ANALySIS: DEALINg WITH HETEROgENEITy AND TEST COMPARISONS

Date/ Time/ Place: Friday 21 / 16:00 / Room 8Category: Diagnostic test accuracy review methods Methods group: Screening and Diagnostic Tests Methods Group Type: TrainingLevel: Intermediatefacilitators: Petra Macaskill, University of Sydney, Australia Target audience: Review authors or statisticians conducting a diagnostic test accuracy meta-analysis

WS26 | DIAgNOSTIC TEST ACCURACy REVIEWS 6: PRESENTINg AND INTERPRETINg RESULTS Of DTA META-ANALySIS

Date/ Time/ Place: Saturday 22 / 14:00 / TENERIfECategory: Diagnostic test accuracy review methods Methods group: Screening and Diagnostic Tests Methods Group Type: TrainingLevel: Basicfacilitators: Chris Hyde, Peninsula Technology Assessment Group (PenTAG), UK Target audience: Review uthors interested in conducting diagnostic test accuracy reviews and users of reviews interested in learning about the use of evidence in diagnostic decision making


WS27 | EffECTIVE SEARCHINg Of THE LILACS DATAbASE fOR SySTEMATIC REVIEWS

Date/ Time/ Place: Saturday 22 / 7:30 am / Room 2bCategory: Searching and information retrievalMethods group: Information Retrieval Methods GroupType: TrainingLevel: Basicfacilitators: Veronica Abdala, BIREME/PAHO/WHO, Brazil; Gabriel Rada, Centro Colaborador Cochrane, Chile; Agustin Ciapponi, Centro Colaborador Cochrane, Argentina Other contributors: Rosemeire Pinto, BIREME/PAHO/WHO, BrazilTarget audience: Review uthors, researchers

WS28 | ENTITy WEbSITE bUILDER: MAkINg THE MOST Of yOUR ENTITy’S ONLINE PRESENCE

Date/ Time/ Place: Friday 21 / 7:30 am / Room 2bCategory: Information and Communication TechnologyMethods group: Not applicableType: TrainingLevel: Intermediatefacilitators: Chris Mavergames, Cochrane Collaboration Web Team, Germany; Evgenia Slavianova, Cochrane Collaboration Web Team, GermanyTarget audience: Entity webmasters or those involved in administering an Entity site

WS29 | EQUITy 101: WHAT EQUITy CAN DO fOR yOU!

Date/ Time/ Place: Saturday 22 / 14:00 / EUROPECategory: Other methods for preparing systematic reviews Methods group: Campbell and Cochrane Equity Methods Group Type: TrainingLevel: Intermediatefacilitators: Erin Ueffing, University of Ottawa, Canada; Elizabeth Kristjansson, University of Ottawa, Canada; Jordi Pardo Pardo, University of Ottawa, Canada; Mark Petticrew, London School of Hygiene and Tropical Medicine, UK; Vivian Welch, University of Ottawa, CanadaContributors: Peter Tugwell, Dept of Medicine, Dept of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa, CanadaTarget audience: Review authors, knowledge users

WS30 | ESTAbLISHINg A SUCCESSfUL COCHRANE REVIEW gROUP SATELLITE

Date/ Time/ Place: Friday 21 / 16:00 / ANTICISCategory: Other topicsMethods group: Not applicableType: DiscussionLevel: Anyfacilitators: Kay Dickersin, US Cochrane Center/Cochrane Eyes and Vision Group, USA; Richard Wormald, Cochrane Eyes and Vision Group, UK; Joy Oliver, South African Cochrane Centre, South AfricaOther contributors: Ann-Margret Ervin, Cochrane Eyes and Vision Group, USA; Kristina Lindsley, Cochrane Eyes and Vision Group, USA; Roberta Scherer, Cochrane Eyes and Vision


Group, USA; Anupa Shah, Cochrane Eyes and Vision Group, UK; Nandi Siegfried, South African Cochrane Centre, South AfricaTarget audience: Restricted; Representatives of Review Groups (Editorial staff and Editors) who are interested in establishing a satellite editorial base

WS31 | EVIDENCE fOR LOW- AND MIDDLE-INCOME COUNTRIES: gUIDANCE fOR CAMPbELL AND COCHRANE REVIEWS

Date/ Time/ Place: Thursday 20 / 14:00 / gOyACategory: Knowledge translation and communicating evidenceMethods group: Campbell and Cochrane Equity Methods GroupType: DiscussionLevel: Basicfacilitators: Damian Francis, University of the West Indies, Jamaica; Elizabeth Kristjansson, Campbell and Cochrane Equity Methods Group, Canada; Tracey Lynn Pérez Koehlmoos, International Centre for Diarrhoeal Disease Research (ICDDR,B), Bangladesh; Mark Petticrew, Campbell and Cochrane Equity Methods Group, Cochrane Public Health Review Group, UK; Birte Snilstveit, International Initiative for Impact Evaluation (3ie), UK; Hugh Waddington, 3ie, UK; Vivian Welch, Campbell and Cochrane Equity Methods Group, CanadaContributors: Peter Tugwell, University of Ottawa, Campbell and Cochrane Equity Methods Group, Canada; Howard White, 3ie, UK Target audience: Review authors, knowledge users, decision-makers

WS32 | EXTRAPOLATION: APPLyINg THE RESULTS fROM SySTEMATIC REVIEWS TO WHOM, WHEN, AND HOW?

Date/ Time/ Place: Friday 21 / 16:00 / AMERICACategory: Knowledge translation and communicating evidence Methods group: Campbell and Cochrane Equity Methods Group Type: DiscussionLevel: Intermediatefacilitators: Mark Petticrew, London School of Hygiene and Tropical Medicine, UK; Erin Ueffing, University of Ottawa, Canada; Elizabeth Kristjansson, University of Ottawa, Canada; Shawna Mercer, CDC Guide to Community Preventive Services, USA; Jordi Pardo Pardo, University of Ottawa, Canada; Peter Tugwell, Medicine & Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa, Canada Research Chair in Health Equity, Canada; Vivian Welch, University of Ottawa, Canada Other contributors: Gemma Phillips, London School of Hygiene and Tropical Medicine, UK; Russell Gruen, Monash University, AustraliaTarget audience: Knowledge users, decision-makers

WS33 | gOINg fROM EVIDENCE TO COVERAgE DECISIONS

Date/ Time/ Place: Friday 21 / 16:00 / Room 12Category: Knowledge translation and communicating evidenceMethods group: Applicability and Recommendations Methods GroupType: DiscussionLevel: Anyfacilitators: Alessandro Liberati, Italian Cochrane Centre, Italy; Andy Oxman, Norwegian Knowledge Centre for Health Services, Norway; Elena Parmelli, Italian Cochrane Centre, Italy Other contributors: Philip Alderson, National Institute for Health and Clinical Excellence, UK; Silvia Pregno, Italian Cochrane Centre, Italy; Massimo Brunetti, Azienda Unità Sanitaria Locale (AUSL) di Modena, Italy; Donato Papini, Emilia Romagna Health and Social Care Agency, Italy Target audience: Policy makers


WS34 | gRADINg THE QUALITy Of EVIDENCE AND PREPARINg ‘SUMMARy Of fINDINgS’ TAbLES fOR DIAgNOSTIC TEST ACCURACy REVIEWS

Date/ Time/ Place: Friday 21 / 16:00 / EUROPECategory: Knowledge translation and communicating evidence Methods group: Applicability and Recommendations Methods Group Type: TrainingLevel: Basicfacilitators: Holger Schünemann, McMaster University, Canada; Patrick Bossuyt, University of Amsterdam, The Netherlands; Jan Brozek, McMaster University, Canada; Gordon Guyatt, McMaster University, Canada; Reem Mustafa, McMaster University, Canada Other contributors: Andrew Oxman, Norwegian Knowledge Centre, Norway Target audience: Review authors, Managing Editors and Editors focusing on diagnostic questions

WS35 | HOW SHOULD WE WRITE UP THE STATISTICAL RESULTS Of META-ANALySES IN THE TEXT AND AbSTRACT Of A COCHRANE SySTEMATIC REVIEW?

Date/ Time/ Place: Friday 21 / 16:00 / Room 9Category: Knowledge translation and communicating evidenceMethods group: Not applicableType: TrainingLevel: Intermediatefacilitators: Elaine Beller, Bond University, Australia; Sally Hopewell, UK Cochrane Centre, UKOther contributors: Kate Cahill, Cochrane Tobacco Addiction Group, UK; Paul Glasziou, Bond University, AustraliaTarget audience: Review authors, Managing Editors, Co-ordinating Editors

WS36 | HOW TO ASk AN ANSWERAbLE QUESTION fOR HEALTH CARE AND HEALTH RESEARCH

Date/ Time/ Place: Thursday 20 / 14:00 / OCEANIACategory: Consumer issues and shared decision makingMethods group: Not applicableType: TrainingLevel: Anyfacilitators: Kay Dickersin, US Cochrane Center, USA; Mingming Zhang, Chinese Cochrane Center, China; Ann Fonfa, Consumers United for Evidence-based Healthcare (CUE), USA; Maryann Napoli, CUE, USA; Nancy Fitton, CUE, USA; Catherine McIlwain, Cochrane Consumer Co-ordinator, UKTarget audience: Consumers

WS37 | HOW TO COMPLETE A COCHRANE PROTOCOL fOR QUALITATIVE EVIDENCE SyNTHESIS

Date/ Time/ Place: Thursday 20 / 14:00 / DENMARK boardroomCategory: Editorial processes and supporting review authors Methods group: Qualitative Research Methods Group Type: TrainingLevel: Basicfacilitators: Janet Harris, University of Sheffield, UK; Angela Harden, University of East London, UK; Jane Noyes, University of Bangor, UK; Karin Hannes, Leuven University, Belgium; Andrew Booth, University of Sheffield, UK; Craig Lockwood, Adelaide University, AustraliaTarget audience: Review authors, Editors and researchers considering the submission of protocols that include qualitative research evidence


WS38 | HOW TO DEVELOP bRIEf ECONOMIC COMMENTARIES fOR COCHRANE INTERVENTION REVIEWS

Date/ Time/ Place: Friday 21 / 16:00 / Room 13Category: Other methods for preparing systematic reviews Methods group: Campbell and Cochrane Economics Methods Group Type: TrainingLevel: Anyfacilitators: Ian Shemilt, Campbell and Cochrane Economics Methods Group, UK Target audience: Review authors, Managing Editors, Co-ordinating Editors, Editors, Trials Search Co-ordinators

WS39 | IMPLEMENTATION Of COPy-EDITINg STANDARDS fOR COCHRANE REVIEWS AND PROTOCOLS

Date/ Time/ Place: Thursday 20 / 14:00 / ANTARCTICACategory: Editorial processes and supporting review authorsMethods group: Not applicableType: TrainingLevel: Basicfacilitators: Nancy Owens, Cochrane/Wiley Copy Edit Support, USAOther contributors: Harriet MacLehose, Cochrane Editorial Unit, UK; Rachel Marshall, Cochrane Editorial Unit, UK; John Hilton, Cochrane Editorial Unit, UKTarget audience: Restricted; Anyone who is involved in editorial processing and copy-editing of Cochrane reviews and protocols

WS40 | INCLUDINg DATA fROM PROTOCOLS ON QUALITATIVE RESEARCH fINDINgS IN REVMAN - CURRENT VERSION AND A WISH LIST.

Date/ Time/ Place: Thursday 20 / 14:00 / DENMARK boardroomCategory: Other methods for preparing systematic reviews Methods group: Qualitative Research Methods Group Type: DiscussionLevel: Anyfacilitators: Craig Lockwood, Belgium; Jane Noyes, Belgium; Andrew Booth, Belgium; Janet Harris, Belgium; Angela Harden, Belgium Target audience: Review authors, researchers considering the submission of protocols on qualitative research findings aiming to contribute to the understanding of the results of effectiveness reviews

WS41 | INfORMATION MANAgEMENT SySTEM WORkSHOP fOR THE COCHRANE TRIAL SEARCH CO-ORDINATORS

Date/ Time/ Place: Saturday 22 / 7:30 am / Room 2aCategory: Information and Communication Technology Methods group: Not applicableType: TrainingLevel: Anyfacilitators: Karen Hovhannisyan, IMS Support, Denmark; Gail Higgins, Cochrane Renal Group, Australia; Lynn Hampson, Cochrane Pregnancy and Childbirth Group, UK; Sheila Wallace, Incontinence Group, UK Target audience: Restricted; Trials Search Co-ordinators


WS42 | INTRODUCTION TO META-ANALySIS 1: bASIC IDEAS fOR NOVICES

Date/ Time/ Place: Thursday 20 / 14:00 / EUROPECategory: Statistical methods and meta-analysis Methods group: Statistical Methods Group Type: TrainingLevel: Basicfacilitators: Joseph Beyene, McMaster University, Canada Target audience: Review authors

WS43 | INTRODUCTION TO META-ANALySIS 2: EffECT MEASURES fOR DICHOTOMOUS OUTCOMES

Date/ Time/ Place: Friday 21 / 16:00 / LA PALMACategory: Statistical methods and meta-analysis Methods group: Statistical Methods Group Type: TrainingLevel: Basicfacilitators: Dimitris Mavridis, University of Ioannina School of Medicine, Ioannina, Greece; Areti Angeliki Veroniki, University of Ioannina School of Medicine, Ioannina, GreeceContributors: Georgia Salanti, University of Ioannina School of Medicine, Ioannina, GreeceTarget audience: Review authors

WS44 | INTRODUCTION TO META-ANALySIS 3: META-ANALySIS Of CONTINUOUS OUTCOMES

Date/ Time/ Place: Saturday 22 / 14:00 / MENINACategory: Statistical methods and meta-analysis Methods group: Statistical Methods Group Type: TrainingLevel: Basicfacilitators: Andy Bryant, Newcastle University, UK; Lesley Smith, Oxford Brookes University, UK Target audience: Review authors

WS45 | INTRODUCTION TO META-ANALySIS 4: DEALINg WITH HETEROgENEITy

Date/ Time/ Place: Thursday 20 / 14:00 / MENINACategory: Statistical methods and meta-analysis Methods group: Statistical Methods Group Type: TrainingLevel: Intermediatefacilitators: Georgia Salanti, University of Ioannina School of Medicine, Ioannina, Greece; Anna Chaimani, University of Ioannina School of Medicine, Ioannina, GreeceTarget audience: Review authors

J

J

J

J


WS46 | INTRODUCTION TO META-ANALySIS 5: INCLUDINg NON-STANDARD STUDIES AND NON-STANDARD DATA

Date/ Time/ Place: Friday 21 / 16:00 / LANzAROTECategory: Statistical methods and meta-analysis Methods group: Statistical Methods Group Type: TrainingLevel: Intermediatefacilitators: Steff Lewis, University of Edinburgh, UK; Doug Altman, University of Bristol, UK Target audience: Review authors

WS47 | INVESTIgATINg AND DEALINg WITH bIAS IN SySTEMATIC REVIEWS

Date/ Time/ Place: Thursday 20 / 14:00 / LANzAROTECategory: Investigating bias Methods group: Bias Methods Group Type: TrainingLevel: Anyfacilitators: Jonathan Sterne, Ottawa Hospital Research Institute Other contributors: Douglas Altman, University of Bristol, UK; Isabelle Boutron, Université Paris, France; David Moher, Ottawa Hospital Research Institute, Canada Target audience: Open for all

WS48 | INVESTIgATINg CLINICAL HETEROgENEITy IN SySTEMATIC REVIEWS

Date/ Time/ Place: Saturday 22 / 14:00 / ANTICISCategory: Other methods for preparing systematic reviewsMethods group: Not applicableType: TrainingLevel: Anyfacilitators: Joel Gagnier, University of Michigan, USATarget audience: Review authors

WS50 | MAkINg A PODCAST fOR A COCHRANE REVIEW

Date/ Time/ Place: Friday 21 / 16:00 / ANTARCTICACategory: Information and Communication TechnologyMethods group: Not applicableType: TrainingLevel: Basicfacilitators: Chris Mavergames, Cochrane Collaboration Web Team, Germany; Mike Clarke, Cochrane Podcast Editor, UKTarget audience: Review authors

J

J


WS51 | MAkINg RESULTS Of PATIENT-REPORTED OUTCOMES INTERPRETAbLE

Date/ Time/ Place: Thursday 20 / 14:00 / LANzAROTECategory: Other methods for preparing systematic reviewsMethods group: Patient Reported Outcomes Methods GroupType: TrainingLevel: Intermediatefacilitators: Gordon Guyatt, McMaster University, Canada; Donald Patrick, University of Washington, USATarget audience: Review authors

WS52 | MAkINg SENSE Of SCIENTIfIC EVIDENCE AND COMMENTINg ON A COCHRANE REVIEW: A DUAL LANgUAgE WORkSHOP fOR CONSUMERS

Date/ Time/ Place: Wednesday 19/ 9:00 am/ Room 9Category: Knowledge translation and communicating evidenceMethods group: Not applicableType: TrainingLevel: Anyfacilitators: Gill Gyte, Consumer Editor, UK; Amanda Burls, CASP International, UK; Jose Emparanza, CASP International, Spain; Juan Cabello, CASP International, SpainTarget audience: Consumers

WS53 | MAXIMISINg THE IMPACT Of SySTEMATIC REVIEWS IN HEALTH POLICy MAkINg: METHODS AND CHALLENgES

Date/ Time/ Place: Friday 21 / 16:00 / vIPSCategory: Knowledge translation and communicating evidenceMethods group: Not applicableType: DiscussionLevel: Anyfacilitators: Duncan Chambers, Centre for Reviews and Dissemination (CRD), University of York, UK; Paul Wilson, CRD, University of York, UK; Claire Glenton, Norwegian Knowledge Centre for the Health Services, Norway; Sarah Rosenbaum, Norwegian Knowledge Centre for the Health Services, Norway; John Lavis, McMaster University, Canada; Paul Garner, Liverpool School of Tropical Medicine, UKContributors: Lakshmi Murthy, UK Cochrane Centre, UKTarget audience: Review authors and others interested in communicating review evidence to policy-makers

WS54 | MEASURES Of PAIN AND fUNCTION IN ‘SUMMARy Of fINDINgS’ TAbLES

Date/ Time/ Place: Thursday 20 / 14:00 / vIPSCategory: Editorial processes and supporting review authorsMethods group: Not applicableType: DiscussionLevel: Advancedfacilitators: Chris Ecclestone, Cochrane Pain, Palliative and Supportive Care Group, UK; Michael Lunn, Cochrane Neuromuscular Disease Group, UKContributors: Peter Tugwell, Cochrane Musculoskeletal Group, CanadaTarget audience: Co-ordinating Editors, Editors, Managing Editors, Review authors


WS55 | META-ANALySIS Of CONTINUOUS OUTCOMES: HELPINg REVIEW AUTHORS NEgOTIATE THE CHANgE SCORE VERSUS fINAL VALUE DEbATE

Date/ Time/ Place: Saturday 22 / 14:00 / Room 9Category: Statistical methods and meta-analysisMethods group: Statistical Methods GroupType: TrainingLevel: Intermediatefacilitators: Joanne McKenzie, School of Public Health and Preventive Medicine, Monash University, Australia; Douglas Altman, Centre for Statistics in Medicine, University of Oxford, UKTarget audience: Review authors

WS56 | METHODOLOgICAL EXPECTATIONS Of COCHRANE INTERVENTION REVIEWS (MECIR) – SEARCHINg fOR STUDIES

Date/ Time/ Place: Saturday 22 / 14:00 / Room 7Category: Searching and information retrievalMethods group: Information Retrieval Methods GroupType: TrainingLevel: Intermediatefacilitators: Carol Lefebvre, UK Cochrane Centre and Cochrane Information Retrieval Methods Group (IRMG), UKOther contributors: Julie Glanville, York Health Economics Consortium and IRMG, UKTarget audience: Restricted; Trials Search Co-ordinators and others who search for studies for Cochrane intervention reviews

WS57 | METHODS fOR INVOLVINg CONSUMERS IN SySTEMATIC REVIEWS

Date/ Time/ Place: Friday 21 / 16:00 / fUERTEvENTURACategory: Consumer issues and shared decision makingMethods group: Not applicableType: TrainingLevel: Anyfacilitators: Kristin Liabo, Social Science Research Unit, Institute of Education, University of London, UK; Sandy Oliver, Social Science Research Unit, Institute of Education, University of London, UK; Rebecca Rees, Social Science Research Unit, Institute of Education, University of London, UK; Ruth Stewart, Social Science Research Unit, Institute of Education, University of London, UKTarget audience: Reveiw authors wanting to involve consumers in their reviews

WS58 | NAVIgATINg THE COCHRANE LIbRARy

Date/ Time/ Place: Wednesday 19 / 18:00 / Room 2bCategory: Knowledge translation and communicating evidenceMethods group: Not applicableType: TrainingLevel: Basicfacilitators: Nigel Thompson, John Wiley & Sons, UKTarget audience: Reveiw authors, Consumers, researchers


WS59 | PEER REVIEWINg THE SEARCH STRATEgy fOR A COCHRANE DIAgNOSTIC TEST ACCURACy SySTEMATIC REVIEW

Date/ Time/ Place: Friday 21 / 16:00 / DENMARK boardroomCategory: Editorial processes and supporting review authors Methods group: Screening and Diagnostic Tests Methods Group Type: TrainingLevel: Intermediatefacilitators: Ruth Mitchell, Cochrane Renal Group, Australia; Anne Eisinga, UK Support Unit for Cochrane Systematic reviews of Diagnostic Test Accuracy, UK; Julie Glanville, York Health Economics Consortium, UK Target audience: Restricted; Trials Search Coordinators, Information Specialists

WS60 | PLAIN LANgUAgE SUMMARIES: THE MOST VALUAbLE PART Of A COCHRANE REVIEW

Date/ Time/ Place: Thursday 20 / 14:00 / LA PALMACategory: Knowledge translation and communicating evidenceMethods group: Not applicableType: DiscussionLevel: Intermediatefacilitators: Tamara Rader, Cochrane Musculoskeletal Group, Canada; Jordi Pardo, Campbell and Cochrane Equity Methods Group, CanadaOther contributors: David Tovey, Cochrane Editorial Unit, UK; Elizabeth Ghogomu, Cochrane Musculoskeletal Group, CanadaTarget audience: Co-ordinating Editors, Managing Editors, Centre Staff, Review authors, Consumers, Consumer advocates, knowledge brokers, communication specialists

WS61 | PREPARINg MATERIALS TO HELP RUN A JOURNAL CLUb

Date/ Time/ Place: Saturday 22 / 14:00 / Room 8Category: Other topicsMethods group: Not applicableType: TrainingLevel: Anyfacilitators: Mike Clarke, Queen’s University of Belfast, UK; Clive Adams, University of Nottingham, UKTarget audience: Open for all

WS62 | REfERENCE MANAgEMENT fOR SySTEMATIC REVIEWS

Date/ Time/ Place: Wednesday 19/ 9:00 am/ Room 2bCategory: Searching and information retrievalMethods group: Not applicableType: TrainingLevel: Basicfacilitators: Michelle Fiander, Cochrane Effective Practice and Organisation of Care Group, Canada; Doug Salzwedel, Cochrane Hypertension Group, CanadaTarget audience: Trials Search Coordinators, Information Specialists, Review authors


WS63 | REVMAN 5.1 fOR COCHRANE INTERVENTION REVIEW AUTHORS – LEARN TO USE ALL THE fEATURES HANDS-ON

Date/ Time/ Place: Saturday 22 / 14:00 / Room 2bCategory: Editorial processes and supporting review authorsMethods group: Not applicableType: TrainingLevel: Anyfacilitators: Joy Oliver, South African Cochrane Centre, South Africa; Babalwa Zani, South African Cochrane Centre, South Africa; Tamara Kredo, South African Cochrane Centre, South AfricaContributors: Elizabeth Pienaar, South African Cochrane Centre, South AfricaTarget audience: Review authors

WS64 | SEARCH STRATEgIES AND DATA SOURCES fOR ADVERSE EffECTS REVIEWS

Date/ Time/ Place: Friday 21 / 16:00 / gERMANy boardroomCategory: Searching and information retrieval Methods group: Adverse Effects Methods Group Type: TrainingLevel: Anyfacilitators: Su Golder, Adverse Effects Methods Group, UK; Andrew Herxheimer, Adverse Effects Methods Group, UKOther contributors: Yoon Loke, Adverse Effects Methods Group, UK; Sunita Vohra, Adverse Effects Methods Group, CanadaTarget audience: Review authors, Trials Search Co-ordinators

WS65 | SEARCHINg fOR STUDIES fOR INCLUSION IN COCHRANE REVIEWS

Date/ Time/ Place: Thursday 20 / 14:00 / Room 2aCategory: Searching and information retrieval Methods group: Information Retrieval Methods Group Type: TrainingLevel: Basicfacilitators: Bernadette Coles, Cancer Research, Wales, UK; Carol Lefebvre, UK Cochrane Centre, UK; Alison Weightman, Cardiff University, UK Target audience: Review authors

WS66 | SEARCHINg TRIALS REgISTERS AND TRIALS RESULTS REgISTERS

Date/ Time/ Place: Friday 21 / 16:00 / ITALy boardroomCategory: Searching and information retrieval Methods group: Information Retrieval Methods Group Type: TrainingLevel: Intermediatefacilitators: Julie Glanville, York Health Economics Consortium, UK; Carol Lefebvre, UK Cochrane Centre, UK Target audience: Trials Search Co-ordinators, Information Specialists, Review authors (with searching experience)

J

J


WS67 | SEARCHINg, SAMPLINg AND SELECTINg fOR QUALITATIVE EVIDENCE SyNTHESIS

Date/ Time/ Place: Friday 21 / 16:00 / TENERIfECategory: Searching and information retrieval Methods group: Qualitative Research Methods Group Type: TrainingLevel: Intermediatefacilitators: Andrew Booth, Qualitative Methods Group, UK; Janet Harris, Qualitative Methods Group, UK; Karin Hannes, Qualitative Methods Group, Belgium Target audience: Review authors, qualitative researchers, Information Specialists

WS68 | SELECTINg AND INTERPRETINg DATA fROM RELEVANT STUDIES Of ADVERSE EffECTS

Date/ Time/ Place: Thursday 20 / 14:00 / / ITALy boardroomCategory: Other methods for preparing systematic reviews Methods group: Adverse Effects Methods Group Type: TrainingLevel: Anyfacilitators: Christine Schmucker, German Cochrane Centre; Andrew Herxheimer, Adverse Effects Methods Group, UK; Su Golder, Adverse Effects Methods Group, UK; Denise Adams, Adverse Effects Methods Group, Canada Other contributors: Yoon Loke, Adverse Effects Methods Group, UK Target audience: Open for all

WS69 | STATISTICAL ISSUES fOR MANAgINg AND CO-ORDINATINg EDITORS: COMMON ERRORS IN REVIEWS, WHAT TO LOOk fOR AND HOW TO SPOT THEM

Date/ Time/ Place: Thursday 20 / 14:00 / AfRICACategory: Editorial processes and supporting review authorsMethods group: Statistical Methods GroupType: DiscussionLevel: Anyfacilitators: Steff Lewis, Centre for Population Health Sciences, University of Edinburgh, UK; Joanne McKenzie, School of Public Health and Preventive Medicine, Monash University, Australia; Helen Worthington, Cochrane Oral Health Group, School of Dentistry, University of Manchester, UK; Chris Cates, Population Health, St George’s University of London, UK; Peter Herbison, Department of Preventive and Social Medicine, University of Otago, New ZealandTarget audience: Co-ordinating Editors, Managing Editors


WS70 | STATISTICAL METHODS fOR INDIVIDUAL PARTICIPANT DATA META-ANALySIS

Date/ Time/ Place: Friday 21 / 16:00 / MENINACategory: Statistical methods and meta-analysisMethods group: Individual Patient Data Meta-analysis Methods Group Type: TrainingLevel: Intermediatefacilitators: Catrin Tudur Smith, University of Liverpool, UK; Richard Riley, Birmingham University, UK Other contributors: Paula Williamson, University of Liverpool, UKTarget audience: Review authors undertaking individual participant data meta-analysis

WS71 | STRUCTURED PEER REVIEW Of SEARCH STRATEgIES fOR SySTEMATIC REVIEWS: PRESSfORUM AND THE PRESS CHECkLIST

Date/ Time/ Place: Thursday 20 / 11:15 / Room 2bCategory: Searching and information retrievalMethods group: Not applicableType: TrainingLevel: Intermediatefacilitators: Douglas Salzwedel, Cochrane Hypertension Group, Canada; Carol Lefebvre, UK Cochrane Centre, UKOther contributors: Jessie McGowan, University of Ottawa, Canada; Margaret Sampson, Children’s Hospital of Eastern Ontario, CanadaTarget audience: Restricted; Trials Search Coordinators, Information Specialists

WS72 | ‘SUMMARy Of fINDINgS’ TAbLES: DISCUSSION Of PRACTICAL ISSUES

Date/ Time/ Place: Saturday 22 / 14:00 / ASIACategory: Other methods for preparing systematic reviews Methods group: Applicability and Recommendations Methods Group Type: DiscussionLevel: Intermediatefacilitators: Chris Cates, UK; Helen Worthington, University of Manchester, UK; Nancy Santesso, McMaster University, Canada Contributors: Holger Schünemann, McMaster University, CanadaTarget audience: Review authors, Editors, Entity and Centre staff

WS73 | SySTEMATIC REVIEWS Of CLINICAL STUDy REPORTS (CSRS) – A SPECIAL fORM Of UNPUbLISHED DATA

Date/ Time/ Place: Thursday 20 / 14:00 / UNESCOCategory: Other methods for preparing systematic reviewsMethods group: Not applicableType: DiscussionLevel: Intermediatefacilitators: Chris Del Mar, Cochrane Acute Respiratory Infections (ARI) Group, Bond University, Australia; Tom Jefferson, Cochrane ARI Group, Italy; Carl Heneghan, University of Oxford, UKOther contributors: Peter Doshi, MIT, USA; Mark Jones, University of Queensland, Australia; Liz Dooley, Cochrane ARI Group, Bond University, Australia; Matthew Thompson, Kaiser Permamante, USA; Rokuro Hama, Paediatrician, JapanTarget audience: Review authors, Consumers, or researchers interested in future reviews of interventions funded largely by industry in which there is an important potential for publication bias.


WS74 | TAkINg WORkfLOWS TO NEW HEIgHTS: AN ADVANCED WORkSHOP fOR MANAgINg EDITORS

Date/ Time/ Place: Thursday 20 / 14:00 / Room 2bCategory: Information and Communication Technology Methods group: Not applicableType: TrainingLevel: Intermediatefacilitators: Becky Gray, IMS Support, USA; Sonja Henderson; IMS Support, UK; Liz Dooley, IMS Support, Australia; Jacob Riis, IMS Development, Denmark; Karen Hovhannisyan, IMS Support, Denmark Other contributors: Rasmus Moustgaard, IMS Development, Denmark; Paolo Rosati, IMS Development, Denmark; Olga Ahtirschi, IMS Development, Denmark Target audience: Restricted; Managing Editors who are experienced users of the workflow system in Archie

WS75 | TESTINg fOR EXCESS STATISTICAL SIgNIfICANCE

Date/ Time/ Place: Saturday 22 / 14:00 / AMERICACategory: Statistical methods and meta-analysisMethods group: Not applicableType: DiscussionLevel: Advancedfacilitators: John Ioannidis, University of Ioannina, GreeceTarget audience: Anyone interested in the topic

WS76 | TEXT ANALySIS TOOLS fOR INfORMATION RETRIEVAL

Date/ Time/ Place: Saturday 22 / 14:00 / ANTARCTICACategory: Searching and information retrievalMethods group: Not applicableType: DiscussionLevel: Intermediatefacilitators: Elke Hausner, Institute for Quality and Efficiency in Health Care (IQWiG), Germany; Julie Glanville, York Health Economics Consortium Ltd., UK; Siw Waffenschmidt, IQWiG, GermanyOther contributors: Raechel Damarell, Flinders Medical Centre, Australia; Jennifer Tieman, Flinders Medical Centre, Australia; Nancy Wilczynski, McMaster University, CanadaTarget audience: Information Specialists

WS77 | THE COMPLEX AND CHALLENgINg MANDATE Of COCHRANE fIELDS: A TRAININg AND SUPPORT WORkSHOP

Date/ Time/ Place: Saturday 22 / 14:00 / OCEANIACategory: Other topicsMethods group: Not applicableType: DiscussionLevel: Basicfacilitators: Denise Thomson, Child Health Field, Canada; Susan Wieland, Complementary and Alternative Medicine Field, USA; Kathy Mahan, Neurological Field, Italy; Alessandro Liberati, Italian Cochrane Centre, Italy; Jessica Thomas, Cochrane Pain, Palliative & Supportive Care Group, UK; Katrina Williams, Child Health Field, AustraliaOther contributors: Jason Wasiak, Prehospital and Emergency Health Field, AustraliaTarget audience: Anyone with an interest in learning more about the activities of Fields and planning ways of working in partnership


WS78 | THE UPDATED COCHRANE RISk Of bIAS TOOL

Date/ Time/ Place: Friday 21 / 16:00 / AfRICACategory: Investigating bias Methods group: Bias Methods Group Type: TrainingLevel: Anyfacilitators: Isabelle Boutron, Université Paris, France; David Moher, Ottawa Hospital Research Institute, Canada; Jonathan Sterne, University of Bristol, UK Other contributors: Jelena Savovic, University of Bristol, UK; Lucy Turner, Ottawa Hospital Research Institute, Canada; Doug Altman, Centre for Statistics in Medicine, University of Oxford, UKTarget audience: Open for all

WS79 | TRANSLATINg CRITICAL APPRAISAL Of A SySTEMATIC REVIEW TO MEANINgfUL PEER REVIEW

Date/ Time/ Place: Thursday 20 / 14:00 / gERMANy boardroomCategory: Editorial processes and supporting review authorsMethods group: Not applicableType: TrainingLevel: Anyfacilitators: Richard Wormald, Cochrane Eyes and Vision Group, UK; Luis Gabriel Cuervo, Pan American Health Organization (PAHO/WHO), USA; Tianjing Li, Cochrane Eyes and Vision Group, USA; Kristina Lindsley, Cochrane Eyes and Vision Group, USAOther contributors: Kay Dickersin, US Cochrane Center, USA; Ann-Margret Ervin, Cochrane Eyes and Vision Group, USA; Anupa Shah, Cochrane Eyes and Vision Group, UKTarget audience: Individuals who are involved or interested in peer review of systematic reviews

WS80 | UPDATINg COCHRANE REVIEWS: fINDINgS Of AN NHS ENgAgEMENT PROJECT AND fUTURE UPDATINg OPTIONS

Date/ Time/ Place: Saturday 22 / 14:00 / vIPSCategory: Editorial processes and supporting review authorsMethods group: Not applicableType: DiscussionLevel: Anyfacilitators: Rachel Marshall, Cochrane Editorial Unit, UK; David Tovey, Cochrane Editorial Unit, UK; Toby Lasserson, Cochrane Editorial Unit, UKTarget audience: Co-ordinating Editors, Managing Editors, Trial Search Co-ordinators

WS81 | USINg gRADE TO ASSESS THE QUALITy Of EVIDENCE fOR PUbLIC HEALTH SySTEMATIC REVIEWS

Date/ Time/ Place: Saturday 22 / 14:00 / Room 12Category: Other methods for preparing systematic reviewsMethods group: Applicability and Recommendations Methods GroupType: DiscussionLevel: Intermediatefacilitators: Eva Rehfuess, Department of Medical Informatics, Biometry and Epidemiology, University of Munich, Germany; Andrew Oxman, Norwegian Knowledge Centre for the Health Services, Norway; Holger Schünemann, Department of Clinical Epidemiology and Biostatistics, McMaster University, Canada Target audience: Review authors of public heatlh topics

J


WS82 | USINg gRADEPRO TO CREATE ‘SUMMARy Of fINDINgS’ TAbLES

Date/ Time/ Place: Friday 21 / 16:00 / Room 2bCategory: Other methods for preparing systematic reviews Methods group: Applicability and Recommendations Methods Group Type: TrainingLevel: Basicfacilitators: Nancy Santesso, McMaster University, Canada; Jan Brozek, McMaster University, Canada Contributors: Holger Schünemann, McMaster University, CanadaTarget audience: Review authors, Editors, Entity and Centre staff

WS83 | USINg HEALTH SySTEMS EVIDENCE TO DEVELOP gUIDANCE fOR POLICy MAkERS ON HEALTH SySTEMS STRENgTHENINg

Date/ Time/ Place: Thursday 20 / 14:00 / Room 9Category: Knowledge translation and communicating evidenceMethods group: Applicability and Recommendations Methods GroupType: DiscussionLevel: Anyfacilitators: Xavier Bosch-Capblanch, Swiss Tropical and Public Health Institute, Switzerland; Simon Lewin, Cochrane Effective Practice and Organisation of Care group, Norwegian Knowledge Centre for the Health Services, Norway; Sandy Oliver, EPPI-Centre, Institute of Education, UK; Elie Akl, Department of Medicine, University of Buffalo, USATarget audience: Review authors, health systems researchers, guideline developers, policymakers

WS84 | USINg SySTEMATIC REVIEWS TO INfORM POLICyMAkINg: THE EXPERIENCE Of EVIDENCE-INfORMED POLICy NETWORkS (EVIPNET) IN THE AMERICAS

Date/ Time/ Place: Saturday 22 / 14:00 / fUERTEvENTURACategory: Knowledge translation and communicating evidenceMethods group: Not applicableType: DiscussionLevel: Anyfacilitators: Tomas Pantoja, Cochrane Effective Practice and Organisation of Care Group/Pontificia Universidad Catolica de Chile, Chile; Evelina Chapman, Pan American Health Organization (PAHO/WHO) EVIPNet Americas Secretariat, Argentina; Luis Gabriel Cuervo, PAHO/WHO, USA; Gabriel Rada, Pontificia Universidad Catolica de Chile, Chile; Blanca Peñaloza, Pontificia Universidad Catolica de Chile, Chile; Marcelo García-Dieguez, Universidad Nacional del Sur – IIE Academia de Medicina, Argentina; Juan Manuel Lozano, Florida International University, USATarget audience: Review authors , Consumers and policymakers

WS85 | USINg THE COCHRANE EVENT MANAgER fOR COLLOQUIA, SyMPOSIA AND OTHER COCHRANE MEETINgS

Date/ Time/ Place: Saturday 22 / 14:00 / DENMARK boardroomCategory: Information and Communication TechnologyMethods group: Not applicableType: TrainingLevel: Basicfacilitators: Martin Janczyk, Cochrane Collaboration Web Team, Germany; Juliane Ried, Cochrane Collaboration Web Team, GermanyTarget audience: Restricted; Future organises of Cochrane Colloquia and regional Cochrane symposia or Contributor’s meetings

J


WS86 | WORkSHOP AgREE II – APPRAISAL INSTRUMENT TO ASSESS CLINICAL gUIDELINES

Date/ Time/ Place: Thursday 20 / 14:00 / TENERIfECategory: Other topicsMethods group: Not applicableType: Training Anyfacilitators: Itziar Etxeandia Ikobaltzeta, Osteba-Basque Office For Health Technology Assessment – Spain; Susana García Rodríguez, Guiasalud-Aragon Institute Of Health Sciences, SpainOther contributors: Juan Ignacio Martín Sánchez, Guiasalud-Aragon Institute Of HealthSciences, Spain; Iñaki Gutierrez Ibarluzea, Osteba-Basque Office For Health Technology Assessment,Spain;MartaLópezDeArgumedoGonzálezDeDurana,Osteba-BasqueOfficeFor Health Technology Assessment, Spain; Rosa Rico Iturrioz, Osteba-Basque Office For Health Technology Assessment, Spain; Elvira Elena García Álvarez, Guiasalud-Aragon Institute Of Health Sciences, SpainTarget audience: Health professionals that are likely to use or develop practice guidelines, researchers from Health Technology Assessment Units that develop practice guidelines.

WS87 | WORkSHOP fOR MANAgINg EDITORS AND ASSISTANT MANAgINg EDITORS: OUR PURSUITS AREN’T TRIVIAL

Date/ Time/ Place: Saturday 22 / 14:00 / gOyA Category: Editorial processes and supporting review authorsMethods group: Not applicableType: TrainingLevel: Anyfacilitators: Karin Dearness, Upper Gastrointestinal and Pancreatic Diseases Group, Canada; Sally Bell-Syer, Cochrane Wounds Group, UKTarget audience: Restricted; Managing Editors, Assistant Managing Editors.

OTHER OTROS

fUTURE DIRECTIONS fOR COCHRANE DATA

SWS88 | USINg THE COCHRANE REgISTER Of STUDIES TO DEVELOP A STUDy-bASED SPECIALISED REgISTER

Date/ Time/ Place: Thursday 20 / 17:45 / Room 2aCategory: Searching and information retrievalMethods group: Not applicableType: TrainingLevel: Anyfacilitators: Ruth Foxlee, Information Specialist at the Cochrane Editorial Unit; team members from Metaxis Ltd; and members of the CRS User Support Team, UK and worldwideTarget audience: Cochrane contributors who currently maintain reference-based registers and would like to convert them to study-based registers


SWS89 | DEVELOPINg yOUR SPECIALISED REgISTER IN THE COCHRANE REgISTER Of STUDIES

Date/ Time/ Place: Thursday 20 / 17:45 / Room 2bCategory: Searching and information retrievalMethods group: Not applicableType: TrainingLevel: Anyfacilitators: Gordon Dooley, Managing Director of Metaxis Ltd; and members of the CRS User Support Team, UK and worldwideTarget audience: Cochrane contributors who wish to explore the advanced features of the CRS.

SWS90 | CENTRAL & THE CRS: A DISCuSSION AND POLICY-SETTING SESSION

Date/ Time/ Place: Friday 21 / 17:45 / gOyACategory: Searching and information retrievalMethods group: Not applicableType: DiscussionLevel: Anyfacilitators: Ruth Foxlee and David Tovey, Cochrane Editorial Unit, UKTarget audience: Any Colloquium participant but it particularly aimed at those with an interest in developing CENTRAL and Cochrane groups who maintain a Specialised Register.

SpECIAL WORKSHOp SWS91 | CLARIfyINg METHODS AND PROTOCOL DESIgN ISSUES fOR SySTEMATIC

REVIEWS THAT INCORPORATE EVIDENCE fROM ECONOMETRIC ANALySES

Date/ Time/ Place: : Saturday 22 / 11:15 / EUROPECategory: Other topicsMethods group: Not applicableType: DiscussionLevel: Anyfacilitators: IanShemilt.UniversityofCambridge,UK;TillBaernighausen. ‎HarvardSchoolofPublic Health, USA; Jorge Hombrados. 3ie International Initiative for Impact Evaluation, UK; Mehmet Ugur. University of Greenwich, UK; Hugh Waddington. 3ie International Initiative for Impact Evaluation, UK.Target audience: Review authors interested in economic issues


SATELLITE WORKSHOpSTALLERES SATÉLITE

SAT01 | REPLICATION AND bIASES IN MOLECULAR RESEARCH

Date/ Time/ Place: Tuesday 18 / 9:00 / Casa de Convalescència, Hospital de Sant Pau, Sant Antoni M. Claret, 171 08041, BarcelonaType: TrainingLevel: Basic-intermediatefacilitators: Dr. John Ioannidis, Stanford University School of Medicine, Human Genome Epidemiology Network, Society for Research Synthesis Methodology, European Journal of Clinical Investigation. USA.Target audience: Health care professionals Language: English

SAT02 | INVESTIgACIÓN EN SEgURIDAD DEL PACIENTE

fecha/ Hora/ Sala: Martes 18 / 10:00 / Agencia Laín Entralgo, Aula 4.3, Calle gran vía, 27 28013, Madrid. Tipo: FormaciónNivel: Básico-intermedioDocentes: Hernando Gaitán, Universidad Nacional de Colombia. Ezequiel García-Elorrio, Universidad Nacional de Colombia. Nick Sevdalis, Imperial College of London, UK. Jesús López Alcalde, Agencia Laín Entralgo, España.A quién va dirigido: Profesionales de la salud en generalIdioma: Castellano

SAT03 | SUMMARy Of fINDINgS TAbLE AND ASSESSMENT Of QUALITy Of EVIDENCE (gRADE)

Date/ Time/ Place: Tuesday 18 / 10:00 / Agencia Laín Entralgo. Aula Magna, Calle gran vía, 27 28013, Madrid. Type: TrainingLevel: Basic-intermediatefacilitators: Holger Schünemann, McMaster University, CanadaTarget audience: People affiliated with editorial teamsLanguage: English

SAT04 | THE METHODS SyMPOSIUM

Date/ Time/ Place: Tuesday 18 / 16:00 / Instituto de Salud Carlos III. Aula Magna, Escuela Nacional de Sanidad, Calle Silesio Delgado, 6 (entrance through Avda. Monforte de Lemos, 5), 28029, MadridType: DiscussionLevel: Intermediatefacilitators: Jackie Chandler, The Cochrane Collaboration Secretariat, UKTarget audience: Those involved in authoring or producing Cochrane reviews that include complex interventions or who have a methodological interest in evidence synthesis, as well as consumer representatives attending the colloquium.Language: English


SAT05 | ODONTOLOgíA bASADA EN LA EVIDENCIA

fecha/ Hora/ Sala: Miércoles 19 / 9:00 / ANTICISTipo: FormaciónNivel: BásicoDocentes: Prof. Dr. Julio Villanueva M., Universidad de Chile. Dr. Alonso Carrasco L., Universidad de Chile. Dr. Ignacio Araya C., Universidad de Chile.A quién va dirigido: Cirujano-dentistas generales y especialistas con interés en incorporar pruebas provenientes de la investigación clínica en la toma de decisiones clínicas.Idioma: Castellano

SAT06 | TALLER DE METANÁLISIS CON STATA

fecha/ Hora/ Sala: Miércoles 19 / 9:00 am / Sala 2bTipo: FormaciónNivel: Básico-IntermedioDocentes: Aureli Tobías, Instituto de Diagnóstico Ambiental y Estudios del Agua (IDAEA), Universidad Pompeu Fabra, España.A quién va dirigido: Todos los usuarios son bienvenidos.Idioma: Castellano

SAT07 | HERRAMIENTA “PRITECTOOLS” EN LA ObSERVACIÓN DE TECNOLOgíAS SANITARIAS TRAS SU INTRODUCCIÓN EN LA PRÁCTICA CLíNICA

fecha/ Hora/ Sala: Miércoles 19 / 9:00 am / AfRICATipo: FormaciónNivel: Básico-IntermedioDocentes: Marisa López García, Avalia-t, España. Leonor Varela Lema, Avalia-t, España. Teresa Cerdá Mota, Complejo Hospitalario de Pontevedra, España.A quién va dirigido: Profesionales sanitarios que desempeñan sus labores en áreas con una alta incorporación tecnologías innovadores en la práctica clínica. Directivos y Gestores hospitalarios y de servicios centrales que desarrollan su actividad en el ámbito de cartera de servicios. Miembros de las agencias de ETS y profesionales de la industria sanitaria con interés en el conocimiento de herramientas de priorización.Idioma: Castellano

SAT08 | APRENDIzAJE bASADO EN LOS PRObLEMAS (AbP): UN SALTO DE CALIDAD EN EDUCACIÓN MÉDICA

fecha/ Hora/ Sala: Miércoles 19 / 9:00 / vIPSTipo: FormaciónNivel: BásicoDocentes: Ricardo Hidalgo Ottolenghi, Centro Colaborador de la Red Cochrane Iberoamericana, Ecuador. Arturo Martí Carvajal, Red Regional Andina del Centro Cochrane Iberoamerican, Venezuela. Gonzalo Sandoval Carrión, Centro Colaborador de la Red Cochrane Iberoamericana, Ecuador. Manuel Sempértegui Gallegos, Centro Colaborador de la Red Cochrane Iberoamericana, Ecuador. Daniel Simancas Racines, Centro Colaborador de la Red Cochrane Iberoamericana, Ecuador. A quién va dirigido: Profesionales de la salud, profesores y docentes en cualquier ámbito sanitarioIdioma: Castellano


SAT09 | fROM NOVICE TO EXPERT TO MENTOR: INCREASINg PARTICIPATION IN THE COCHRANE COLLAbORATION IN LOW AND MIDDLE INCOME COUNTRIES

Date/ Time/ Place: Wednesday 19 / 9:00 am / MENINAType: DiscussionLevel: Basicfacilitators: Dr. Manu Mathew, INFORMER, Manipal University, India. Dr. Shivika Chandra, INFORMER, NIMHANS, India. Dr. Akshay Sharma, INFORMER, Emory University, EUA. Vikas Sud, INFORMER, Kasturba Medical College, India. Mrs. Vasumathi Sriganesh, QMed Knowledge Foundation, India. Dr. Kiran Ejaz, Aga Khan University Hospital, Pakistan. Dr. Prathap Tharyan, Christian Medical College, Cochrane Schizophrenia Group, India. Zbys Fedorowicz, Bahrain Branch of the UK Cochrane Centre, Bahrain.Target audience: Open to everybodyLanguage: English

SAT10 | TALLER JbI CONNECT+ (THE JOANNA bRIggS INSTITUTE CLINICAL ONLINE NETWORk Of EVIDENCE fOR CARE AND THERAPEUTICS)

fecha/ Hora/ Sala: Jueves 20 / 11:15 am / AULA 8Tipo: FormaciónNivel: BásicoDocentes: Laura Albornos, Instituto de Salud Carlos III, EspañaA quién va dirigido: Profesionales de enfermería y documentalistasIdioma: Castellano


TALLERES REDIBAM-GpC

R01 | REDIbAM-gPC: ¿CÓMO INCORPORAR LA SEgURIDAD DE LOS PACIENTES EN LA ELAbORACIÓN DE gPC?

fecha/ Hora/ Sala: Miércoles 19 / 18:00 / vIPSTipo: FormaciónNivel: Básico-IntermedioDocentes: Eduardo Briones, Servicio Andaluz de Salud, España. Carlos González Guitán, Bibliosaúde, EspañaA quién va dirigido: Profesionales de la salud en generalIdioma: Castellano

R02 | ELAbORACãO DE INDICADORES DE SEgURANçA A PARTIR DAS gPC bASEADAS EM EVIDêNCIA

fecha/ Hora/ Sala: Jueves 20 / 16:00 / Sala 9Tipo: FormaciónNivel: Básico-IntermedioDocentes:WanderleyMarquesBernardo,AssociaçãoMédicaBrasileiraeConselhoFederaldeMedicina, Brasil.A quién va dirigido: Profesionales de la salud en generalIdioma: Portugués

R03 | EVIDêNCIA DE bASE PARA AS gUIAS DE SEgURANçA DOS PACIENTES: UMA ANÁLISE METODOLÓgICA

fecha/ Hora/ Sala: Jueves 20 / 18:00 / Sala 9Tipo: FormaciónNivel: Básico-IntermedioDocentes: Antonio Vaz Carneiro, Faculdade de Medicina da Universidade de Lisboa, Centro de EstudosdeMedicinaBaseadanaEvidência,InstitutodeFormaçãoAvançada,BibliotecaCentral–CentrodeDocumentaçãoeInformação,ProgramaHarvardMedicalSchool-Portugal,Portugal.A quién va dirigido: Profesionales de la salud en generalIdioma: Portugués

© E

:M: P

rom

oció

n de

Mad

rid, S

.A. |

CAT

EDR

AL

DE

LA A

LMU

DEN

A

pOSTERSpÓSTERES

POSTER SESSION 1 • THRuSDAY OCT. 20SESIÓN DE PÓSTERES 1 • jUEVES, 20 DE OCTUBRE

10:30 - 11:15 1ST FLOOR HALL • 2ND FLOOR HALLVESTÍBULO 1ER PISO • VESTÍBULO 2º

POSTER SESSION 2 • FRIDAY OCT. 21SESIÓN DE PÓSTERES 2 • VIERNES, 21 DE OCTUBRE


POSTER SESSION 3 • SATuRDAY OCT. 22SESIÓN DE PÓSTERES 2 • SÁBADO, 22 DE OCTUBRE


POST

ERS

PÓST

ERES

80 | posters • pósters

pOSTER SESSION 1 THURSDAy OCT. 20SESIÓN DE pÓSTERES 1 JUEVES, 20 DE OCTUBRE

10:30-11:151st floor Hall

vestíbulo 1er piso

SEARCHINg AND INfORMATION RETRIEVAL (P1A1- P1A55)

P1A1: Is the retraction of journal articles in electronic journals and databases consistent and timely? A case study. Wright K, McDaid C.

P1A2: Comprehensive searching for systematic reviews: a comparison of database performance. Beyer F, Wright K.

P1A3: Threading the Needle we found in the Haystack - identifying ongoing trials with the Pan African Clinical Trials Registry. Abrams A, Pienaar E.

P1A4: Filled Gaps? Data after a year of the Pan African Clinical Trials Registry efforts to increase understanding and awareness of the child-focused clinical trial landscape. Abrams A.

P1A5: From final search to publication of HTA reviews: does the time gap have an influence on the usefulness of their results? Parekh-Bhurke S, Cook A, Chatting D, Fairbank E, Clarke A.

P1A6: Bibliometric analysis of 100 most cited Cochrane systematic reviews. Uthman O, Okwundu C.

P1A7: User-friendly search strategies for geriatric evidence in Medline. Van de Glind EMM, van Munster BC, Spijker R, Scholten RJ, Hooft L.

P1A8: Testing search strategies for geriatric medicine in the Cochrane Database of Systematic Reviews. Van de Glind EMM, Young C, Spijker R, Scholten RJ, van Munster BC, Stott DJ, Hooft L.

P1A9: Reconceptualising searching and screening: how new technologies might change the way that we identify studies. Thomas J, O’Mara A.

P1A10: Sorting the wheat from the chaff: how does the Cochrane HIV/AIDS Specialized Trials Register compare to searching standard electronic databases? Zani B, Oliver J, Siegfried N.

P1A11: Finding public health evidence: how many stones need to be turned? Morgan H, Bauschmann M, Weightman A.

P1A12: Are the searches of network meta-analysis comprehensive or well-reported? Tian J, Yang K, Liu A, Li L.

P1A13: What is the role of public trials registers in Cochrane systematic reviews? Blackhall K, Glanville J, Ker K.

P1A14: A Survey of Searching CBM and LILACS Databases in Cochrane Systematic Reviews. Chen Y, Yao L, Wang Z, Liang H, Liang F.

P1A15: The sensitivity and precision of adverse effects search filters in MEDLINE, EMBASE and Science Citation Index (SCI). Golder S, Loke Y.

P1A16: The usefulness of different information sources for retrieving adverse effects data for a systematic review. Golder S, Loke Y.

P1A17: A comparison of Embase systematic review filters. Martin S, McHugh J.

P1A18: A comparison of Embase randomised controlled trial filters. Martin S, McHugh J.

P1A19: A comparison of two search methods for determining the scope of systematic reviews. Forsetlund L, Kirkehei I, Harboe I, Odgaard-Jensen J.

P1A20: Using a collaborative online platform to identify systematic reviews in LILACS. Rada G, Ciapponi A, Glujovsky D, Rivera S, Roa M, Abdala V.

P1A21: Searching the Chinese literature for public health interventions: Can it value add to a systematic review? Baker P, Sun J, Weightman A Francis D.

posters • pósters | 81

P1A22: Hard-to-reach and difficult-to-define: searching for ‘hidden’ populations.An example frompublic health. Cooper C, Levay P, Lorenc T, Craig G, Marrero-Guillamón I.

P1A23: Word frequency analysis of over a million words to support the development of search strategies on‘health-relatedvalues’.PetrorvaM,SutcliffeP,FulfordB,DaleJ.

P1A24: Unique trial identification numbers are underreported in biomedical publications. Van de Wetering F, Haring T, Scholten R, Hooft L.

P1A25: Access to ongoing paediatric drug trials in the Netherlands. Hooft L, Weber E, Hamelinck V, Offringa M.

P1A26: A central repository for data extracted in systematic reviews. Hadar N, Keefe S, Parkin C, Iovin R, Lau J1

P1A27: Cochrane Database utilization analysis: a 10 year trend of one medical center in Taiwan. Chen KH, Chen C, Kuo KN, Tzeng PC, Chien LT, Liu HE.

P1A28: Locating evidence for developing countries: a case study of three public health reviews. Stansfield C.

P1A29: “Irrelevant” or “neglected”? An analysis of RCTs in the ARI Group. Thorning S, Van Driel M, Del Mar C.

P1A30: Appraisal of search strategies in industry submissions for technology appraisal (ASSIST): reviewing search methods of industry submissions to NICE using a structured checklist. Allen A, Misso K, Riemsma R, Kleijnen J.

P1A31: Syncope and other adverse events associated with Cholinesterase Inhibitors: Systematic Review of the literature vs analysis of the FDA Adverse Events Database. López-Arrieta JM.

P1A32: Developing a search filter for identifying primary care studies in general medical journals. Roberts NW, Gill PJ, Wang KY, Heneghan C.

P1A33: The rate of publication of randomized controlled trials is near-exponential (2.5 times increase/decade with > 1.5 million computer listed trials) - A new strategy is required to fufil the Cochrane Challenge. Chow TKF

P1A34: Where and how to find data on safety: what do systematic reviews of complementary therapies tell us? Pilkington K, Boshnakova A

P1A35: Coding clinical trials and systematic reviews in The Cochrane Library using standard international schemas. Hawkins B, Ervin A, Dickersin K.

P1A36: Improving the efficiency of searches in Cochrane systematic reviews. Thorning S, Del Mar C, Van Driel M.

P1A37: Accuracy of the MeSH term “Breast Neoplasms”: ten years on. Tai FM, Willson ML, Ghersi D.

P1A38: Inconsistent quality of reporting of searching clinical trials registries in Cochrane systematic reviews and protocols. Ko H, Tai FM, Ghersi D, Askie LM.

P1A39: The Current Status of Clinical Research in Traditional Korean Medicine, South Korea. Jang B, Go H, Lee Y, Park S, Kim J, Cho KH.

P1A40: How does the number and scatter of trials vary by discipline? Glasziou P, Thorning S, Erueti C, Hoffmann T.

P1A41: Utilization analysis of Chinese abstract of the Cochrane Database of Systematic Reviews in three university hospitals. Chen C, Chen KH, Kuo KN, Tzeng PC, Chien LT, Lo HL, Tam KW.

P1A42: Development of search strategies to identify reports of off- label drug use in MEDLINE. Mesgarpour B, Müller M, Herkner H.


P1A43: Developing software for combining search queries to design efficient search strategies. Mesgarpour B, Mesgarpour M, Müller M, Herkner H.

P1A44: Identification of biomedical journals in Spain and Latin America. Bonfill X, Bonfill A, José E, GarciaM,RaiherS,ArandaE,RadaG,RincónD,TristánM,TorresA,HidalgoR,SimancasD,LópezL, Jiménez C, Piña M, Correa R, Rojas A, Loza C, Féliz E, Gianneo O, Patrón C, Martí A.

P1A45: Systematic Review Service (SRS) - China. Xia J.

P1A46: Handsearching respiratory conference abstracts: a comparison with abstracts identified by an EMBASE search. Stovold E, Hansen S.

P1A47: Ankle brachial index to predict cardiovascular events in primary health care, a systematic review.GalvãoALC1,SteinAT2,PellandaLC3,MarcadentiA4

P1A48: Geographic and language distribution of trials in Cochrane systematic reviews related to Acupuncture. Tung Y, Hou M, Chen Y.

P1A49: Drugs costs before and after bariatric surgery: A systematic review. Stein AT, Lopes EC, Heineck I, Athaydes G, Souto KP, Meinhardt NG.

P1A50: The updating of clinical practice guidelines: a systematic review of the research evidence. Martínez García L, Arévalo-Rodríguez I, Solà I, Hemens B, Vandvik PO, Haynes B, Alonso-Coello P.

P1A51: Uncommon language: The challenges of inconsistent terminology use for evidence synthesis. Parker RM, Hayden JA.

P1A52: A snowballing technique to ensure comprehensiveness of search for systematic reviews: a case study. Vedula S, Mahendraratnam N, Rutkow L, Kaufmann C, Rosman L, Twose C, Dickersin K.

P1A53: Searching far and wide for occupational prevention literature: Where do we go to find relevant studies? Van Eerd D, Mahood Q, Slack T.

P1A54: Identification and analysis of search strategies and filters carried out in systematic reviews indexed in Lilacs. Overview. Puga MEDS, Pereira RA, Figueiró MF, Melnik T, Carvalho APV, Riera R.

P1A55: Title-Abstract versus Title-Only Citation Screening Strategies for Systematic Reviews and Meta-Analyses. Mateen F, Oh J, Tergas A, Bhayani N, Kamdar B.

EDITORIAL PROCESSES AND SUPPORTINg REVIEW AUTHORS (P1A56- P1A68)10:30-11:15 • 1st floor Hall • Vestíbulo 1er piso

P1A56: International activity within Cochrane Review Groups. Allen C, Clarke M, Richmond K

P1A57: Experiences of undertaking a diagnostic test accuracy review with the Cochrane Oral Health Group. Walsh T, Littlewood A, Liu J.

P1A58: Epidemiology, Quality and Reporting Characteristics of the Randomized Controlled Trials on TCM for Gastric Cancer Published in Chinese Journal- Ma B, Ke Y, Su X, Xian L, Li Y, Yang K.

P1A59: Changes in Randomized Controlled Trials Reporting Quality Over Time: A Systematic Review of Journals from China in pediatrics. Ma B, Li H, Liu W, Zhang Y, Hu Q, Zhang Z.

P1A60: Reporting Standard for Qualitative Research: a good or a bad idea? Preliminary results from a Delphi study. Hannes K, Heyvaert M, Slegers K Van den Brande S, Vandewiele W, Van Houdt S, Van Nuland M.

P1A61: Obtaining funding for IPD meta-analyses: top tips for a successful application. Rydzewska L., Tierney J., Vale C.


P1A62: Helping readers understand review update status: pilot of a simple system. Sinclair D, Garner P.

P1A64: A tool to improve efficiency and quality in the production of protocols for Cochrane reviews of diagnostic test accuracy. Pennant M, Wisniewski S, Hyde C, Davenport C, Deeks J, on behalf of the Cochrane DTA ET.

P1A65: UK Prioritisation methods for Cochrane Reviews. Bailey SE, Stamp RJ, Clarke M.

P1A66: Improving the participation of women from developing countries in the Cochrane Collaboration: a pilot study. Koehlmoos TP, Nasser M, Kiwanuka S.

P1A67: From Barcelona to Madrid: history and quality of update reporting of Cochrane reviews flagged as updates in 2003 and analysed for the Barcelona Colloquium. Bastian H, Clarke M, Doust J, Glasziou P.

P1A68: Report on The Cochrane Empty Review Project Consensus Meeting: A proposal of empty review reporting guidelines and an invitation for feedback. Montgomery P, Yaffe J, Shepard L, Hopewell S.

EDITORIAL PROCESSES AND SUPPORTINg REVIEW AUTHORS (P1b69-P1b80)

P1b69: The Cochrane Empty Review Project: Prevalence and characteristics of systematic reviews without included studies in The Cochrane Database of Systematic Reviews. Shepard L, Yaffe J, Montgomery P, Hopewell S.

P1b70: A comparative analysis of systematic reviews published in Chinese academic journals and Cochrane library. Chen Y, Yao L, Liang F, Wang Q, Li J, Wei D, Xu H.

P1b71: Review or original article? The manuscript category of systematic review and meta-analysis in high-impact biomedical journals. Tam K, Tsai L, Kuo KN, Chen C, Lo H.

P1b72: Evaluation of data-synthesis in systematic reviews of studies on outcome prediction models. Van den Berg T, Heymans MW, Leone SS, Vergouw D, Hayden JA, Verhagen AP, de Vet HC.

P1b73: Editorial policies of hematology and oncology journals: An analysis of author instructions. Meerpohl JJ, Wolff RF, Grambauer N, Antes G, von Elm E.

P1b74: The influence of CONSORT on the quality of reporting of RCTs: An updated systematic review. Turner L, Moher D, Shamseer L, Weeks L, Peters J, Plint A, Altman D, Schulz K.

P1b75: A case report on updating Cochrane Reviews. Nicola Maayan

P1b76: When should systematic reviews of effects restrict studies to those conducted in low- and middle-income countries: a proposal? Munabi-Babigumira S, Lewin S, Glenton C, Oxman A.

P1b77: Using program theory to understand heterogeneity in systematic effectiveness reviews. Cargo M, Stankov I, Thomas J, Hannes K, Saini M, Mayo-Wilson E, Rogers P.

pOSTER SESSION 1 THURSDAy OCT. 20SESIÓN DE pÓSTERES 1 JUEVES, 20 DE OCTUBRE

10:30-11:152nd floor Hall

vestíbulo 2º piso


P1b78: Analysing the growth in impact of the Cochrane Database of Systematic Reviews (CDSR). Pentesco-Gilbert D, Stewart G.

P1b79: Does one click access matter? Global Usage of The Cochrane Review – 2010 analysis. Wilkins S, Stewart G, Pentesco-Gilbert D.

P1b80: How to involve consumers: a guide for Cochrane Editors. McIlwain C.

gLObAL HEALTH AND EQUITy (P1b81-P1b102)10:30-11:15 • 2nd floor Hall • Vestíbulo 2º piso

P1b81: Ivermectin and benzimidazoles for treating strongyloides infection. Echevarria J, Gotuzzo E, Samalvides F, Terashima A.

P1b82: Sex- and gender-based analyses in Cochrane reviews: methods and lessons learned. Ueffing E, Pardo Pardo J, Welch V, Borkhoff CM, Kristjansson E, Petticrew M, Tugwell P.

P1b83: Methodological Quality of Randomized Controlled Trials on Gastric Cancer Treated with Traditional Chinese Medicine Published in Chinese Journal. LI H, HU Q, LIU W, MA B.

P1b84: Financial health equity. Intervention for balance and financial stability of national health providing institutions, health promoters and insurers. Kadar I.

P1b85: Agreement and alignment: current status of clinical practice guidelines within the Southern African Development Community. Kredo T, Gerritsen A, van Heerden J, Conway S, Siegfried N

P1b86: Neglected Tropical Diseases: are global policies based on reliable evidence? Nagpal S, Garner P.

P1b87: High 5s project – Hospital Survey on Patient Safety Culture results from Germany. Kolbe M, Lessing C, Fishman L, Renner D, Thomeczek C.

P1b88: Cutaneous Leishmaniasis International Observatory: an initiative for Evidence-based Global Health.GonzálezU,Ruiz-BaquésA

P1b89: The Role of the Medical Information Database in Managing the East Japan Disaster. Nango E, Naito T, Toyoshima Y, Yoshimoto H, Nakayama T.

P1b90: A Systematic Review Identifies Substantial Heterogeneity Of Studies Evaluating Effects Of Rural-to-urban Migration On Cardiovascular Risk Factors In Low And Middle Income Countries. Hernandez AV, Pasupuleti V, Deshpande A, Bernabe-Ortiz A, Miranda JJ.

P1b91: Integrating prevention of mother-to-child HIV transmission programmes to improve uptake: a systematic review. Tudor Car L, Van Velthoven MH, Brusamento S, Elmoniry H, Car J, Majeed A, Tugwell P, Welch V, Marusic A, Atun R.

P1b92: Evidence-based African first aid guidelines and training materials. Van de Velde S, De Buck E, Vandekerckhove P, Volmink J.

P1b93: Criteria for judging the effectiveness of public health interventions. Denison E, Vist GE.

P1b94: Using “Implications for practice” from Cochrane reviews to promote worldwide improvements in healthcare. Newbatt E, Gholitabar M, McGuire H, Ullman R.

P1b95: Evidence-based medicine as a safety parameter for the judicialization of health policies. Marin dos Santos D, Puga ME, Bartolomei C, Marchewka T.


P1b96: A novel approach to building evidence for improving communication about childhood vaccinationsinlow-andmiddle-incomecountries:the‘communicatetovaccinate’(COMMVAC)project.Lewin S, Hill S, Kaufman J, Galak N, Kis-Rigo J, Anderson L, Bosch-Capblanch X, Hussein L, Lin V, Mahomed H, Rhoda L, Robinson P, ben Saude de Castro Freire S, Waggie Z, Wiysonge C.

P1b97: VIP (Very Integrated Program) Project on alcohol and drug abusers in Southern Sweden - RCT of efficacy of the adding the Health Promotion and Rehabilitation for treatment of alcohol and drug abusers. Hovhannisyan K, Ehrnström M, Kovacs J, Skagert E, Hau Skibelund D, Thornqvist K, Tønnesen H.

P1b98: The international distribution of RCTs in Cochrane dementia intervention reviews. Marcus S, Noel-Storr A, Struthers C.

P1b99: Assessing applicability, scaling up and equity issues in Cochrane reviews: a worked example from a review of lay health worker interventions in primary and community health care for chronic conditions. Lewin S, Munabi-Babigumira S, Glenton C, Scheel I, Bosch-Capblanch X, Daniels K, van Wyk B Aja G, Zwarenstein M.

P1b100: Clinical practice guideline: dental care for patients with Epidermolysis Bullosa. Krämer SM, Villanueva J, Serrano C, Galvez P, Zillmann G, Araya I, Oliva P, Carrasco A, Brignardello R, Yanine N, Cornejo M.

P1b101:Examining‘transportability’issuesinsystematicreviews:theexampleofparentinginterventionsin developing countries. Gardner F, Knerr W, Lucie C.

P1b102: Re-analysing Equity in a Cochrane Review: Smoking Cessation in Pregnancy. O’Mara A, Oliver S, Chamberlain C, Caird J, Barnett-Page E, Thomas J.

kNOWLEDgE TRANSLATION IN PATIENT SAfETy (P1b103-P1b117)10:30-11:15 • 2nd floor Hall • Vestíbulo 2º piso

P1b103: The building blocks of safety: creating multi-disciplinary micro-systems and departmental PSOs as the foundation for a successful patient safety program. Shaw K, Rickard S, Reay T, Thomson D.

P1b104: Assessment of hospital capacities in patient safety in the Philippines. Acuin J.

P1b105: Safe care for children: a scoping review of what we know, and what we need to find out. Thomson D, Seto I, Scanlon M.

P1b106: Six sigma applications for patient safety in a university hospital. Mejia HM.

P1b107: A survey analysis of patient for patient safety in China. Zhang Q, Li Y, Zhang L, Yin Q, Shang L, Wei X, Zhang M.

P1b108: Patient for patient safety research in Cochrane Library. Zhang Q, Zhang M.

P1b109: Patients for patient safety: a systematic review. Li Y, Huang Y, Nie Y, Li J, Zhang M.

P1b110: Knowledge translation in patient safety: what barriers are present to asses the evidence in practitioners? Perez S, Rodriguez V, Cattivera C, Pardo J, García Elorrio E.

P1b111: Paediatric patient safety: the distinctive nature of childhood must be part of the equation. Thomson D, Matlow A, Rickard S, Scanlon M, Williams K.

P1b112: Evidence evaluation in ranking target areas of interest for a national patient safety campaign. Lauvrak V, Norderhaug IN, Saunes IS, Krogstad U.


P1b113: Opioids for chronic pain: evidence of effectiveness, consistency of use, and public health issues. Harris J.

P1b114: Evidence to support patient safety improvement. Harris J

P1b115: EXTRACTING Clinically Relevant Messages from Drug Class Review. Melvin C, Carey T, Ranney L.

P1b116: Instruments and methodologies used for detecting and characterizing adverse events in ambulatorycare:asystematicreview.GaitánDuarteH,VallejoOrtegaMT,GarcíaDieguezM,EsandiME, de Luca M, Milberg M, Cho M, Monserrat - Capella D, Reveiz L.

P1b117: Update of Cochrane systematic review of audit and feedback demonstrates stability in findings – will future trials be helpful? Ivers N, Jamtvedt G, Flottorp S, Young J French S, O’Brien MA, Johansen M, Odgaard-Jensen J, Oxman A, Grimshaw J.

EDUCATION AND TRAININg (P1b118- P1b132)10:30-11:15 • 2nd floor Hall • Vestíbulo 2º piso

P1b118: A Survey of the awareness rate of GRADE in China. Chen Y, Yang K, Wang Z, Yao L, Wang X.

P1b119: Building capacity in EBHC: What is happening in the African region? Rohwer A, Young T.

P1b120: Reporting Quality of Randomized Controlled Trials on Gastric Cancer Treated with Traditional Chinese Medicine Published in Chinese Journal. Qi G, Lin X, Chen Z, Wang T, Ma B.

P1b121: An effective model for training social workers in evidence-based practice in Korea. Hwang S.

P1B122: The effect evaluation of the postgraduate training program of systematic reviews. Weng YH, Shih YH, Lo HL, Kuo KN, Chen CF, Chiu YW.

P1b123: Complex interventions required to comprehensively educate allied health practitioners on evidence-based practice. Dizon JM, Grimmer-Somers K.

P1b124: Evidence based practice workshop for senior managers in Ethiopia. Abdulwadud O, Young T, Hailu K, Rangwala A, Midekssa M, Volmink J, Garner P.

P1b125: Measuring the quality of End-of-Life Care: Palliative Care of Cancer Patients. Ko W.

P1b126:DevelopmentofasystematicreviewunitoftheBotucatuMedicalSchool(FMB),SãoPauloState University in Brazil. El Dib R, Rudge MV, Schellini SA, Barretti P, Cataneo A, Nogueira CR, Betini M, Yoshida WB.

P1b127: Introduction to EBP in the Humanitarian Services of the Belgian Red Cross-Flanders: Experiences from a newly developed workshop. Dieltjens T, Van de Velde S.

P1b128: Educational Models and Their Application in Medical Research Training: a Meta-analysis. Ejaz K, Zia N, Shamim MS.

P1b129: Mentoring clinicians in conducting systematic reviews through a clinical fellowship program. Chau M, Pitt V, Green S, Gruen R, Bragge P.

P1b130: Current practice of Filipino physiotherapists in Metro Manila, Philippines. Dizon JM, Grimmer-Somers K, Kumar S.

P1b131: Access alone does not guarantee use: the need for training to use evidence based resouces. Sriganesh V.

P1b132: Igniting minds: Use of Cochrane resources as educational tools for training medical students in developing countries. Shivika Ch.


INfORMATION AND COMMUNICATION TECHNOLOgy (P1b133-P1b134)10:30-11:15 • 2nd floor Hall • Vestíbulo 2º piso

P1b133: Do e-interventions for medication management in ambulatory care pose a threat to patient safety? A systematic review. Carling C.

P1b134: Are computerized clinical decision support systems effective at improving the process of care and patient outcomes, and what makes an effective system? A decision-maker-researcher partnership systematic review. Roshanov P, Hemens BJ, Nieuwlaat R, Souza N, Sahota N, Wilczynski J, Fernandes N, Haynes RB.

METHODS fOR PREPARINg REVIEWS (NON-STATISTICAL) (P2A135-P2A196)P2A135: The COMET (Core Outcome Measures in Effectiveness Trials) Initiative. Williamson P, Altman D, Blazeby J, Clarke M, Gargon E.

P2A136: Purity or pragmatism: how does systematic review methodology from health care translate to the field of development? Stewart R, van Rooyen C, de Wet T.

P2A137: Reviewing psychometric properties of HRQL measures in mental health: practical experience. Papaioannou D, Brazier J.

P2A138: External validity and generalizability of systematic reviews in primary health care: adapting the methodology to conduct the review. Nasser M, van Binsbergen JJ, van de Laar FA, van Weel C, Buechter R.

P2A139: Prioritising whether and when to update Cochrane reviews. Hopewell S, Takwoingi Y, Sutton A.

P2A140: Uncertainty in control group risk can, in systematic reviews, undermine confidence in estimates of effect. Guyatt G, Vandvik P, Spencer F, Akl E, Falck-Ytter Y, Schunemann H.

P2A141: Estimating risk differences in patient-important events when studies have focused on surrogate outcomes: application to systematic reviews and practice guidelines. Guyatt G, Akl E, Murad MH, Falck-Ytter Y, Gould M, Eikelboom J.

P2A142: The evidence base for interventions delivered to children in primary care: an overview of Cochrane systematic reviews. Gill P, Wang KY, Mant D, Hartling L, Heneghan C, Perera R, Klassen T, Harnden A.

P2A143: Variability of outcome measures among trials of topical Chinese herbal medicines for musculoskeletal injuries. Wang L, Yuan Q, Li X, Li Y.

P2A144: Still too little qualitative research to shed light on results from reviews of effectiveness trials: A case study of a Cochrane review on the use of lay health workers. Glenton C, Lewin S, Scheel I.

pOSTER SESSION 2 fRIDAy OCT. 21 SESIÓN DE pÓSTERES 2 VIERNES, 21 DE OCTUBRE


vestíbulo 1er piso


P2A145: Guidelines for conducting and reporting reviews of reviews: Dealing with topic relevance and double-counting. O’Mara AJ, Jamal F, Parry W, Lorenc T, Cooper C.

P2A146: Using EpiData software to extract data for Cochrane systematic review. Liu Z, Li X, Visconte D, Lewith G, Liu J.

P2A147: Indirect meta-analysis of uncontrolled studies about two independent regimes: an case report. Sun T, Wang J, Fang J.

P2A148: A rapid systematic review versus a Cochrane systematic review: an empirical comparison. Rizzo M, Llewellyn A, Martin A.

P2A149: Development and Evaluation of a Study Designs Typology for Medical Literature of Intervention. Seo HJ, Kim SY, Park JE, Lee YJ, Shin SS, Hahn SK.

P2A150: Validation and application of a systematic review and narrative synthesis within mental health services research. Bird V, Leamy M, Williams J, Le Boutillier C, Slade M.

P2A151: Systematic review and synthesis of quantitative and qualitative research: a worked example to assess community preferences. Tong A, Howard K, Jan S, Cass A, Rose J, Chadban S, Allen R, Craig J.

P2A152: Causal mapping for systematic reviews of complex social interventions. Lorenc T, Clayton S, Neary D, Petticrew M, Whitehead M.

P2A153: A worked example of “best fit” framework synthesis: A potentially more consistent or reliable form of qualitative data synthesis? Booth A, Cooper K.

P2A154: Mixed-methods synthesis for community-level public health interventions: Some considerations from a review of skin cancer prevention. Lorenc T, Jamal F, O’Mara A, Cooper C.

P2A155: Overviews of systematic reviews often do not assess methodological quality of included reviews. Büchter R, Pieper D, Jerinic P.

P2A156: The data was unobtainable - a survey of the reporting of missing data in a sample of Cochrane reviews. Struthers C, Noel-Storr A.

P2A157:Mixingwiththe‘unclean’: includingnon-CochranereviewsalongsideCochranereviewsinoverviews of reviews. Foisy M, Becker LA, Chalmers JR, Boyle RJ, Simpson EL, Williams HC.

P2A158: Risk difference estimation and reporting in systematic reviews. Alonso-Coello P, Neumann I, Carrasco-Labra A, Brignardello-Petersen R, Irfan A, Solà I, Dahm P, Glujovsky D, Johnston B, Martinez L, Ramirez-Morera A, Sun X, Vandvik PO, Akl E, Tikkinen KA, Iorio A, Santesso N, Brozek J, Schünemann H, Guyatt G.

P2A159: Using Qualitative Evidence to Inform a Review of Effectiveness: A Case Study of Integrating Qualitative Data in a Systematic Review of Effectiveness of ECT for Adult Depression. Berg R, Leiknes KA, Hoie B.

P2A160: Methodological Perspectives on a Realist Synthesis: An Explanatory Analysis of the Effectiveness of Female Genital Mutilation/Cutting (FGM/C) Abandonment Efforts. Berg R, Denison E.

P2A161: New and emerging methods of research synthesis: are they given sufficient attention? Petrova M.

P2A162: Feasibility of fast track systematic review for policy makers: interchangeability between pneumococcal conjugate vaccines. Ciapponi A, García Martí S, Rey-Ares L, Glujovsky D, Bardach A, Valanzasca P, Lee A, Cafferata ML.

P2A163: Use of WOMAC for the assessment of treatment benefit for the pain of osteoarthritis of the knee. Woolacott N, Corbett M, Slack R, Rice S.


P2A165: Defining study designs in The Cochrane Collaboration: do all Cochrane Review Groups talk the same language? López-Alcalde J, Calcerrada N, Callejo D, Reza M, Gracia FJ, Maeso S, Escalona S,NietoB,FernándezdeLarreaN,ValentínB,BlascoJA.

P2A166: Why and when children are different: guidance on appropriate inclusion of child health data in systematic reviews. Thomson D, Williams K, Hartling L.

P2A167: Systematic reviews of complex interventions: from bare bones to greater policy relevance. Snilstveit B, Waddington H.

P2A169: Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews. Melnik T, Soares B, Puga E, Atallah A, Rufino C.

P2A170: Nonrandomised studies in reviews of effective professional practice and the organisation of health care: Do authors consider them and do they find them? Glenton C, Lewin S, Mayhew A, Scheel IB.

P2A171: Determining appropriate inclusion criteria for reviews of public health interventions: skin cancer prevention as a case study. McDaid C, Sowden A, Paton F.

P2A172: Piloting realist review methods to assess cost-effectiveness within the context of a systematic review. Anderson R, Pearson M, Shepperd S, Pawson R, Hunt H, Cooper C, Shemilt I.

P2A173: Amalgamating individual patient data for meta-analysis: an I.T. perspective. Hilken N, Middleton L, Champaneria R, Daniels J.

P2A174: Report of an Evidence-Based Practice of Acupuncture Treatment of Essential Hypertension. Guo XF, Wu DR.

P2A175: A descriptive analysis of overviews of reviews published between 2000 and 2010. Hartling L, Chisholm A, Thomson D, Dryden DM.

P2A176: Methodological challenges associated with network meta-analyses: The experience of the Musculoskeletal Group. Tanjong Ghogomu E, Maxwell L, Singh J, Christensen R, Wells G, Buchbinder R, Tugwell P.

P2A177: Are all Cochrane reviews born equal? Methodological quality across different Review Groups. Pantoja T, Moreno G, Mayhew A, Rivera S, Claro JC.

P2A178: Systematic reviews of the effectiveness of quality improvement strategies and programmes: some methodological issues. Pantoja T, Mayhew A, Grimshaw J.

P2A179: Minimal clinically important differences in acute pain. Tendal B, Ortner N, Gøtzsche PC, Hróbjartsson A.

P2A180: Does Patient Expectation Affect Treatment Outcomes?: A Preliminary Investigation on Expectations and Outcomes. Lee H, Zhang X, Cho S, Lee H.

P2A181: Consulting with young people to inform systematic reviews: an example from a review on the effects of schools on health. Jamal F, Harden A, Wells H, Bonell C.

P2A182: Using systematic reviews to study adverse drug reactions: the example of heparin-induced thrombocytopenia. Junqueira DRG, Carvalho MDG, Perini E.

P2A183: A network meta-analysis of randomized controlled trials of target therapy for mRCC. Chan A, Leung H.

P2A184: How useful is GRADEpro for assessing evidence from epidemiological or diagnostic accuracy studies. Gholitabar M, Ullman R, Newbatt E, Fields E, Kenny J.


P2A185: Systematic reviews in dentistry have problems including split-mouth and cross-over trials in meta-analysis. Carrasco-Labra A, Brignardello-Petersen R, Araya I, Yanine N.

P2A186: Designs and Analysis of N-of-1 trials: A systematic review. Perdices M, Barrowman N, Sampson M, Shamseer L, Bukutu C, Vohra S.

P2A187: Acoherentframeworkforchoosing‘fitforpurpose’reviewmethods.OliverS,ThomasJ,Gough D.

P2A188: Incorporating the GRADE approach in overviews of SR: an example from an overview in neonatal respiratory care. Rojas M, Lozano J, Sola I, Bonfill X.

P2A189: A pilot Mixed Methods Appraisal Tool (MMAT) for systematic mixed studies reviews. Pluye P, Cargo M, Robert E, Bartlett G, O’Cathain A, Griffiths F, Boardman F, Gagnon M, Rousseau M.

P2A190: Systematic Reviews of Adverse Events. Is Screening by Title and Abstract Enough? Zorzela L, Punja S, Joffe A, Hartling L, Loke Y, Vohra S.

P2A194: Challenges facing reviewers preparing overviews of reviews. Flodgren G, Shepperd S, Eccles M.

P2A195: GRADE in Cochrane Systematic Reviews : An Investigation. Xiao J, Zhen H, Chen Y, Yuan J, Ke W, Li Y, Li M, Zhao X, Li X, Liu Y.

P2A196: Drug reviews should state industry-related bias in abstracts and plain language summaries. Napoli M, Simi S.

INVESTIgATINg bIAS (P2A197-P2A202)10:30-11:15 • 1st floor Hall • Vestíbulo 1er piso

P2A197: Association between risk of bias and the effects of interventions on mortality in of randomized controlled trials in critical care medicine. Unverzagt S, Prondzinsky R.

P2A198: Extraction error or interpretation: A case study of event data extraction in systematic reviews from three high-impact, high-quality peer-reviewed sources. Carroll C, Scope A, Kaltenthaler E.

P2A199: Heterogeneity in systematic reviews on spinal surgery: a meta-epidemiological study. Jacobs W, Kruyt M, Verbout A, Oner C.

P2A200: Attributes of non-randomized studies associated with bias. Sandhu L, Tomlinson G, Kennedy E, Wei A, Baxter N, Urbach D.

P2A201: Reporting of participant flow diagrams in published reports of randomized trials. Hopewell S, Hirst A, Collins G, Mallett S, Yu L, Altman D.

P2A202: Quality of studies reporting patient-reported outcomes identified within a systematic review on low-dose rate brachytherapy for localized prostate cancer. Peinemann F, Grouven U, Sauerland S.


pOSTER SESSION 2 fRIDAy OCT. 21 SESIÓN DE pÓSTERES 2 VIERNES, 21 DE OCTUBRE


vestíbulo 2º piso

INVESTIgATINg bIAS (P2b203-P2b260)

P2b203: Systematic reviews of paediatric surgical interventions: quantity, coverage and quality. McGee R, Craig J, Webster A.

P2b204: Core outcomes in systematic reviews of paediatric surgical interventions. McGee R, Craig J, Webster A.

P2b205: “Fatal flaws” in randomised controlled trials of interventions for low-back pain. Henschke N, Ostelo R, van Tulder M.

P2b206: Trends over time in the size and quality of randomised controlled trials of interventions for chronic low-back pain. Henschke N, Kuijpers T, Rubinstein S, van Middelkoop M, Ostelo R, Verhagen A, Koes B, van Tulder M.

P2b207: The risk-of-bias and standards of reporting of published randomized controlled trials of medical education (Med Ed) research. Horsley T, Rabb D, Campbell C, Hamstra S, Cook D.

P2b208: Are overview of (systematic) review really of good quality and transparent information? Li L, Yang K, Han D, Tian J, Sun T.

P2b209: What are the reporting and methodological qualities of network meta-analysis? Li L, Sun T, Han D, Yang K, Tian J.

P2b210: Epidemiology and quality of reporting of conference abstracts related to randomized controlled trials in renal transplantation. Wang X, Jiang J, Li L, Tian J, Tian H, Ying X.

P2b211: The relationship between risk of bias and effect size: randomized controlled trials. Dolores F, Héctor M.

P2b212: Definitions of intention-to-treat in the face of missing outcome data: a systematic survey of methodology papers. Alshurafa M, Guyatt GH, Akl EA, Haines T, Gentles S, Rios L, Tran C, Lamontagne F, Moayyedi P, Walter SD, Briel M.

P2b213: Methodological and reporting quality of systematic reviews on influenza. Jiang J, Wang X, Tian.

P2b214: Characteristics of randomized controlled trials (RCT) published in Latin America and the Caribbean’s (LAC) in 2010. Reveiz L, Glujovsky D, Pinzon CE, Asenjo-Lobos C, Cortes M, Canon M, Bardach A, Comandé D, Cardona AF.

P2b215: Impact of the trial registration initiative in Latin America and the Caribbean’s: a study of randomized controlled trials published in 2010. Reveiz L, Bonfill X, Glujovsky D, Pinzon CE, Asenjo-Lobos C, Cortes M, Canon M, Bardach A, Comandé D, Cardona AF.

P2b216: Does the sensitivity of tests for Down Syndrome really decrease with maternal age? A case-study illustrating the potential impact of loss to follow up on review conclusions. Pennant M, Guo B, Alldred K, Neilson J, Alfreivic Z, Deeks J.

P2b217: Split-Mouth and crossover trials in dentistry are neither well differentiated, nor well analyzed or reported. Brignardello-Petersen R, Carrasco-Labra A.

P2b218: Are there discipline-specific quality measures? A systematic review of meta-epidemiological studies. Jacobs W, Kruyt M, Moojen W, Verbout A, Oner C.

P2b219: Epidemiology and publication history of randomized controlled trials that were discontinued. Blümle A, Kasenda B, Saccilotto R, Briel M, von Elm E.

P2b220: Sponsors’ influence on reporting of results in industry-sponsored trials: a comparison of protocols and published papers. Lundh A, Krogsbøll LT, Gøtzsche PC.


P2b221: Critical appraisal checklist for systematic reviews of clinical prediction models. Moons KG, Bouwmeester W, Collins G, Mallet S, Altman D, Reitsma J.

P2b222: Comparison of adverse effects data derived from different study designs. Golder S, Loke Y, Bland M.

P2b223: How do systematic reviews of insulin and drug therapies for diabetes deal with heterogeneity of results? Sun X, Troung J, Dattani N, Wong E, Kapend P, Bianca H, Sherifali D, Wang L, Nereberg K, Guyatt G.

P2b224: Sponsorship of drug and device studies and research outcome. Lundh A, Lexchin J, Sismondo S, Busuioc OA, Bero L.

P2b225: Adding unpublished Food and Drug Administration (FDA) data changes the results of meta-analyses. Hart BL, Lundh A, Bero LA.

P2b226: Overestimation of treatment benefits in single-centre osteoarthritis trials may be related to sample size: meta-epidemiological study. Nüesch E, Trelle S, Reichenbach S, Jüni P.

P2b227: Assessing the quality of non-randomised comparative studies: Our experience of using the Cochrane Collaboration’s risk of bias tool. Robertson C, Ramsay C, Gurung T, Mowatt G, Pickard R, Sharma P.

P2b228: A meta-epidemiological approach for evaluating bias and small study effects in networks of interventions. Chaimani A, Schmid C, Vasiliadis H, Salanti G.

P2b229: First results of a Systematic Review of Metaanalyses on the Efficacy of SSRI and SNRI in the Treatment of Major Depression. Koesters M, Zhang Y, Weinmann S, Cipriani A, Barbui C, Becker T.

P2b230: What can we learn from Chinese randomized controlled trials? A systematic review of Chinese venlafaxine studies. Koesters M, Zhang Y, Ma YC, Weinmann S, Becker T, Jin WD.

P2b231: Industrial funding of research is associated with practice of survival analysis. Vlassov V, Gemjian E.

P2b232: True methodological quality of trials are not reflected in their reporting. Mhaskar R, Magazin A, Soares H, Kumar A, Djulbegovic B.

P2b233: Impact of reported vs. actual methodological quality assessment on treatment effect size. Mhaskar R, Magazin A, Kumar A, Djulbegovic B.

P2b234: Observer bias in randomised clinical trial with continuous outcomes. An analysis of trials with both blind and nonblind outcome assessors. Hróbjartsson A, Thomsen ASS, Emanuelsson F, Thomsen B, Hilden J, Ravaud P, Boutron I, Brorson S.

P2b235: Pooled standardised mean differences and estimated heterogeneity between trials depend on the type of assessment tool analysed: meta-epidemiological study. Da Costa BR, Rutjes AWS, Johnston BC, Nüesch E, Reichenbach S, Guyatt G, Jüni P.

P2b236: Methodological adequacy of articles published in two open-access Brazilian cardiology periodicals. Macedo CR, Silva DL, Melnik T, Rachel R, Pedrosa A, Torloni R, Silva EMK, Atallah AN, Puga ME.

P2b237: Are We Evaluating Methodological Quality in the Same Way? Comparison of Tools Used in General Health Research and Physical Therapy with the Risk of Bias Tool. Armijo-Olivo S, Ospina M, Rowe B, Hartling L.

P2b238: Methodological quality of malaria RCTs conducted in Africa. Lutje V, Gerritsen A, Siegfried N.

P2b239: A systematic review on the efficacy of statins in animal model. Pecoraro V, Moja L, Dall’Olmo L, Cappellini G, Liberati A, Garattini S.


P2b240: Shifting effects in three randomised controlled trials on music therapy in mental health. Gold C, Erkkilä J, Crawford M.

P2b241: Reporting randomized clinical trials in surgery can be improved; a systematic review. Verhagen AP, v Middelkoop M, Rubinstein SM, Jacobs WC, Ostelo RW, Peul W, Koes BW, v Tulder MW.

P2b242: Assessing risk of bias in non-randomised studies and incorporating GRADE: Initial experience with a newCochrane ‘risk of bias’ tool under development.MacLennanS, ImamuraM,DahmP,Neuberger M, Reeves B, MacLennan G, Omar MI, McClinton S, Griffiths L, N’Dow J.

P2b243: Conflicting Guidelines for Screening Mammography: Influence of Author’s Specialty and Conflicts of Interest. Burda B, Holmer H, Ogden L, Fu R, Norris S.

P2b244: Assessment of trial risk of bias among Cochrane reviews: a cross-sectional analysis. Abou-Setta A, Dryden D, Hamm M, Moher D, Klassen T, Hartling L.

P2b245: Does stratification analysis indicate the confounding factors in meta-analysis of observational studies? Naing C, Mak JW.

P2b246: Unplanned crossover in randomised controlled trials: consequences for efficacy and safety outcomes. D’Amico R, Bonafede E, Balduzzi S, Longo G, Guarneri V, Piacentini F, Moja L, Liberati A.

P2b247: Applicability of R-AMSTAR instrument to appraise systematic reviews. Martínez-Zapata MJ, Rigau D, Selva A, Gich I, Bonfill X.

P2b248: How often do decision analyses of interventions agree with matching systematic reviews? Mhaskar R, Georgiev H, Wao H, Kumar A, Djulbegovic B.

P2b249: Epidemiology of the type of intention-to-treat reporting in meta-analyses. Montedori A, Bonacini MI, Luchetta ML, Papini D, Rocchi RE, Orso M, Cozzolino F, Abraha I.

P2b250: Using AMSTAR to assess the methodological quality of systematic reviews: an external validation study. Parmelli E, Banzi R, Fernandez Del Rio MDP, Minozzi S, Moja L, Pecoraro V, Liberati A.

P2b251: Systematic evaluation of the methodology of randomized controlled trials of anticoagulation in patients with cancer. Rada G, Schünemann H, Labedi N, Akl E.

P2b252: An online tool to assess the potential impact of missing outcome data on the estimates of treatment effect of trials. Akl E, Agarwal N, Guyatt G.

P2b253: Conflict of interest policies for clinical practice guideline organizations do not measure up to IOM standards. Norris SL, Holmer HK, Ogden LA.

P2b254: Reporting of conflicts of interest in Cochrane reviews of trials of pharmacological treatments. Roseman M, Bero LA, Coyne JC, Lexchin J, Turner EH, Thombs BD.

P2b255: The placebo response in neuropathic pain trials: it’s not what you think. Selph S, Carson S, McDonagh M.

P2b256: Concordance of reporting of primary outcomes in abstracts and full text of randomized clinical trials: is there an outcome reporting bias? Ribic C, Lamontagne F, Johnston B, Briel M, You J, Sun X, Busse J, Bassler D, Vera C, Al-Shurafa M, Mills E, Guyatt G, Cook D, Akl E.

P2b257: Conflict of interest among clinical practice guidelines authors. Selph S, Holmer H, Ogden L, Norris S.

P2b258: Questionable early stopping: case study of supplemental perioperative oxygen and the incidence of surgical site infection. Tikkinen KAO, Garcia-Alamino JM, Devereaux PJ, Guyatt GH, Alonso-Coello P.


P2b259: The quality of trials in quality improvement: systematic review of risk of bias in diabetes studies. Ivers N, Tricco A, Turner L, Moher D, Grimshaw J.

P2b260: Development of the McHarm: A tool evaluating validity of the collection and reporting of harms. Santaguida P, Keshavarz H, MacQueen G, Levine M, Beyene J, Raina P.

DIAgNOSTIC TEST ACCURACy REVIEW METHODS (P2b261-P2b271)10:30-11:15 • 2nd floor Hall • Vestíbulo 2º piso

P2b261: Reporting of meta-analyses and systematic reviews of screening tests in China. Tian HL, Tian JH, Yi K, Gou YN, Yang KH.

P2b262: Methodological developments and statistic software used in diagnostic systematic reviews in China. Chong L, Sun R.

P2b263: Epidemic characteristics and quality of meta-analysis/systematic review in screening test. Tian HL, Gou YN, Yi K, Tian JH, Wang XJ, Yang KH.

P2b264: Addressing methodological challenges in evaluating diagnostic tests: combining the “Grading of Recommendations Assessment, Development and Evaluation (GRADE)” approach and the RAND/UCLA Appropriateness Method to produce clinical recommendations. Ballini L, Vignatelli L, Negro A, Maltoni S, Grilli R.

P2b265: Multivariate meta-analysis of diagnostic test accuracy studies with multiple thresholds per study. Riley R, Guha A, Biswas A, Smith-Bindman R, Deeks J.

P2b266: Overinterpretation of results in diagnostic test accuracy studies: evidence of “spin”. Ochodo E, de Haan M, Reitsma J, Lotty H, Bossuyt P, Leeflang M.

P2b267: What measures of accuracy should we present in DTA reviews? Jameson CM, Whiting PF, Burke M, Ben-Shlomo Y, Sterne JAC.

P2b268: Discrepancy in relative test performance due to modelling strategy in comparative diagnostic meta-analysis: a case study. Takwoingi Y, Abba K, Garner P, Deeks J.

P2b269: Can generalizability be considered in systematic reviews of diagnostic test accuracy? Scheibler F, Janssen I, Schröer-Günther M, Sauerland S.

P2b270: Methodological filters for the identification of delayed cross-sectional studies. Noel-Storr A, Beecher D.

P2b271: Adjusting for indirectness in comparative test accuracy meta-analyses. Leeflang MMG, Di Nisio M, Rutjes AWS, Zwinderman AH, Bossuyt PMM.


pOSTER SESSION 3 SATURDAy OCT. 22 SESIÓN DE pÓSTERES 3 SÁBADO, 22 DE OCTUBRE


vestíbulo 1er piso

kNOWLEDgE TRANSLATION AND COMMUNICATINg EVIDENCE (P3A272-P3A332)

P3A272: What kind of evidence can be found in incident reporting systems? Systematic evaluation of incident reports to identify risks using syringe pumps. Rohe J, Hahnenkamp C, Dichtjar T, Sangiuno HA, Thomeczek C, Schleppers A.

P3A273: How to obtain NNT from Cohen’s d: comparison of two methods. Furukawa TA, Leucht S.

P3A274: Development of a methodological framework for systematic review-based evidence briefings. Chambers D, Wilson P.

P3A275:Cochranereviews:beyondimplicationsforresearch.GonzálezU.

P3A276: Building a database of validated pediatric outcomes. Adams D, Sivakumar L, Nasser H, Surrette S, Hartling L, Vohra S.

P3A277: Patient values and preferences for decision making in antithrombotic therapy: a systematic review. MacLean S, Mulla S, Jankowski M, Akl E, Vandvik P, Ebrahim S, McLeod S, Bhatnagar N, Guyatt G.

P3A278: Publication of IPD meta-analyses in the Cochrane Database of Systematic Reviews: potential barriers and opportunities. Rydzewska L, Tierney J, Clarke M, Stewart L, Rovers M.

P3A279: The strategies and measures of improvement of the quality of clinical trials in China. Wu T, Li Y.

P3A280: Investigating determinants of experts’ judgement on appropriateness for diagnostic tests when using the “Grading of Recommendations Assessment, Development and Evaluation (GRADE)” method for resenting evidence. Ballini L, Negro A, Vignatelli L, Maltoni S, Grilli R.

P3A281: Evidence-based guidelines in a teaching primary care health service: the beginning of evidence-based medicine in the Amazonian region. Andriolo RB, Silva BNG, Atallah N.

P3A282: Characteristics of studies included for HTA reports. Wolff R, Ravaud P, Liberati A, Bonfill X, Antes G.

P3A283: How many evidence based guidelines in China.Yang K, Chen Y, Yao L, Liang H, Wang Z, Xiao X, Wang Q.

P3A284: Evaluating the feasibility of interventions for use within NHS mental health services. Bird V, Leamy M, Le Boutillier C, Williams J, Slade M.

P3A285: Logic model as a knowledge translation tool for complex interventions in systematic reviews. Augustincic Polec L, Ueffing E, Welch V, Tanjong Ghogomu E, Pardo Pardo J, Grabowsky M, Attaran A, Tugwell P.

P3A286: Systematic review of clinical practice guidelines and consensus statements about living kidney donation. Tong A, de Bruyn J, Wong G, Chapman J, Craig J.

P3A287: Chinese Cochrane Database of Systematic Reviews of Cochrane Library: a nationwide survey of utilization in Taiwan. Chiu YW, Wen YH, Kuo KN.

P3A288: Uptake of Cochrane Acute Respiratory Infections reviews in primary care guidelines. Van Driel M, Thorning S, Dooley L, van der Wouden H.

P3A289: Scoring trials on the efficacy-effectiveness continuum – a systematic analysis. Witt C, Manheimer E, Lüdtke R, Hammerschlag R, Lao L, Berman B.

P3A290: Interactive tools to teach the public to be critical consumers of information about health care: What’s out there? Krause LK, Schwartz L, Woloshin S, Oxman A.


P3A291: Partnership to improve health research reporting in Spanish-speaking countries-especially Latin America and Caribbean. Villanueva E, Simera I, Cuervo LG, Altman D, Moher D, Reveiz L.

P3A292: Evidence-based practice in first aid and prevention guidelines of Belgian Red Cross-Flanders. Pauwels NS, Dieltjens T, Van de Velde S, De Buck E.

P3A293: How evidence-based are the pharmaceutical industry’s printed promotional material presented to physicians in three Latin American countries. Ciapponi A, Reveiz L, Glujovsky D, García Martí S, Rey Ares L, Bardach A, Ramírez Moreno L, Ferreira AM, Rubinstein F, Rada G.

P3A294: Strategies to reduce attrition in randomised trials: a methodology review. Brueton V, Tierney J, Stenning S, Nazareth I, Meredith S, Harding S3, Rait G.

P3A295: Do the European clinical guidelines recommend evidence based interventions for drug addiction? A benchmark exercise. Ferri M, Bo A, Allara E.

P3A296: Progress in time to update of Cochrane systematic reviews. Ngamjarus C, Jaidee W, Laopaiboon M.

P3A297: Bringing evidence into practice: use of a rapid review methodology to formulate medical recommendations for the Red Cross Blood Service. De Buck E, Van de Velde S, Dieltjens T, Vandekerckhove P.

P3A298: Deficient Reporting and Interpretation of Non-Inferiority Clinical Trials In Antiretroviral-naïve HIV Patients: A Systematic Review. Hernandez AV1, Pasupuleti V1, Deshpande A, Collins JA, Vidal JE.

P3A299: Setting priorities for comparative effectiveness research on the management of primary angle closure (PAC): A survey of Asia-Pacific clinicians. Yu T, Li T, Puhan M, Dickersin K.

P3A300: Course “Hot topics in pharmacotherapy”: a way to disseminate evidence. Garjón Parra J, Erviti López J, Azparren Andía A, Gorricho Mendívil J, López Andrés A.

P3A301: Do systematic reviews within EPOC contain sufficient information about effect and enough information about the intervention to make informed policy decisions? Holte HH.

P3A302: How and when to pool data in meta-analyses to make the results clinically meaningful. Ringerike T, Klemp M.

P3A303: Long-term harm and memory impairment in electroconvulsive therapy treatment for depression – preliminary results from a systematic review with integrative methodological approach. Leiknes KA, Høie B, Jarosch-von Schweder L, Berg R, Smedslund G.

P3A304: Use of indirect comparison methods in systematic reviews: a survey of Cochrane review authors’ views. Abdelhamid A, Loke YK, Parekh S, Chen Y, Sutton A, Eastwood A, Holland R, Song F.

P3A305: Generation of quality of care indicators based on systematic reviews. Osorio D, Aller M, Roqué M, Foradada C, Vives A, Rigau D, Bonfill X.

P3A306: Graphic display for effective reporting of evidence quality tables.Khan K, Mignini L, Borowiack E, Ross C, Kowalska M, Zapalska A, Mol B, Meads C, Walczak J.

P3A307: Mapping research gaps in interventions related with the Millennium Development Goal (MDG) 5-A (maternal mortality) in the “implication for research” section of Cochrane reviews.Higgins V, Chapman E, Reveiz L, Cuervo LG.

P3A308: A Citation Analysis of Cochrane systematic reviews in Chinese Science Citation Database. Chen Y, Wei D, Li J, Xu H, Zhu S.

P3A309: A systematic review of the quality and types of instruments used to assess KTE implementation and impact. Irvin E, Cole D, Keown K, Kramer D, Brenneman Gibson J, Kazman Kohn M, Mahood Q, Slack T, Amick III B, Phipps D, Garcia J, Morassaei S.


P3A310: The impact of systematic reviews on health care policy. Frances Bunn.

P3A312: Determining the role of patient values and preferences in the development and review of preference-sensitive practice guidelines. MacLean S, Akl E, Johnston B, Guyatt G.

P3A313: A US hospital-based health technology assessment center to improve the quality, safety and cost-effectiveness of patient care. Mitchell M, Williams K, Umscheid C.

P3A314: Simple‘quick’searchestoanswerquestionsarisinginclinicalpractice.JordanJ,StevensonK, Lewis R.

P3A315: A multi-faceted provider education program designed for consistent, evidence-based clinical practice change within an integrated care delivery system. Okawa G.

P3A316: Effectiveness of quality improvement strategies to improve the management of diabetes: Systematic review and meta-regression. Tricco A, Ivers N, Moher D, Turner L, Galipeau J, Halperin I, Vachon B, Ramsay T, Manns B, Tonelli M, Shojania K, Grimshaw J.

P3A317: Exploring the experiences with a new policy for managing conflict of interest in guideline developers. Neumann I, Akl E, Guyatt G.

P3A318: Judiciary branch and scientific evidence: an analysis of judicial decisions on galsufase. Marin dos Santos D, Atallah A, Dallari Jr. H, Barroso L.

P3A319: High impact collaborations: Examples from the Cochrane HIV/AIDS Group. Horvath T, Kennedy GE, Rutherford GW.

P3A320: Do Cochrane reviews inform the development of clinical practice guidelines? The case of hypertension. Al-Ansary L, Tricco A, Adi Y, Al-Ghonaim M, Bawazeer G, Perrier L, Tashkandi M, Straus S.

P3A321:Impactofanevidencebasedpediatricselectronicjournal.GonzálezMP,BuñuelJC,Gonzálezde Dios J, Esparza MJ, Aizpurua P.

P3A322: Do Cochrane reviews drive clinical decision-making at the point of care? Moja L, Banzi R, Cinquini M, Moschetti I, Pecoraro V, Tagliabue L, Liberati A.

P3A323: Mr. Pickwick and his child went on a field trip and returned empty handed: the widening gap between non-randomised studies and evidence for circadian rhythm sleep disorders management in a paediatric population. Khan S, Heussler H, McGuire T, Pache D, Dakin C, Cooper D, Norris R, Flenady V, Charles B.

P3A324: Including diverse study types in systematic reviews to address multiple questions about public health interventions: the case of a review of school effects on health. Harden A, Bonell C, Jamal F, Wells H.

P3A325: Measuring organizational readiness for knowledge translation in chronic care: a mixed methods systematic review on theories and instruments. Gagnon M, Légaré F, Ouimet M, Estabrooks CA, Roch G, Labarthe J, Ghandour EK, Tremblay N, Grimshaw J..

P3A326: Use of Cochrane reviews in NICE clinical guidelines. Alderson P, Tan T.

P3A327: Developing a web-based international register of clinical prediction rules for primary care. Keogh C, Wallace E, Fahey T.

P3A328: Synthesis of recommendations for clinical use of biomarkers in oncology. Trevisiol C, Pregno S, Rosin C, Fabricio ASC, Gion M.

P3A329: Collaborative Knowledge Networks (CKN) for guideline development: a Kaiser Permanente and BMJ Evidence Centre case study. Davino-Ramaya MD C, Brunnhuber MD K, Haynes MPH J, Simpkins MD C, Tom MS G, Minhas MB ChB R, Robbins MD C.


P3A330: Reporting Guidelines for Systematic Review Protocols. Moher D1, Shamseer L1, Clarke M2, Ghersi D3, Liberati A4, Petticrew M5, Shekelle P6, Stewart L7

P3A331: An extrapolation checklist to answer “Can I use the results of this systematic review in a disadvantaged population? Ueffing E, Petticrew M, Welch V, Clarke M, Gruen R, Guyatt G, Kristjansson E, Mercer S, Pardo Pardo J, Tugwell P.

P3A332: Systematic Review of the Impact of Reporting Guidelines on publication quality. Moher D, Palepu A, Shamseer L, Turner L, Altman D, Hirst A, Hoey J, Schulze K, Simera I.

kNOWLEDgE TRANSLATION AND COMMUNICATINg EVIDENCE (P3b333-P3b345)

P3b333: Developing a typology of activities for linking research evidence to research use. Tripney J, Kenny C, Gough D.

P3b334: Agree instrument: a good instrument for family practice training. Stein AT, Khan GS.

P3b335: Access to The Cochrane Library: results of Canada’s national pilot license initiative. Squires J, Grimshaw J, Schaafsma ME.

P3b336: Do value judgments play a role in evidence-based recommendations when information is based on proof of concept? Hutton B, Lee K, O’Grady T, Shukla V.

P3b337: Proof of value decisions from proof of concept data: a review of Canadian formulary review recommendations. Shukla V, O’Grady T, Clifford T, Hutton B.

P3b338: Lowering lipids enhances the effect of statins in preventing cardiovascular outcomes. Contreras J, Schmid C, Alsheikh-Ali A.

P3b339: Resource use compared to evidence of effectiveness as an indirect measure of clinical quality and a basis for improvement. Harris J

P3b340: A Canadian example of facilitating the uptake of syntheses into public health practice. Docorby K, Tirilis D, Husson H, Robeson P, McCrae L, Greco L.

P3b341: Bringing Best Evidence to Front Line Clinicians. Tejani A, Adlparvar C.

P3b342: Evidence to support process improvement: what’s available, and how to proceed. Harris J.

P3b343: Cochrane Journal Club: going from strength to strength? Curtis T.

P3b344: Who is listening? – A qualitative study of Cochrane podcast users. Stewart G, Mavergames C.

P3b345: Cochrane review of school-based interventions for the prevention of human immunodeficiency virus (HIV) and sexually transmitted infections (STIs) in adolescents: Why biological outcomes are important. Mason-Jones A, Mathews C, Kagee A, Lombard C.

pOSTER SESSION 3 SATURDAy OCT. 22 SESIÓN DE pÓSTERES 3 SÁBADO, 22 DE OCTUBRE


vestíbulo 2º piso


STATISTICAL METHODS (P3b346-P3b381)10:30-11:15 • 2nd floor Hall • Vestíbulo 2º piso

P3b346: Trial Sequential Analyses of Meta-analyses from a Cochrane Review of Targeting Intensive versus Conventional Glycaemic Control in Patients with Type 2 Diabetes. Hemmingsen B, Lund S, Gluud C, Vaag A, Almdal T, Hemmingsen C, Wetterslev J.

P3b347: A comparison of subgroup analyses in grant applications and publications. Boonacker CW, Hoes AW, van Liere - Visser K, Schilder AG, Rovers MM.

P3b348: The impact of underpowered studies in meta-analyses reported by Cochrane reviews. Turner R, Bird S, Higgins J.

P3b349: Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. Bowden J, Tierney J, Copas A, Burdett S.

P3b350: Individual participant data meta-analysis of prognostic factor studies: state of the art? Riley R, Abo-Zaid G, Sauerbrei W.

P3b351: The effect of the assessment goal on the interpretation of subgroup findings and the corresponding conclusions. Bender R.

P3b352: Exploring treatment by covariate interactions in mixed treatment comparison meta-analysis: individual patient-level covariates versus aggregate trial-level covariates. Donegan S , Williamson P, D’Alessandro U, Tudur-Smith.

P3b353: Is it reasonable to pool estimates of intervention effect estimated from different analytical methods for continuous outcomes? A meta-epidemiological study. McKenzie JE, Deeks JJ.

P3b354: IPD meta-analysis of time-to-event data: one-stage versus two-stage approaches to estimating the hazard ratio. Bowden J, Tierney J, Simmonds M, Copas A, Higgins J.

P3b355: The use of an ordered multinomial logit model in network analysis: an example in psoriatic arthritis. Craig D, Epstein D, Yang H, Bojke L, Sculpher M, Woolacott N.

P3b356: Classification of Methods for Evaluation of Treatment Selection Markers: A Systematic Review. Tajik P, Mol BW, Bossuyt PM.

P3b357: Adverse events of antiepileptic drugs, across indications: Can randomised controlled trial data from non-epilepsy indications be included in meta-analysis for AEDs used in epilepsy? Tudur-Smith C, Marson A.

P3b358: Exploring the effects of different treatment doses by ‘blurring’ the nodes of a treatmentnetwork: application to a Cochrane overview for multiple sclerosis. Del Giovane C, Mavridis D, Vacchi L, Filippini G, Salanti G.

P3b359: Meta-analysis of diagnostic studies: SROC modelling - the profile log-likelihood approach based upon the proportional hazard model. Charoensawat S, Böhning D.

P3b360: How to improve the credibility of meta-analysis? How to avoid mistakes in choosing the statistical method of estimation? The Bayesian and traditional approaches. Nikodem M, Walczak J, Borowiack E, Siedmiogrodzki K, Zapalska A, Khan K, Meads C, Mol B, Oude Rengerink K, Thangaratinam S, Zamora J

P3b361: Meta-analytical approaches for diagnostic and prognostic prediction research: incorporating published univariable associations in multivariable analysis of individual patient data. Debray T, Koffijberg H, Lu D, Vergouwe Y, Steyerberg EW, Moons KGM.


P3b362: Aggregating published prediction models with individual patient data: a comparison of different approaches. Debray T, Koffijberg H, Vergouwe Y, Steyerberg EW, Moons KGM.

P3b363: Comparison of results from different imputation techniques of missing data in an anti-obesity drug trial. Jørgensen AW, Lundstrøm LH, Wetterslev J, Astrup A, Gøtzsche PC.

P3b364: Individual participant data meta-analyses compared with meta-analyses based on aggregate data. Tudur Smith C, Marcucci M, Rovers M, Riley R, Oyee J, Iorio A, Williamson P, Clarke M.

P3b365: Meta-analysis of treatment by patient subgroup interactions using summary data: a case study and suggestions for future practice. Fisher D, Tierney J, Vale C, Copas A, Parmar M.

P3b366: Re-analysis of meta-analyses in Cochrane reviews using robust statistical methods. Smedslund G, Mowinckel P

P3b367: Meta-analysis of ordinal outcome measures in stroke trials - can we do better? Weir J, Lewis S, Sandercock P, Thomas B, Murray G.

P3b368: Issues affecting the validity of a network meta-analysis of acupuncture and other physical therapies for the relief of chronic pain due to osteoarthritis of the knee. Rice SJC, Woolacott NF, Corbett MS, Slack R.

P3b369: Imputing 2x2 contingency tables from odds ratios: difficulties, constraints and impact in meta-analysis results. Veroniki AA, Patsopoulos N, Pavlides M, Salanti G.

P3b370: Predicting the need to update a systematic review. Takwoingi Y, Hopewell S, Sutton A, Marshall R, Tovey D.

P3b371: Feasibility of establishing a central repository for the individual participant data from research studies. Altman D, Clarke M, Dwan K, Riley R, Williamson P.

P3b372: The hazards of extracting hazard ratios from survival curves for meta-analyses in observational studies. Imamura M, MacLennan S, Dahm P, Neuberger MM, Omar MI, MacLennan G.

P3b373: Standardized mean differences may be used to derive odds ratios of treatment response: meta-epidemiological study. Da Costa BR, Rutjes AWS, Johnston BC, Reichenbach S, Nüesch E, Guyatt G, Jüni P.

P3b374: Likelihood approach to evaluating evidence in meta-analysis. Assam P, Chan E.

P3b375: Interpreting pooled estimates in systematic reviews involving continuous variables. Thorlund K, Johnston B, Furukawa T, Patrick D, Schunemann H, Walter S.

P3b376: Calculation of variance of treatment effects when these are not reported for all arms of trials with more than two arms. Cates C, Karner C.

P3b377: Minimal important difference in meta-analyses: applying anchor-based and distribution-based methods to increase precision. Johnston B, Thorlund K, da Costa B, Furukawa T, Guyatt G.

P3b378: The calculation of hazard ratios from data published in reports of randomised controlled trials; are they valid? Glenny A, Furness S, Worthington H.

P3b379: When do indirect and mixed treatment comparisons result in invalid findings? A graphical explanation. Jansen JP, Schmid C, Salanti G.

P3b380: Flexible models for network meta-analysis of survival data. Jansen JP.

P3b381: Exploring indirect effects of comparative effectiveness in a Cochrane review. Devine B.


CONSUMER ISSUES AND SHARED DECISION MAkINg (P3b382-P3b400)10:30-11:15 • 2nd floor Hall • Vestíbulo 2º piso

P3b382: From Patient to Advocate. Ford P.

P3b383: Evidence, Evidence Gaps, and the Consumer Viewpoint: Lessons from the US Mammography Guidelines. Johnson L, Wale J.

P3b384: Different conclusions drawn from same topic: what and why? Tian J, Liu A, Yang K, Li L.

P3b385: How to build evidence network of interventional studies? Li L, Sun T, Han D, Tian J, Yang K.

P3b386: Dissemination of the Cochrane reviews: a national survey among the regional hospitals in Taiwan. Chiu YW, Weng YH, Shih YH, Lo HL, Kuo KN.

P3b387: Shared decision-making interventions for children with chronic conditions: determining the clarity of the evidence. Sutcliffe K.

P3b388: Consumer Support and education beyond national borders: A case study. Walsh M, Rader T.

P3b389: Incorporating patients’ perspectives in hospital-based health technology assessment (HTA): The views of HTA producers, hospital managers and patients. Gagnon M, Desmartis M, Lepage-Savary D, Gagnon J, St-Pierre M, Rhainds M, Lemieux R, Gauvin F, Légaré F.

P3b390: A Bibliometric Analysis of Cochrane collaboration and its products. Chen Y, Xiao X, Wang Z, Yao L, Yang K.

P3b391: Evidence-based medicine and the right to health: economic and legal sustainability. Marin dos Santos D, Atallah A, Riera R, Silva E.

P3b392: Treatment information-seeking by people with multiple sclerosis in the internet age: Stage 1 findings of the IN-DEEP project. Hill S, Filippini G, Summers M, Beecher D, Synnot A, Mosconi P, Shapland S, Colombo C, Baroni I, Osborne R, Traversa S.

P3b393: Cochrane CENTRAL & CAFÉ (Communication Access Framework and Evidence): Locating intervention studies on clinical communication for communicatively vulnerable populations. Hemsley B, Worrall E, Kis-Rigo J, O’Halloran R, Hill S.

P3b394: Are claims made in advertisements of nutritional supplements in South African women’s magazines supported by research evidence? Schoonees A, Volmink J.

P3b395: Behind the dementia headlines – a systematic look at the quality of reporting of dementia research in two UK national newspapers. Noel-Storr A1, Struthers C, Marcus S.

P3b396: Social relevance of Evidence-based medicine in the Brazilian drug market. Marin dos Santos D, Barroso L, Atallah A, Silva E.

P3b397: Giving Brazilian women access to evidence based information in Portuguese: the translation of Pregnancy and Childbirth Group PLS. Audebert Delage Silva DR, Grilo Diniz CS, Mulheres em Rede pela Maternidade Ativa PDP.

P3b398: Selective publication of clinical trials and legal response: the right to health and information. Marin dos Santos D, Atallah A, Dallari Jr. H, Bartomolei C.

P3b399:Evidence-basedcivilaction: thecaseof theBrazilian ‘CompanionLaw’.AudebertDelageSilva DR, Kondo C, Grilo Diniz CS, Mulheres em Rede pela Maternidade Ativa PDP.

P3b400: The Cochrane Library for Consumers – a new website (beta). McIlwain C, Mavergames C.


SESIÓN DE pÓSTERES 1VIERNES, 21 DE OCTUBRE

10:30-11:15vestíbulo 2º piso

L1: Encuesta sobre conocimiento y actitudes de los médicos hacia las Guías de Práctica Clínica en el Instituto Mexicano del Seguro Social. Norma Patricia Constantino Casas, Consuelo Medécigo Micete, Adriana Valenzuela Flores, Arturo Viniegra Osorio, Yuribia Millán Gamez, Laura del Pilar Torres Arreola, Santiago Echeverría Zuno, Fernando Sandoval Castellanos

L2: El proceso de construcción de una escala para medir la elección informada de métodos anticonceptivos entre las mujeres que acuden a un programa de planificación familiar. Patricio Valdés, Ana M. Alarcón, Sergio Muñoz.

L3: Una escala válida y fiable para medir la percepción de la elección informada en el Programa de Planificación Familiar. Patricio Valdés, Ana M. Alarcón, Sergio Muñoz.

L4: Overuse of indwelling urinary catheter in non-intensive care unit patients in University hospital. Lucieni Oliveira Conterno, Juliana Lobo Andrade, Wallan Mason, Carlos Rodrigues da Silva Filho.

L5: Balance de un nuevo modelo de gestión en salud. (OUTSOURCING). Indicadores de gestión hospitalaria 2009-2010. Maracaibo. Zulia-Venezuela 2011. Mónica Chirinos, Ricaurte Salom, Thais Romero, Esther Melendez,

L6: Determinantes sociales asociadas a desordenes musculo-esqueléticos: Contribución de etnicidad, genero y nivel socioeconómico a resultados de discapacidad e inflamación articular en pacientes chilenos portadores de estas enfermedades. Ana María Alarcón, Sergio Muñoz, Carlos Martínez, Jossel Gutiérrez, Aldo Vidal.

L7: Necesidades en rehabilitación de los niños con discapacidad: Percepción de los niños, los padres y los profesionales de rehabilitación. Jesús Alberto Plata Contreras, Teresita Martínez Restrepo, Carlos AlbertoQuinteroValencia.

L8: Impacto clínico y asistencial de un programa de diagnóstico y tratamiento rápido del cáncer de pulmón. Anna Selva, Ignasi Bolíbar, Alfonso Torrego, Mª Cinta Pallarès

L9: Ensayo clínico aleatorizado, multicéntrico, controlado, paralelo, simple ciego, con enmascaramiento del tratamiento al evaluador, que evalúa la eficacia del plasma rico en plaquetas (PRP) autólogo en el tratamiento de las roturas musculares. Martinez-Zapata MJ, Orozco LL, Soler R, Rodas G, Balius R, Bosch A, Urrutia G, Bonfill X.

L10: Tabaco y nivel de ingresos: Revisión Sistemática y Meta-análisis. Agustín Ciapponi, Ariel Bardach, Demián Glujovsky, Patricia Aruj, Agustina Mazzoni, Luz Gibbons, Bruno Linetzky, Brunilda Casetta.

pÓSTERES LATINCLEN


SESIÓN DE pÓSTERES 2SÁBADO, 22 DE OCTUBRE

10:30-11:15vestíbulo 2º piso

L11: Sensibilidad al estrés y trastornos de la conducta alimentaria: Un modelo de asociación. Sergio Muñoz, Rosa Behar, Patricia Cordella, Karina Jaramillo, Manuel Ortiz y Jaime R. Silva.

L12: Efectividad del apoyo social en la recuperación funcional, afrontamiento y calidad de vida del paciente con discapacidad secundaria a EVC en el IMSS. Alberto Peréz Rojas, Laura del Pilar Torres Arreola, Sonia Patricia de Santillana

L13: Efectividad del tratamiento del Síndrome Déficit Atencional en Chile. Mónica Velásquez, Carlos Vallejos, Patricio Valdés, Roberto Reveco, Sergio Puebla.

L14: Validación de un Cuestionario de Frecuencia de Consumo de Alimentos en el Cono Sur de Latinoamérica. Natalia Elorriaga, Gabriela Cormick, Monica Britz, Solange Martínez, Rocío Suárez, Vilma Irazola, Adolfo Rubinstein.

L15: Sistema de Identificación de Documentos Medico-Asistenciales de un Hospital. Barcelona – España. 2011. Mónica Chirinos, Teresa Puig, Nuria Lluis, Xavier Bonfill,

L16: Prevalência de Depressão e qualidade de vida dos pacientes renais crônicos em hemodiálise na região de Marília - São Paulo / Brasil. Ricardo Correa Ferreira, Carlos Rodrigues da Silva Filho, Lucieni de Oliveira Conterno

L17: Mejora de la adecuación de la práctica asistencial y clínica en el Hospital de la Santa Creu i Sant PaudeBarcelona.MJesúsQuintana,TeresaPuig,NúriaLluís,IgnasiBolíbar,IgnasiGich,.IvanSolà,Gerard Urrútia, Xavier Bonfill.

L18: FSH humana altamente purificada frente a la FSH recombinante en la reproducción humana asistida. Martinez-Zapata MJ, Vázquez J, Roqué M, Solà I, Urrutia G.

L19: Valores de referencia para la Calidad de vida en Medellín (Colombia) con el Cuestionario de Salud SF-36. Héctor García, Luz Lugo, Claudio Vera.

L20: Desafíos en el análisis estadístico: una experiencia en un estudio aleatorizado por conglomerados. MartínRondón,DianaPinto,JuanCorrea,LucasSalas,JuanCamacho,JulianaQuintero.

© E

:M: P

rom

oció

n de

Mad

rid, S

.A. |

MU

SEO

REI

NA

SOfí

A

MORE...MÁS...

PRE - AND POST - COLLOQUIUM EVENTSACTOS PRE - y POST- COLLOQUIUM


SOCIAL EVENTSACTOS SOCIALES

PREMIOS y RECONOCIMIENTOSPRIzES AND AWARDS

MO

RE.

..M

ÁS.

..

106 | more...• más...

pRE - AND pOST - COLLOQUIUM EVENTSACTOS pRE - y pOST- COLLOQUIUM

MONDAy, OCTObER 17 LUNES, 17 DE OCTUBRE


09:00 - 17:00 ‘Communicatetovaccinate’project (Closed. Agencia Laín Entralgo, Room 3.1)

TUESDAy, OCTObER 18 MARTES, 18 DE OCTUBRE


09:00 – 14:00 Evidence building and synthesis research (Closed, ISCIII)

09:00 – 15:00 Annual editorial meeting for the Cochrane Public Health group (Closed. ISCIII)

09:00 – 18:00 Steering Group (1) (Closed, ISCIII)

10:00 – 17:00 Archie development advisory committee (Closed, Agencia Laín Entralgo, Aula 3.1)


09:00 – 13:00 Replication and biases in molecular research (SAT01. Hospital de Sant Pau (Barcelona))

09:00 – 17:00 Summary of findings table and assessment of quality of evidence (GRADE) (SAT03. Agencia Laín Entralgo, Aula Magna)

10:00 – 19:00 Taller de investigación en seguridad del paciente (SAT02. Agencia Laín Entralgo, Aula 4.3)

16:00 – 20:00 The Methods Symposium (SAT04. Aula Magna, Escuela Nacional de Sanidad. ISCIII)

more...• más... | 107

WEDNESDAy, OCTObER 19 MIéRCOLES, 19 DE OCTUBRE


09:00 – 13:30 Odontología basada en la evidencia (SAT05. Palacio de Congresos, ANTICIS)

09:00 – 13:30 Taller de metanálisis con STATA (SAT06. Palacio de Congresos, Room 2b)

09:00 – 13:30 Herramienta“Pritectools”enlaobservacióndetecnologíassanitariastrassu introducción en la práctica clínica (SAT07. Palacio de Congresos, AfRICA)

09:00 – 13:30 Aprendizaje basado en los problemas (ABP): Un salto de calidad en educación médica (SAT08. Palacio de Congresos, vIPS)

09:00 – 13:30 Making sense of scientific evidence and commenting on a Cochrane Review: A dual language workshop for consumers Cómo entender la evidencia científica a partir de una revisión

Sistemática Cochrane: Un taller bilingüe para pacientes y ciudadanos(WS52. Palacio de Congresos, Room 9)

09:00 – 13:30 From novice to expert to mentor: Increasing participation in the Cochrane Collaboration in low and middle income countries

(SAT09. Palacio de Congresos, MENINA)

THURSDAy, OCTObER 20JUEvES, 20 DE OCTUBRE


11:15 – 12:45 TallerJBICOnNECT+(TheJoannaBriggsInstituteClinicalonlinenetworkof evidence for care and therapeutics (SAT10. Palacio de Congresos, Room 8)

108 | more...• más...

SUNDAy, OCTObER 23DOMINgO, 23 DE OCTUBRE


09:00 – 17:00 GRADE Working Group (Closed, Agencia Laín Entralgo, Room 2.2)

09:00 – 18:00 Steering Group (Agencia Laín Entralgo)

09:30 – 12:00 CPAG Colloquium debriefing breakfast (Closed)

more...• más... | 109

THURSDAy 20TH OCTObER 201117:45 – 19:15 PRACTICAL WORkSHOPS

SWS88 | USINg THE COCHRANE REgISTER Of STUDIES TO DEVELOP A STUDy-bASED SPECIALISED REgISTER (Room 2a)

To be facilitated by Ruth Foxlee, Information Specialist at the Cochrane Editorial Unit; team members from Metaxis Ltd; and members of the CRS User Support Team, UK and worldwide

The Cochrane Register of Studies (CRS) is the new Specialised Register (SR) management system developed by Metaxis Ltd on behalf of The Cochrane Collaboration. The CRS is the mandatory mechanism for submitting SRs to the Cochrane Central Register of Controlled Trials (CENTRAL), but it also offers new functionality to enhance working practices in relation to SR maintenance.

In this practical workshop we will explore some of the features available in the CRS that will help Cochrane groupswhowishto‘studify’theirregisters.Participantswillhavetheopportunitytoexploreandcustomisetheinbuilt algorithms for matching references to studies. They will learn how to create and populate a study record both manually and from a trials registry. We will also explore the mechanism for automatically creating study/reference links based on existing Cochrane Reviews. This workshop is aimed at Cochrane contributors who currently maintain reference-based registers and would like to convert them to study-based registers.

SWS89 | DEVELOPINg yOUR SPECIALISED REgISTER IN THE COCHRANE REgISTER Of STUDIES (Room 2b)

To be facilitated by Gordon Dooley, Managing Director of Metaxis Ltd; and members of the CRS User Support Team, UK and worldwide

The Cochrane Register of Studies (CRS) is the new Specialized Register (SR) management system developed by Metaxis Ltd on behalf of The Cochrane Collaboration. The CRS is the mandatory mechanism for submitting SRs to the Central Register of Controlled Trials (CENTRAL), but it also offers new functionality to enhance working practices in relation to SR development and maintenance.

Participants of this practical workshop will have the opportunity to explore a range of CRS features including fuzzy matchingandduplicatefinding,usingthe‘junk’,workingwithtrialsregistries,andmakingthemostoftopicslistsin the CRS. This workshop is aimed at Cochrane contributors who wish to explore the advanced features of the CRS.

fRIDAy 21ST OCTObER 201111:15 – 12:45 SPECIAL SESSION:

fUTURE DIRECTIONS fOR COCHRANE DATA (S1; gOyA)

“Data is the new oil”, so say organisations and experts around the world, who believe that data will have as great an impact on the 21st Century as oil had on the 20th Century. The foundations of The Cochrane Collaboration are


A SERIES Of EVENTS EXPLORINg THE OPPORTUNITIES fOR DOINg MORE WITH COCHRANE DATA PROVIDED by THE COCHRANE

REgISTER Of STUDIES (CRS) AND THE CENTRAL REgISTER Of CONTROLLED TRIALS (CENTRAL)

110 | more...• más...

built on the data it mines and synthesises, from randomised controlled trial reports, to the findings of Cochrane Reviews.

This special plenary session will launch a series of events examining the possibilities for developing, expanding and linking the data published in The Cochrane Library in the context of the release of the new Cochrane Register of Studies (CRS) and the ongoing review of the Cochrane Register of Controlled Trials (CENTRAL). Presentations will range from discussion of the immediate changes that the CRS can facilitate, to an exploration of what could be possible, now and in the future, for linking and presenting Cochrane data. This session is open to any Colloquium participant, with the following agenda:

S1O1 | Opening presentation: an exploration of where we are and where we could be in five to ten years. An introduction to the work of the CENTRAL Development Committee, the development of the CRS, and the possibilities for doing more with our data (David Tovey, Editor in Chief of The Cochrane Library, UK)

S1O2 | Value-adding with the CRS (Ruth Foxlee, Information Specialist at the Cochrane Editorial Unit; and Gordon Dooley, Managing Director of Metaxis Ltd, UK)

S1O3 | Examining the potential value of the Systematic Review Data Repository (SRDR) to Cochrane (Stanley Ip, Tufts Medical Center, USA)

S1O4 | Data linking: the next dimension. A report from the Star Trek Crew (Chris Mavergames, Manager of the Cochrane Web Team, Germany)

17:45 – 19:15 PRACTICAL WORkSHOP

QUESTIONS AND DISCUSSION

SWS90 | CENTRAL & THE COCHRANE REgISTER Of STUDIES: A DISCUSSION AND POLICy-SETTINg WORkSHOP (gOyA)

To be facilitated by Ruth Foxlee, Information Specialist at the Cochrane Editorial Unit; and David Tovey, Editor in Chief of The Cochrane Library, UK

The Cochrane Register of Studies (CRS) is the new Specialised Register (SR) management system developed by Metaxis Ltd on behalf of The Cochrane Collaboration. It offers a springboard for the development of the Cochrane Central Register of Controlled Trials (CENTRAL) by taking advantage of the latest developments in information technology.

In this discussion and policy-setting workshop we will explore the feasibility of a study-based CENTRAL, the types of records eligible for inclusion in CENTRAL and the possibilities for creating links between CENTRAL records, other Cochrane records, and records from external resources. We will also cover questions such as who is eligible to search the CRS, what are our priorities for acquiring copyright access to external records, and how the CRS could be marketed commercially. This workshop is open to any Colloquium participant, but is particularly aimed at those with an interest in developing CENTRAL and Cochrane groups who maintain an SR.

DURINg THE COLLOQUIM AT THE COCHRANE EXCHANgE EXHIbITION SPACE

COCHRANE EXCHANgE: CRS HELP CLINICS

The Collaboration’s dedicated exhibition space, the Cochrane Exchange, will be home to daily help clinics during the Colloquium aimed at supporting users of the CRS. Topics covered in help sessions will include importing and exporting, searching, tracking and reporting. Users can also make an appointment or drop in to the Exchange to get help and support from the Metaxis and CRS User Support teams on any question or problem.

more...• más... | 111

SOCIAL EVENTSACTOS SOCIALES

E

P

E

O

P

T

WELCOME RECEPTION - WEDNESDAY, OCT. 19 (20:30h.) RECEPCIóN DE BIENvENIDA - MIÉRCOLES, 19 OCT. (20:30h.)1.

On this first night of the Colloquium, we would like to give everyone a warm welcome with a toast to break the ice. We shall be accompanied by the virtuous musicians of the Cuarteto Pagagnini (Eduardo Ortega, Gartxot Ortiz and Fernando Clemente, captainded by Ara Malikian). They form a wonderfully amusing and cutting-edge group, masters of the violin, cello, and stage performance arts.

Pagagnini is a musical show full of humor and great gestural expression. The musicians and actors play and enact Mozart, Pachelbel, Chopin, Boccherini, Falla, Sarasate, and of course, Paganini, but also involve popular genres such as rock or folk. Their performance not only gives listeners a taste of classical music, it also possesses other virtues of more importance and depth. Only those who are exceptional are able to parody their own art. Long life to the musicians!

En la primera noche del Colloquium queremos dar una cálida bienvenida a todos con un cóctel y un buen brindis para romper el hielo. Nos acompañarán los virtuosos músicos del Cuarteto Pagagnini (Eduardo Ortega, Gartxot Ortiz, y Fernando Clemente, capitaneados por Ara Malikian). Son unos auténticos diablos, únicos. Maestros del violín, del violonchelo, y del sentido de las tablas y el espectáculo.

Pagagnini es una obra gestual y musical, sin palabras y con sentido del humor. Los músicos, y actores, revisan a Mozart, Pachelbel, Chopin, Boccherini, Falla, Sarasate y por supuesto Paganini, pero también géneros populares como rock y folk. Su espectáculo no solo acerca al gran público a la música clásica sino que posee otras virtudes de más calado y profundidad. Y es que solo los virtuosos son capaces de parodiar su propio arte. ¡Vivan los músicos!

This event will take place at the Galería de Cristal of the Palacio de Cibeles, which is in the city’s Ayuntamiento (City Hall), located in Madrid’s emblematic Plaza Cibeles.

El evento tendrá lugar en la Galería de Cristal del Palacio de Cibeles, que actualmente alberga al Ayuntamiento de la ciudad, situado en la emblemática Plaza de Cibeles de Madrid.

112 | more...• más...

Address:•PlazadeCibeles.

How to get there (transportation):

1. bus: Walk 3 minutes from Palacio de Congresos to the bus stop located in Paseo de la Castellana 95. Once there, take bus number 150, 27 or 14. After about 20 minutes, get off at the Recoletos stop # 3 and walk 2 minutes to the Plaza Cibeles.

2. Taxi: The trip takes a few minutes. The price will be quite low if you share the ride.

3. Metro: Banco de España (L2). You may have

to commute subway lines a couple of times

Dirección:Plaza de Cibeles.

Cómo ir allí (recomendación):

1. Autobús: Caminar 3 minutos desde el Palacio de Congresos hasta la parada de autobús situada en Paseo de la Castellana 95. Una vez allí, coger la línea 150, 27 ó 14 de autobús. Después de un trayecto de unos 20 min, bajar en la parada de Recoletos núm. 3, y caminar 2 minutos hasta la Plaza de Cibeles.

2. Taxi: Comparta un taxi y llegará en pocos minutos a un precio muy reducido.

3. Metro: Banco de España (L2) pero son necesarios diversos transbordos.

fee: • Free access for Colloquium attendees (the identification card is mandatory) who havepreviously registered for this event.

• Accompanying person: access with the complete

pass (see below) or with a ticket for the event, which can be purchased at the Colloquium Secretariat for 20 €.

• Registration:Check availability at the information desk

Coste: • Acceso gratuito para los asistentes al Colloquium

debidamente acreditados y previamente inscritos en este evento.

• Acompañantes: acceso con el forfait completo de acompañante (ver más abajo) o con el ticket (20 €) del acto que deberá adquirir en la Secretaría del Colloquium.

• Inscripciones: Preguntar disponibilidad en la secretaría

Palacio de Congresos de Madrid

Palacio de Cibeles

150 - 27 - 14

Taxi

more...• más... | 113

LW DINNER + fLAMENCO SHOW - THURSDAY, OCT. 20 (21:00h.)CENA + ESPECTáCULO fLAMENCO - JUEVES, 20 OCT. (21:00 h.)2.

We propose you to enjoy a good dinner animated by a Spanish ballet and flamenco show at the Florida Park club (http://www.floridapark.net), one of the most traditional in Madrid and located at the centric Parque del Retiro. The show will be performed by the Ballet Español Besos del Sur; it will be a good opportunity to admire an elegant and pleasant show that is quite representative of one of the most typical Spanish folklores.

At the end of the show, everyone will have the chance to join the dance with a session of varied music.

Les proponemos disfrutar de una buena cena acompañada de un espectáculo de ballet español y flamenco, en la sala Florida Park (http://www.floridapark.net), una de las de mayor tradición de Madrid y ubicada en el céntrico Parque del Retiro. El espectáculo estará protagonizado por el Ballet Español Besos del Sur y será una buena oportunidad para disfrutar de un espectáculo elegante y ameno que nos acerca a uno de los folclores españoles más típicos.

Al finalizar el espectáculo todo el mundo tendrá la oportunidad de sumarse al baile con una variada sesión de baile disco.

Address:•AvenidaMenéndezPelayo(infrontofCalleIbiza),entering through the Parque del Retiro entrance.

How to get there (transportation):

1. Metro: Ibiza station (L9). Instructions from the Palacio de Congresos: take line 10 directionHospitalReinaSofía.Atthefirststop(Plaza de Castilla) transfer to line 9, direction Arganda del Rey. Get off at Ibiza station and walk 100 m, towards the Parque del Retiro. Total estimated time: 20 mins.

2. Taxi: share a taxi and you will get there in a few minutes at a low cost. Estimated duration: 15 mins.

Dirección:•AvenidaMenéndezPelayo(frentecalleIbiza)yalaentrada del Parque del Retiro.

Cómo ir allí (recomendación):

1. Metro: estación Ibiza (L9). Instrucciones desde el Palacio de Congresos: tome la línea 10 en dirección a Hospital Reina Sofía. En la primera estación (Plaza de Castilla) haga transbordo a la línea 9 dirección Arganda del Rey. Descienda en la estación Ibiza y camine 100 m entrando en el Parque del Retiro. Tiempo estimado: 20 mins.

2. Taxi: comparta un taxi y llegará en pocos minutos a un precio muy reducido. Tiempo estimado: 15 mins.

114 | more...• más...

Consejo:• Recomendamos que se llegue un poco antes

del inicio del espectáculo para poder pasear por el Parque del Retiro, el parque urbano más emblemático de Madrid. Vale la pena!

Coste: • Asistentes al Colloquium: 40 €, debidamente

acreditados y previamente registrados para este evento.

• Acompañantes: acceso con el forfait completo de acompañante (ver más abajo) o con el ticket (60 €) del acto que deberán adquirir en la Secretaría del Colloquium.

• Inscripciones: Preguntar disponibilidad en la secretaría

Advice:• We recommend that you arrive a bit early to have

some time to take a walk around the Parque del Retiro, the most emblematic urban park of Madrid. It’s worth it!

fee:• Colloquium attendees: 40 €, duly accredited and

previously registered for this event.

• Accompanying persons: access with the accompanying pass (see below) or with a ticket for the event, which can be purchased at the Colloquium Secretariat for 60 €.

• Registration:Check availability at the information desk

Palacio de Congresos de Madrid

Florida Park

Ibiza

Taxi

more...• más... | 115

EW fREE EVENINg - FRIDAY, OCT. 21NOCHE LIBRE - VIERNES, 21 OCT.3.

We have not programmed any activity for this Friday evening to allow you to discover what Madrid night-life is all about at your own pace. Take advantage of this opportunity and visit some of the best museums in the world: the Prado (www.museodelprado.es), the Reina Sofia (www.museoreinasofia.es), and the Thyssen (www.museothyssen.org) museums, all located along the Paseo del Prado.

For further information, please refer to the “Visitor tips” section in this programme book or at the Colloquium’s webpage.

fees and museum information:• For about 15 € you can buy an “Abono Paseo del

Arte”, a special voucher that allows you to visit each one of these top class art museums once during your stay.

• From 18:00 to 20:00 the entrance to the Prado Museum is 5 €. In some special cases, the entrance is free. Look for the Spanish paintings of Velazquez, Goya, Murillo,… they’re exceptional! The museum closes at 20:00h.

• TheentrancetotheReinaSofiaMuseumis7€if

you go before 19:00h. From 19:00 h until closing (20:45h) the entrance is free. Without a doubt, the crown jewel of this museum is Pablo Picasso´s “Gernica”.

• The Thyssen Museum is also very interesting. but it closes at 19:00h.

EatingAfter satisfying your artistic appetite, you can taste the very diverse and delicious Madrid cuisine. You can easily find a wide selection of excellent restaurants that serve food from all over Spain as well as from different countries.

If you want to try something typical, have some tapas: with a group of friends, hop from bar to bar and try one or several varied and savory small dishes. Enrich the taste with a good Spanish wine or beer. The most typical area to have tapas is located near the Plaza Mayor (which is worth the visit in itself. You can walk there from the Paseo del Prado). You may also like the Mercado de San Miguel, a great place for an incredible gastronomical experience about 300 m from the Plaza Mayor, or the bars in the streets adjacent to the Plaza (Cava baja, Cava alta, Mayor,..).

El viernes 21 no hemos programado ninguna actividad para que todos tengan la oportunidad de descubrir la noche madrileña por si mismos. Les recomendamos aprovechar la excepcional oportunidad de disfrutar de alguno de los mejores museos del mundo: el del Prado (www.museodelprado.es), el Reina Sofía (www.museoreinasofia.es) y el Thyssen-Bornemisza (www.museothyssen.org), todos ellos situados a pocos metros a lo largo del Paseo del Prado.

Para más información, consultar el apartado “Consejosparaelvisitante”deestemismoprogramao en la página del Colloquium.

Coste e información sobre los museos: • Porunos15€sepuedeadquirirun“AbonoPaseodelArte”quelepermitirávisitarunavezcadaunode de estos establecimientos durante su estancia en la ciudad.

• De 18:00 a 20:00 la entrada al Museo del Prado

cuesta 5 € y en algunos casos especiales, es gratuita. Priorice las colecciones de pintura española (Velázquez, Goya, Murillo,…..son únicas!). Cierra a las 20 h.

• La entrada al Museo Reina Sofía cuesta 7 € hasta las 19 h y a partir de entonces y hasta la hora de cierre (20:45) es gratuita. Sin duda, la joya del museo es el Gernika de Pablo Picasso.

• El Museo Thyssen también es muy interesante pero cierra a las 19 h.

gastronomíaDespués de haber satisfecho el apetito artístico o incluso directamente, tiene la oportunidad de saborear la muy diversa y atractiva cocina de la ciudad. Encontrará una infinidad de buenos restaurantes de todas las partes de España y de ámbito internacional.

Si quiere probar algo muy típico, cene de tapas: vaya con un grupo de amigos de bar en bar y pruebe en cada uno de ellos uno o varios platillos de comida a cuál más sabrosa, regados con buen vino español o cerveza. La zona más típica para las tapas es la situada cerca de la Plaza Mayor (zona que bien merece una visita por si misma y a la que puede llegar a pie desde el Paseo del Prado). Si puede, entre en el mercado de San Miguel (a 300 m de la Plaza Mayor), verdadero monumento al buen paladar, y/o en los bares de las calles adyacentes (Cava baja, Cava alta, Mayor,…).

116 | more...• más...

Mercado de San Miguel•PlazaSanMiguel,1

Plaza Mayor•PlazaMayor,30

Museo Thyssen•C/PaseodelPrado,8

Museo Reina Sofía•C/SantaIsabel,52

Museo del Prado•C/RuizdeAlarcón,23

Parque Retiro

Opera, Sol, Anton Martín, Banco de España, Atocha

Taxi

more...• más... | 117

E

g

T

g

gALA DINNER AND fAREWELL PARTy - SATURDAY, OCT. 22 (21:00h.)CENA DE gALA y fIESTA DE DESPEDIDA - SÁBADO, 22 OCT. (21 :00h.)

4.

The 19th Colloquium Cochrane will say “Friends forever” to all the participants with a Farewell Party on the last day of the Colloquium. The event will finish where it started, at the Palacio de Congresos de Madrid. We will have dinner, music, and above all, lots of fun. Come ready to have a wonderful time!.

El19ºColloquiumCochranediráungran “Amigosparasiempre”atodoslosasistentesconunaFiestade Despedida el último día del Colloquium. El evento tendrá su fin donde empezó todo, en el mismo Palacio de Congresos de Madrid. Habrá cena, canciones, música y diversión.¡Imprescindible venir con ganas de pasarlo bien!

Great Musical Festival and karaoke. Sign up and offer your best songs to the public and maybe win a prize! Contact [email protected] for more details.

Gran Festival de canciones con la ayuda de un karaoke. ¡Apúntese a ofrecer las mejores baladas a la concurrencia y de paso ganar un premio de reconocimiento! Contacte con [email protected] para conocer más detalles.

118 | more...• más...

TLLive music with La Buena Estrella Orchestra. This successful group from Madrid is formed by musicians with distinguished careers and a large national and international repertoire. Hits from yesterday, today and always are, ultimately, all the ingredients needed to enjoy an unforgettable evening...

Toda la música de baile con La Orquesta La Buena Estrella. Este exitoso grupo musical de Madrid está formada por músicos de distinguida trayectoria profesional, con un amplio repertorio nacional e internacional. Éxitos de ayer, hoy y siempre, en definitiva, con todos los ingredientes necesarios para disfrutar de una velada inolvidable...

fee:• Free access for Colloquium attendees (the identification card is mandatory) who havepreviously registered for this event.

• Accompanying person: access with the complete pass (see below) or with a ticket for the event, which can be purchased at the Colloquium Secretariat for 65 €.

• Registration:

Check availability at the information desk

Coste: • Acceso gratuito para los asistentes al Colloquium

debidamente acreditadas y previamente inscritas en este evento.

• Acompañantes: acceso con el forfait completo de acompañante (ver más abajo) o con el ticket (65 €) del acto que deberá adquirir en la Secretaría del Colloquium.

• Inscripciones:

Preguntar disponibilidad en la secretaría

more...• más... | 119

Accompanying persons passThis all inclusive package is meant for those who accompany a registered Colloquium attendee. It includes access to all social events (Welcome, Dinner+Flamenco Show, Dinner+Farewell party) as well as to the lunches served in the Colloquium venue on the 20th, 21st and 22nd of October.

• fee: 225 €

• Registration: Registration to social events for those who accompany a registered Colloquium attendee may be paid by credit card or cash. Please go to the information desk.

Attendance to sporadic eventsIf an accompanying person wants to attend only a few of the Colloquium social events, s/he can buy the corresponding ticket(s) at the Colloquium Information desk. This should be done in advance, since some of the shows have limited places.

forfait para acompañantesEste paquete “todo incluido”, pensado para laspersonas que acompañan a un/a asistente al Colloquium, comprende el acceso a todos los eventos sociales (Recepción de Bienvenida, Cena+Espectáculo Flamenco, Cena+Fiesta deDespedida) además de las comidas (mediodía) servidas en la sede del Colloquium los días 20, 21 y 22 de Octubre.

• Coste: 225 €

• Inscripciones: Las inscripciones para asistir al Colloquium como acompañante y a los Eventos Sociales se pueden abonar con tarjeta de crédito o en metálico. Dirígase a la secretaría del Colloquium.

Asistencia a algún acto puntualSi un acompañante desea asistir sólo a alguno de los eventos sociales del Colloquium, puede adquirir el ticket correspondiente. Recomendamos que se haga con antelación pues algunos de los actos tienen un aforo limitado.

120 | more...• más...

pRIZES AND AWARDSpREMIOS y RECONOCIMIENTOS

THE THOMAS C. CHALMERS AWARDPREMIO THOMAS C. CHALMERS

Five prizes are awarded during the Colloquium to recognise some of the best contributions to the Cochrane Collaboration. More details on these Prizes and Awards as well as past recipients can be found at http://www.cochrane.org/about-us/awards-scholarships-funding-initiatives/annual-prizes-and-awards.

Durante el Coloquium se concederán cinco premios para reconocer algunas de las mejores aportaciones a la Colaboración Cochrane. Hay más detalles disponibles sobre estos premios y reconocimientos, así como sobre anteriores ganadores en http://www.cochrane.org/about-us/awards-scholarships-funding-initiatives/annual-prizes-and-awards

Presentation at the Closing Plenary Session, Saturday October 22Presentación en la Sesión de Clausura, el Sábado 22 de octubre THOMAS C. CHALMERS, MD(1917-1995)

The Thomas Chalmers Award was established with individual donations to celebrate and recognise Tom’s interests, and was awarded for the first time at the 2nd Cochrane Colloquium in Hamilton, Canada in 1994. The Award is given at each Colloquium to the principal author of both the best oral and the best poster presentation addressing methodological issues related to systematic reviews given by an early career investigator. The presentations must demonstrate originality of thought, high quality science, relevance to the advancement of the science of systematic reviews, and clarity of presentation.

Presentations are judged by the Thomas C Chalmers Award Committee during the course of the Colloquium, and the two recipients receive a certificate and US$500 each. See the Colloquium Committees section for a list of the Thomas C Chalmers Award Committee members. A list of past recipients can be found at http://www.cochrane.org/about-us/awards-scholarships-funding-initiatives/annual-prizes-and-awards.

El Premio Thomas Chalmers se creó con donaciones de particulares para celebrar y reconocer los intereses de Tom, siendo concedido por primera vez en el segundo Coloquium Cochrane de 1994 en Hamilton, Canadá. El premio se otorga en cada Coloquium al autor principal de la mejor presentación oral y de la mejor presentación de pósters que aborden las cuestiones metodológicas relacionadas con las revisiones sistemáticas, impartidas por un investigador en el inicio de su carrera. Las presentaciones deberán demostrar originalidad de pensamiento, ciencia de alta calidad, relevancia para el avance de la ciencia de las revisiones sistemáticas, y claridad de presentación.

Las presentaciones son evaluadas por el Comité del Premio Thomas C. Chalmers durante el transcurso del Colloquium; los dos premiados reciben un certificado y 500 dólares americanos cada uno. Vea la sección Comités del Colloquium para conocer la lista del comité del Premio Thomas C Chalmers. Los ganadores anteriores se pueden consultar en http://www.cochrane.org/about-us/awards-scholarships-funding-initiatives/annual-prizes-and-awards

more...• más... | 121

THE CHRIS SILAgy PRIzE PREMIO CHRIS SILAgy

Presentation at The Cochrane Collaboration’s Annual general Meeting, Thursday October 20 Presentación en la Reunión Anual general de la Colaboración Cochrane, Jueves 20 de octubre CHRIS SILAgy, AO, MD(1960-2001)

The Prize is awarded to an individual who has made an extraordinary contribution to the work of The Cochrane Collaboration and consists of AU$1,000 (drawn from the Chris Silagy Memorial Fund), a certificate and expenses associated with attending the Colloquium (to be met by The Cochrane Collaboration). Potential recipients of the Chris Silagy Prize are required to have:

• made an extraordinary contribution to The Cochrane Collaboration;

• made a contribution that exceeds the expectations of their employment;

• made a contribution to The Cochrane Collaboration that would not be recognised outside the scope of this Prize;

• been identifiedby theirpeersasconsistentlycontributing to a spirit of collaboration.

Nominations and selection

A call for nominations is made via The Cochrane Collaboration’s mailing lists in April each year. A selection panel of three individuals is appointed from past members of the Steering Group and its advisory committees, and the previous year’s Prize recipient (if not conflicted). A governing committee oversees the Prize. See the Colloquium Committees section for a list of the Governing Committee for the Chris Silagy Prize members. A list of past recipients can be found at http://www.cochrane.org/about-us/awards-scholarships-funding-initiatives/annual-prizes-and-awards.

El Premio se otorga a una persona que haya hecho una contribución extraordinaria a la labor de la Colaboración Cochrane y consiste en 1.000 dólares australianos (extraídos de la Chris Silagy Memorial Fund), un certificado y los gastos derivados de la asistencia al Coloquium (que serán cubiertos por la Colaboración Cochrane). Los posibles receptores del Premio Chris Silagy deben haber:

• hecho una contribución extraordinaria a la Colaboración Cochrane;

• una contribución que supere las expectativas de su empleo;

• una contribución a la Colaboración Cochrane que no sería reconocida fuera del alcance de este premio;

• sido identificadosporsuscompañeroscomopersonas que aportan siempre un espíritu de colaboración.

Las candidaturas y la selección

La convocatoria de candidaturas se realiza a través de las listas de correo de la Colaboración Cochrane, en abril de cada año. Se nombra un comité de selección de tres personas a partir de miembros anteriores del Grupo de Coordinación y de sus comités asesores, además del destinatario del premio del año anterior (si no resulta conflictivo). Un comité directivo supervisa el premio. Vea la sección Comités del Colloquium para conocer el Comité del Premio Chris Silagy. Una lista de los ganadores anteriores se encuentra en http://www.cochrane.org/about-us/awards-scholarships-funding-initiatives/annual-prizes-and-awards.

122 | more...• más...

THE bILL SILVERMAN PRIzE PREMIO BILL SILvERMAN

Presentación en la Reunión Anual general de la Colaboración Cochrane, jueves 20 de octubre Presentation at The Cochrane Collaboration’s Annual general Meeting, Thursday October 20. WILLIAM SILVERMAN, MD(1924-2004)

The Bill Silverman Prize acknowledges explicitly the value of criticism of The Cochrane Collaboration, with a view to helping to improve its work, and thus achieve its aim of helping people make well-informed decisions about health care by providing the best possible evidence on the effects of healthcare interventions. The establishment of the Prize was approved by the Cochrane Collaboration Steering Group in 2007, and awarded for the first time in early 2008.

The Prize is offered annually and the authors of a piece of research published or presented in the preceding 12 months (July to June) will be eligible. The criteria for the Prize are that the publication or presentation evaluated any aspect of the preparation, maintenance or dissemination of Cochrane reviews or the work of The Cochrane Collaboration more generally, and:

• was of high quality;• was accompanied by constructive suggestions

on how the relevant aspects of the work of The Cochrane Collaboration could be improved; and

• has had, or is likely to have, a positive impact onthescientificquality,relevanceanduseofCochrane reviews.

The prize comprises a cash award of US$1,000 and a certificate. The cash award goes to the corresponding author of the selected publication or presentation. The Prize Committee calls for nominations for the Prize in May. Nominations can be made by anyone, including the authors of the publication or presentation being nominated. The Prize Committee comprises five members, at least three of whom do not have an active role within any Cochrane entity. See the Colloquium Committees section for a list of the Bill Silverman Prize Committee members. A list of past recipients can be found at http://www.cochrane.org/about-us/awards-scholarships-funding-initiatives/annual-prizes-and-awards.

El premio Bill Silverman reconoce explícitamente el valor del sentido crítico en la Colaboración Cochrane, con el fin de ayudar a mejorar su labor y así lograr su objetivo de ayudar a las personas a tomar decisiones informadas sobre el cuidado de la salud mediante la mejor evidencia posible sobre los efectos de las intervenciones sanitarias. El establecimiento del Premio fue aprobado por el Steering Group de la Colaboración Cochrane en 2007 y otorgado por primera vez a principios de 2008.

El premio es ofrecido cada año, siendo candidatos los autores que hayan publicado o presentado un trabajo de investigación en los últimos 12 meses (de julio a junio). Los criterios para el premio son que la publicación o presentación evalúe cualquier aspecto de la preparación, mantenimiento y difusión de las revisiones Cochrane o el trabajo de la Colaboración Cochrane en general, y:

• sea de alta calidad; • incluya sugerencias constructivas sobre cómo

se podrían mejorar aspectos relevantes de la labor de la Colaboración Cochrane, y

• tenga o sea probable que tenga un impacto positivo en la calidad científica, relevancia yuso de las revisiones Cochrane.

El premio incluye un aporte en metálico de 1.000 dólares americanos y un certificado. El premio en efectivo se destina a los autores de la publicación o presentación seleccionada. El Comité del Premio convoca las posibles candidaturas al premio en mayo. Las nominaciones pueden ser hechas por cualquier persona, incluidos los autores de la publicación o presentación que son nominados. El Comité del Premio está integrado por cinco miembros, por lo menos tres de los cuales no tienen un papel activo dentro de ninguna entidad Cochrane. Vea la sección Comités del Colloquium para conocer la lista de los miembros del comité del Premio Bill Silverman. Una lista de los ganadores anteriores se encuentra en http://www.cochrane.org/about-us/awards-scholarships-funding-initiatives/annual-prizes-and-awards.

more...• más... | 123

THE kENNETH WARREN PRIzE PREMIO KENNETH WARREN

Presentation at The Cochrane Collaboration’s Annual general Meeting, Thursday October 20 Presentación en la Reunión Anual general de la Colaboración Cochrane, jueves 20 de octubre kENNETH WARREN, MD(1929-1996)

The Kenneth Warren Prize is awarded annually to the principal author of whichever systematic review published in the Cochrane Database of Systematic Reviews, and authored by a national living in a developing country, that is judged to be both of high methodological quality and relevant to health problems in developing countries. The Prize for any given year is open to the principal author of a review published in Issues 1 to 6 of The Cochrane Library that year, or Issues 6 to 12 of the previous year.

The judgement is made by a panel comprised entirely of nationals of developing countries (see the Colloquium Committees list and members). The Prize recipient receives a certificate and US$1,000. Also, the travel, accommodation and conference registration costs of the Prize recipient and of the Chair of the selection panel are met to enable attendance at the Cochrane Colloquium to receive and present the Prize. See the Colloquium Committees section for a list of the Kenneth Warren Prize Committee members. A list of past recipients can be found at http://www.cochrane.org/about-us/awards-scholarships-funding-initiatives/annual-prizes-and-awards.

El Premio Kenneth Warren se concede anualmente al autor principal de cualquier revisión sistemática publicada en la Base de Datos Cochrane de Revisiones Sistemáticas que esté escrita por alguien procedente y que viva en un país en desarrollo, y que sea considerada de alta calidad metodológica y relevante para los problemas de salud en los países en desarrollo. El premio para cualquier año está abierto al autor principal de una revisión publicada en los números 1 a 6 de la Cochrane Library de ese año, o de los números 6 a 12 del año anterior.

El veredicto es emitido por una comisión compuesta en su totalidad por nacionales de países en desarrollo (véase la lista de Comités del Colloquium y sus miembros). El ganador del Premio recibe un certificado y 1000 dólares americanos. Además, se cubren los costos de viaje, alojamiento e inscripción al Coloquium del destinatario del Premio y del moderador del comité de selección a fin de posibilitar su asistencia al Colloquium Cochrane y así recibir y presentar el premio. Vea la sección Comités del Colloquium para conocer la lista de los miembros del comité del Premio Kenneth Warren. La lista de los ganadores anteriores se encuentra en http://www.cochrane.org/about-us/awards-scholarships-funding-initiatives/annual-prizes-and-awards.

124 | more...• más...

THE ANNE ANDERSON AWARD EL PREMIO ANNE ANDERSON

Presentation at The Cochrane Collaboration’s Annual general Meeting, Thursday October 20 Presentación en la Reunión Anual general de la Colaboración Cochrane, Jueves 20 de octubre ANNE ANDERSON, MD(1937 - 1983)

The aim of the Anne Anderson Award is to recognise and stimulate individuals contributing to the enhancement of women’s visibility and participation in the Cochrane leadership. This award intends to recognise a member of The Cochrane Collaboration who has contributed meaningfully to the promotion of women as leaders and contributors to The Cochrane Collaboration. The establishment of the Award was approved to be given for three years (from 2011 to 2013) by the Cochrane Collaboration Steering Group in principle in 2010.

The recipient will designate the cash award of 1000 USD to assist a woman from a low-resource setting in her Cochrane Collaboration activities.

Past or current active women members of The Cochrane Collaborationare eligible for the award. Recipients will be selected based on the following criteria: emotional and cognitive intelligence, serving as an inspiration to others, evidence of cumulative accomplishment, originality and independence of thought, personal qualities, team building, leadership and mentorship. We will also consider in the selection process the nominee’s contribution to or enhancement of women’s visibility within the Collaboration, participation in The Cochrane Collaboration and other leadership, and other accomplishments within the context of the Cochrane Collaboration. See the Colloquium Committees section for a list of the Anne Anderson Award Committee members.

El objetivo del Premio Anne Anderson es reconocer y estimular a las personas que contribuyen a la mejora de la visibilidad de las mujeres y su participación en el liderazgo de Cochrane. Este premio pretende reconocer a un miembro de la Colaboración Cochrane que haya contribuido significativamente a la promoción de las mujeres como líderes y colaboradoras de la Colaboración Cochrane. El establecimiento del Premio fue aprobado para ser ofrecido durante tres años (2011 a 2013) por el Steering Group de la Colaboración Cochrane al principio de 2010.

El receptor destinará el premio en efectivo de 1000 dólares americanos a ayudar a una mujer de bajos recursos de un entorno relacionado con sus actividades de la Colaboración Cochrane.

Serán elegibles para el premio las mujeres que sean antiguos miembros de la Colaboración Cochrane o que aún lo sean actualmente. Los beneficiarios serán seleccionados en base a los siguientes criterios: la inteligencia emocional y cognitiva, sirviendo de inspiración a los demás, la evidencia de los logros acumulados, la originalidad y la independencia de pensamiento, cualidades personales, trabajo en equipo, liderazgo y orientación. También se tendrá en cuenta en el proceso de selección la contribución del candidato a la mejora de la visibilidad de las mujeres dentro de la Colaboración, la participación en la Colaboración Cochrane, el liderazgo de los demás y otros logros en el marco de la Colaboración Cochrane. Vea la sección Comités del Colloquium para conocer la lista de los miembros del Comité del Premio Anne Anderson.

more...• más... | 125

PAHO – IbEROAMERICAN COCHRANE NETWORk AWARD PREMIO OPS – RED COCHRANE IBEROAMERICANA

Presentation at the Closing Plenary Session, Saturday October 22 Presentación en la Sesión de Clausura, el Sábado 22 de octubre

PAHO/WHO in collaboration with the Red Cochrane Iberoamericana, thanks to a kind contribution of the “Agencia Española de Cooperación Internacional para el Desarrollo” (AECID), created this award to: recognize systematic reviews and protocols that promote the Health Agenda for the Americas 2008-2017 agreed by the governments of the Americas in 2007; promote the development of new reviews; and inspire young researchers to contribute systematic reviews that guide research that contribute to informed decisions for health.

The theme of this year is Strengthening the Health Systems in the Americas. Its objective is to promote research that contributes to robust health systems through Cochrane Reviews. An award will be given to one systematic review and one protocol that responds to current research questions relevant to the health systems in the Americas.

The award recognizes the authors of a systematic review judged by its importance, usefulness, and high methodological quality, which contributes to strengthen health systems in the Americas. The award consists in recognition of the team during the event and covering the participation in the Colloquium of an author designated by the team and agreed with the organizers. Potential recipients of the PAHO – Iberoamerican Cochrane Network Award are required to:

• be relevant for the Health Agenda for the Americas 2008-2017.

• take into account aspects of equity.• be perceived by the selection panel, as useful

for the strengthening of the national health systems.

• include authors with connection to an institution of the Americas and resident in a country of Latin America or Caribbean.

• high methodological quality.

La OPS/OMS en colaboración con la Red Cochrane Iberoamericana, gracias a la contribución de la Agencia Española de Cooperación Internacional para el Desarrollo (AECID), crearon este premio para: reconocer las revisiones sistemáticas y protocolos que impulsen la Agenda de Salud para las Américas 2008 – 20017 acordada por los gobiernos de las Américas en 2007; promover el desarrollo de nuevas revisiones; e inspirar a investigadores jóvenes para que contribuyan con revisiones sistemáticas a orientar la investigación dirigida a informar las decisiones en salud.

El tema de este año es “Fortalecimiento de losSistemas de Salud de lasAméricas” y tiene comoobjetivo promocionar la investigación que contribuya a fortalecer los sistemas de salud mediante revisiones Cochrane. Se premiará una revisión sistemática y un protocolo que respondan preguntas de investigación que sean relevantes para las Américas.

El premio reconoce los autores de una revisión sistemática reconocida por su relevancia, utilidad y alta calidad metodológica que contribuya a fortalecer los sistemas de salud en las Américas. El premio consiste en el reconocimiento al equipo y la participación de uno de los autores en el Colloquium. Pueden recibir el Premio OPS – Red Cochrane Iberoamericana aquellas revisiones que:

• sean relevantes para la Agenda de Salud de las Américas 2008-2017

• tomen en cuenta aspectos de equidad.• sean útiles para el fortalecimiento de los

sistemas nacionales de salud en América Latina

• incluyanautoresconafiliaciónaunainstituciónde las Américas y residentes en un país de América Latina o el Caribe.

• tenga alta calidad metodológica

© E

:M: P

rom

oció

n de

Mad

rid, S

.A. |

PA

LAC

IO D

E C

RIS

TAL

, PA

RQ

UE

DEL

RET

IRO

MADRID: THE BASICS MADRID: LO BÁSICO

AbOUT MADRIDACERCA DE MADRID

CONSEJOS PARA EL VISITANTEvISITOR TIPS

THE

bA

SIC

LO B

áSI

CO

128 | Madrid:Thebasics•Madrid: lo básico

Bancos, cambio y preciosTodas las oficinas bancarias (con un horario aproximado de lunes a viernes de 8.30 a 14.00 horas), así como las oficinas de cambio en las principales ciudades, ofrecen al viajero la posibilidad de cambiar divisas. Dicho servicio también se ofrece en buena parte de los hoteles y agencias de viaje.

De igual forma, el pago con las tarjetas de crédito internacionales más conocidas está muy extendido entre los comercios españoles que suelen indicarlo con carteles a la entrada del establecimiento. Cuando realice el pago deberá presentar el pasaporte o su documento identificativo. Los cheques de viaje, acompañados del pasaporte, son también admitidos en la mayoría de los hoteles, restaurantes y comercios.

MonedaEn España, al igual que en otros países de la Unión Europea, se utiliza el euro.

Agua potableEspaña cuenta con rigurosos sistemas de control que garantizan la calidad del agua. El suministro de agua potable está asegurado en la totalidad del territorio.

ElectricidadEl voltaje en España es de 220 voltios y 50 hercios de corriente alterna. Los enchufes cumplen todos con la normativa europea y responden al sistema de patillas redondas. En cualquier caso, en la mayoría de los hoteles existen adaptadores para clavijas especiales.

Números de emergenciaEl número de teléfono gratuito 112 es válido en todo el territorio de España.

HorariosLos horarios comerciales más usuales son de lunes a sábado desde las 9.30 a las 13.30 horas y de las 16.30 a las 20 horas. Los grandes centros comerciales y almacenes tienen un horario continuado de 10 a 21 ó 22 horas. Las farmacias tienen un horario habitual de 9.30 a 13.30 horas y de 16.30 a 20 horas, si bien existen en las grandes ciudades algunas que permanecen abiertas las veinticuatro horas del día.

SeguridadComo en cualquier otro país, existen unas medidas de seguridad mínimas. Se recomienda evitar transitar por lugares solitarios o poco alumbrados, así como los juegos de azar en la calle. Es aconsejable que lleve encima tan sólo el dinero que necesite en cada

ABOUT MADRIDACERCA DE MADRID

banks, bureau de Change and CostsAll banks (open Mondays through to Fridays, from 08:30 to 14:00h, approximately) as well as Bureau de Changes in main cities, can exchange money. This service can also be found in selected hotels and travel agencies.

Payments made using recognised international credit cards are commonly accepted in most Spanish shops. They usually have signs indicating this option at the entrance of the establishments. When you make a payment by card you should show your passport or ID card. Traveller’s cheques, accompanied by a passport, are also accepted in most hotels, restaurants and shops.

CurrencyIn Spain, as in most other EU countries, the euro is the currency used.

Drinking waterSpain has a stringent control system which guarantees a high water quality. The supply of drinking water is guaranteed throughout the country.

ElectricityElectricity supply in Spain is AC 220 volts, 50 Hertz. The sockets meet European regulations and use the round pin system. However, most hotels have adaptors for different plugs.

Emergency numbersDial 112 free of charge (valid throughout Spain). HoursThe usual business hours are from Monday-Saturday, from 09:30 to 13:30h, and 04:30 to 20:00h. Major shopping centres and department stores are open all day from 10:00 to 21:00 or 22:00h. Chemists are usually open from 09:30 to 13:30h and from 16:30 to 20:00, although some chemists in large cities stay open round the clock.

Personal safetyAs in any other country, there are basic security measures one should take. Avoid walking around empty or poorly lit areas, and avoid gambling on the streets. It is advisable to carry only the money you will need for each day.

You must pay attention in crowded places, such as public transport or department stores. In recreational places do not leave valuable objects like mobile phones or cameras.

Madrid:Thebasics•Madrid: lo básico | 129

salida. Hay que prestar atención a los sitios en los que se producen aglomeraciones de gente, como los transportes públicos o los grandes almacenes.

En los lugares de ocio y esparcimiento no deje a la vista objetos como teléfonos móviles o cámaras fotográficas.

La prevención es la mejor solución para no sufrir ningún problema a este respecto. Si necesita ayuda puede contactar con la Policía en el número de teléfono 091.

fumarNo está permitido fumar en ningún establecimiento cerrado o transporte ni en las inmediaciones de un centro educativo/infantil o sanitario.

TelecomunicacionesSi desea efectuar una llamada a España desde el extranjero,deberámarcar+34(códigodeEspaña)y a continuación, el número de teléfono, compuesto de 9 cifras.

Si desea llamar desde España a otro país deberá marcar 00 seguido del código del país y el número de teléfono. Puede efectuar llamadas desde cabinas telefónicas. Estas cabinas funcionan con monedas o con tarjetas que se pueden adquirir en los estancos.Si desea efectuar llamadas dentro de España deberá marcar el número sin ningún tipo de prefijos. Este número consta siempre de 9 dígitos, sea un teléfono fijo o móvil.

Si desea utilizar su móvil en España debe saber que la cobertura se basa en la tecnología GSM, que no es compatible con la de algunos países como Estados Unidos o Japón. En este caso es necesario disponer de un móvil tribanda. Si su tecnología es compatible, resulta conveniente que contacte con el operador de su país para asegurarse de que puede utilizar su móvil en España (su operador deberá activarle el servicio de itinerancia internacional roaming). Una vez realizados los pasos en su país de origen, podrá utilizar el móvil en España como si su terminal fuera español:esdecir,deberámarcarel00+elcódigodelpaís para realizar llamadas internacionales.

Si desea conectarse a Internet podrá dirigirse a numerosos establecimientos que ofrecen este servicio: locutorios, cibercafés, etc. También encontrará conexiones en los aeropuertos, las principales estaciones de tren y de autobús, así como en algunos centros comerciales.

Prevention is the best solution to not suffer any problems in this regard. If you need help you can contact the Police on 091.

SmokingSmoking is not allowed in any establishment which is closed off or within any type of transportation or in the vicinity of a school/ child or a health clinic.

TelecommunicationsIf you wish to make a call to Spain from abroad, you should dial +34 (the code for Spain) followed by the telephone number (9 digits).

If you want to call another country from Spain, then dial 00 followed by the countries code and the telephone number. You can make calls from phone boxes. These work with coins or cards available from “estancos” (licensed outlets for tobacco/ stamps).

If you wish to make national calls within Spain, just dial the number without the prefix. This number should have 9 digits, regardless of whether it is a landline or mobile.

To use your mobile in Spain you should be aware that coverage here uses GSM technology, meaning that it is incompatible with some countries such as the USA or Japan. In this case you will need a tri-band mobile in order to call. If you have a compatible handset, you should get in touch with your mobile phone company to make sure that you can use your mobile in Spain (they will activate the international roaming service on your account). Once you’ve taken these steps in your country of residence, you’ll be able to use your mobile in Spain as if it were a Spanish handset: i.e. you can dial 00 followed by the country code to make international calls.

If you wish to get online, you should go to one of the many establishments that offer internet connections: telephone houses, cybercafés, etc. Internet connections are also available at airports, major railway and bus stations, and at some shopping centers.

TippingIn any establishment in Spain, service is included with the price of the meal or drink. However, tipping is a common practice at bars and restaurants, hotels, and taxis, depending on the total price for the service, and on the generosity of the client. It is usually around five to ten percent of the total price.


PropinasLa totalidad de los establecimientos en España incluye el precio del servicio. Sin embargo, la práctica de la propina sí es habitual en los bares y restaurantes, hoteles y taxis, dependiendo del importe y de la generosidad del cliente, si bien suele oscilar entre un cinco y un diez por ciento del importe total.

TransportesMadrid dispone de una extensa red de metro (que funciona de 06:00 hasta las 01.30 horas), autobús (hay servicio durante toda la noche) y tren. La forma más económica para utilizar estos servicios es comprando el Abono Turístico que permite hacer viajes ilimitados dentro de la fecha de validez. Este Abono se puede adquirir en todas las estaciones de la red de metro, en las Oficinas de Turismo, en las Oficinas del Consorcio Regional de Transportes, en lugares de interés turístico y a través de Internet; también se puede adquirir en algunos estancos y quioscos. Además, Madrid dispone de 15.600 taxis que se pueden parar por la calle sólo haciendo una señal con la mano.

Descuento de IvA y bienes prohibidosSi la residencia del comprador está fuera de la Unión Europea, puede solicitar la devolución de los impuestos de sus compras, siempre que superen el importe global de 90,15 euros. Para ello debe solicitar en el comercio el cheque Tax free.Existen varias empresas en España autorizadas para gestionar la devolución del IVA (Impuesto de Valor Añadido) a turistas. El trámite es muy sencillo, tan solo hay que seguir los siguientes pasos para obtener la devolución:

1. Solicitar la factura tax-free y mostrar su acreditación de residencia (pasaporte).

2. Mostrar sus compras y sellar las facturas tax-free en la aduana. (El plazo de sellado desde la fecha de compra es de 3 meses.)

3. Solicitar el importe de devolución a la empresa gestora. Todas ellas tienen puntos de reembolso de IVA en los principales aeropuertos o fronteras españolas para su cobro en efectivo. También puede hacerlo mediante el ingreso del IVA en la tarjeta de crédito, transferencia bancaria o cheque internacional.

ClimaEspaña es uno de los países más cálidos de Europa. En Madrid, las temperaturas suelen estar entre 8 y 20 grados centígrados en octubre.

TransportationMadrid has an extensive underground system (which runs from 06:00 until 01:30), bus service (that runs all night) and an overground train network. The cheapest way to make use of these services is to buy the Tourist Travel Pass which allows unlimited travel within the valid dates. This Pass is available in all metro stations, Tourist Offices, at the offices of the Regional Transport Consortium, at tourist attractions and online, or you can buy them at tobacconists and newsstands. In addition, Madrid has 15,600 taxis which can be hailed down on the street just making a hand signal.

VAT relief and prohibited goodsIf a consumer’s residence is outside the European Union, then he/she can claim back the tax on purchases, as long as in total they reach a total in excess of 90.15 euros. In order to claim back tax you should ask for a tax-free receipt at the point of sale.There are various companies in Spain authorised to process the reimbursement of VAT (Value Added Tax) to tourists. The procedure is very straightforward. You just have to follow these steps to receive a tax refund:

1. Ask for a tax-free receipt and show your proof of residence (passport).

2. Show your purchases and stamp the tax-free receipts at customs. (Receipts must be stamped within 3 months of purchase.)

3. Claim the amount due from the company processing the claim. They all have VAT reimbursement points at main Spanish airports and borders, for payments to be made in cash. You can also have the VAT repaid onto your credit card, by bank transfer or international cheque.

WeatherSpain is one of the warmest countries in Europe. In Madrid, temperatures in October usually range between 8 and 20 degrees.


VISITOR TIpSCONSEJOS pARA EL VISITANTE

Madrid is one of the great centers of world culture. On this page you will find some suggestions on ways one could enjoy the rich variety of leisure, major museums, emblematic buildings and monuments, dining, nightlife and shops that the city has to offer. We recommend that you visit the Madrid tourism site for more detailed information and to learn more about what the city has to offer.

Furthermore, the cities attractions go beyond its borders. Just two hours away are nine sites classified asWorldHeritagebyUNESCO:AlcaládeHenares,Toledo, Cuenca, Segovia, Avila, Salamanca, Córdoba, the Royal Monastery and Site of San Lorenzo de El Escorial and Aranjuez Cultural Landscape.

Madrid es uno de los grandes centros de la cultura mundial. En esta sección encontrará algunas posibilidades para gozar de su rica oferta de ocio: visitas a los grandes museos, a los edificios y monumentos más emblemáticos, ofertas en gastronomía, vida nocturna, comercio… Recomendamos visitar la página de turismo para ampliar la información aquí facilitada así como para conocer las alternativas puntuales de la oferta cultural de la ciudad.

Además, los atractivos de la ciudad de Madrid van más allá de sus fronteras. A tan sólo dos horas de distancia se encuentran nueve enclaves catalogados por la UNESCO como Patrimonio de la Humanidad: Alcalá de Henares, Toledo, Cuenca, Segovia, Ávila, Salamanca, Córdoba, el Monasterio y Real Sitio de San Lorenzo de El Escorial y el Paisaje Cultural de Aranjuez.

MADRID - WHAT TO SEE? WHERE TO gO? WHAT TO DO? MADRID - ¿QUé vER? ¿A DóNDE IR? ¿QUé HACER?

© E

:M: P

rom

oció

n de

Mad

rid, S

.A. |

Gra

n Ví

a


THE PRADO MUSEUMFrom its privileged location surrounded by trees and some of Madrid´s greatest monuments, the National Museum of the Prado is one of the most visited attractions in the capital. The museum is home to the most important Spanish painting collection in the world.

THySSEN-bORNEMISzA MUSEUMThe Thyssen-Bornemisza, with almost 1,000 works, is located in a cultural and artistic itinerary that is unique in the world. Come to the museum and enjoy a privileged tour of seven centuries of European painting, from its origins in the 13th century to the end of the 20th century.

REINA SOfíA MUSEUMWorks by Dali, Miró and Juan Gris join Picasso’s Guernika on a fascinating journey through the history of contemporary art. The new scheme that commenced in 2009 contrasts works from different painters, origins, periods and subjects, thus illustrating different facets of the avant-garde.

MAJOR ARTS CENTRESAs well as the major museums, the Art Walk, stretching from north to south along the Paseo de la Castellana, is home to important exhibition halls, foundations and institutes, which play a fundamental part in the country’s cultural life. Matadero Madrid, Centro Cultural Conde Duque and Círculo de Bellas Artes are just some of the most important ones.

MUSEO DEL PRADOUbicado en un lugar privilegiado, rodeado de árboles y de algunos de los mejores monumentos de Madrid, el Museo Nacional del Prado es uno de los atractivos de la capital más visitados. El museo alberga la colección de pintura española más importante del mundo.

MUSEO THySSEN-BORNEMISzACon cerca de 1.000 obras de arte, el Thyssen-Bornemisza está ubicado en un itinerario cultural y artístico único en el mundo. El museo le invita a realizar un privilegiado recorrido por los siete siglos de la historia de la pintura europea, desde sus inicios en el siglo XIII hasta las postrimerías del siglo XX.

MUSEO REINA SOfíAObras de Dalí, Miró y Juan Gris acompañan al Guernika de Picasso en un apasionante recorrido por la Historia del Arte contemporáneo. El nuevo plan museológico, inaugurado en mayo de 2009, pone en diálogo obras de distintos autores, orígenes, periodos y temáticas, para mostrar las distintas caras de la vanguardia.

gRANDES CENTROS CULTURALESAdemás de los grandes museos del Paseo del Arte, de norte a sur, a lo largo del eje de la Castellana, se suceden salas de exposiciones, fundaciones e institutos que juegan un papel fundamental en la vida cultural del país. Matadero Madrid, Centro Cultural Conde Duque o el Círculo de Bellas Artes son algunos de los más importantes.

MUSEUMS AND CULTURAL CENTRES MUSEOS y ESPACIOS CULTURALES

© E

:M: P

rom

oció

n de

Mad

rid, S

.A. |

Mus

eo T

hyse

m-B

orne

mis

za


CAIXAfORUM MADRIDUn espacio vivo que abre sus puertas al arte antiguo, moderno y contemporáneo, a la música y la poesía, al arte multimedia, a los debates y a las actividades sociales y educativas. Su espectacular sede, situada en el paseo del Prado en la antigua Central Eléctrica de Mediodía, es ya uno de los nuevos iconos de la ciudad.

TEATRO REALLa reina Isabel II fundó este teatro para que fuera uno de las más prestigiosas óperas del mundo. Desde su reapertura en 1997, acoge en su amplísima caja escénica, montajes propios y producciones internacionales de gran calidad. Una visita imprescindible para los amantes del género lírico.

BIBLIOTECA NACIONALIdentificar, preservar, conservar y difundir el patrimonio documental español son las funciones de esta biblioteca que atesora más de 30.000 manuscritos, cerca de 3.000 incunables y unos 500.000 impresos anteriores a 1831. Su museo es un apasionante recorrido por la historia del libro.

CAIXAfORUM MADRIDIt emerges as a live space opening its doors to old, modern and contemporary art, to music and poetry, to multimedia art, to debates, and to social and educational activities. The spectacular building housing it, located on Paseo del Prado in the former Mediodía Electric Power Station, is already one of the new landmarks in the city.

TEATRO REALWhen Queen Isabel II founded the theatre she intended to turn it into one of the most prestigious opera houses in the world. Since reopening in 1997, it has welcomed to its vast stage both its own productions and artists from around the globe. A must visit for lovers of opera.

SPANISH NATIONAL LIbRARyThis library works to identify, preserve, conserve and disseminate the written heritage of Spain. The museum, which houses over 30,000 manuscripts, around 3,000 incunabula and some 500,000 examples of printed matter, is a fascinating journey through the history of the book.

© E

:M: P

rom

oció

n de

Mad

rid, S

.A. |

EspacioCultural“Matadero”

© E

:M: P

rom

oció

n de

Mad

rid, S

.A. |

Tea

tro R

eal


ROyAL PALACE AND ROyAL ARMOURy Home to the Kings of Spain from Carlos III all the way through to Alfonso XIII, Madrid´s Royal Palace is now open to anyone who wants to take a trip through Spanish history. Visitors can wander through the many rooms, enjoying the beautiful architecture and the art collection still housed here.

TEMPLE Of DEbODRenowned among people from Madrid as an ideal place to watch stunning sunsets, this incredible monument, which is over two thousand years old, was brought over from Egypt and built stone by stone in the heart of Madrid. After taking a delightful walk around the park, step into the temple’s interior for a very interesting visit.

HERITAgEIf you are interested in learning more about the architecture of Madrid, you have to visit the official historical heritage website for Madrid. There are a selection of 220 buildings which reflect all the styles and types which make up the image that is Madrid, which seeks to highlight the city’s architectural wealth

MONUMENTAL MADRIDThe great city which is now Madrid began as a small fortress that Mohammed I, Emir of Córdoba, built in the ninth century for defensive purposes.

PALACIO REAL y ARMERíA REALMorada regia desde Carlos III hasta Alfonso XIII, el Palacio Real está abierto a los ciudadanos que quieran hacer un viaje por la historia de España paseando por sus estancias, contemplando sus colecciones pictóricas y recreándose en su arquitectura. Además, cuenta con una de las armerías más importantes del mundo.

TEMPLO DE DEBODFamoso entre los madrileños por ser un buen lugar para contemplar espectaculares puestas de sol, este impresionante monumento con más de dos milenios de historia fue traído desde Egipto y construido piedra a piedra en pleno centro de Madrid. El paseo por sus alrededores se completa con una interesante visita al interior.

PATRIMONIO HISTóRICOSi está interesado en conocer al detalle la arquitectura de la ciudad, tiene que visitar la web oficial del Patrimonio Histórico madrileño. Una selección de 220 edificios que refleja todos los estilos y tipologías que conforman la imagen de Madrid y que pretende dar a conocer la riqueza arquitectónica de la ciudad.

MADRID MONUMENTALLa gran ciudad que hoy es Madrid comenzó siendo una pequeña fortaleza que Mohamed I, emir de Córdoba, mandó construir en el siglo IX con fines defensivos.

bUILDINgS AND MONUMENTSEDIfICIOS y MONUMENTOS

© E

:M: P

rom

oció

n de

Mad

rid, S

.A. |

Cas

a de

la V

illa


gASTRONOMygASTRONOMíA

THE AgES Of MADRIDOne century, one building. You can travel through history visiting places that, due to their architectural value, best represent the essence of Madrid: the Chapel of Santa María de la Antigua, Casa de los Lujanes, the Monastery of the Descalzas Reales, Plaza Mayor, El Prado museum, the Bank of Spain, etc.

THE ROyAL MONASTERy Of DESCALzASThis XVI century building is a royal monastery where the royals Charles I and Isabella of Portugal resided; it was later converted into a convent for Franciscan nuns. The walls retain a historical and artistic legacy which is worth visiting. But the visit has to be quiet so as to not disturb the silence of the place.

LAS EDADES DE MADRIDUn siglo, un edificio. Puede pasear a través de la historia por aquellos lugares que, por su valor arquitectónico, mejor representan la esencia de Madrid: la ermita de Santa María de la Antigua, la Casa de los Lujanes, el Monasterio de las Descalzas Reales, la Plaza Mayor, el Museo del Prado, el Banco de España, etc

MONASTERIO DE LAS DESCALzAS REALESEste singular edificio del siglo XVI es un antiguo monasterio real donde residieron Carlos I e Isabel de Portugal, posteriormente reconvertido en un convento de monjas franciscanas. Sus paredes conservan un legado histórico y artístico digno de ser visitado. Eso sí, el paseo ha de ser silencioso para no interrumpir el recogimiento del lugar.

gASTRONOMíA MADRILEñADescubra los platos más típicos de Madrid, desde el cocido, el besugo y los callos madrileños hasta los dulces más castizos, como las torrijas, los barquillos o los huesos del santo. Y no se olvide de incluir en su ruta gastronómica los vinos madrileños con denominación de origen y las típicas tapas.

MADRID’S gASTRONOMyDiscover the most typical dishes from Madrid, cocido, besugo and callos, but also traditionnal pastries such as torrijas, barquillos and huesos de santo. Don’t forget to taste on your culinary tour the well-known tapas and the wines from the Madrid Community region

© E

:M: P

rom

oció

n de

Mad

rid, S

.A. |

Pal

acio

Rea

l


MICHELIN STAR RESTAURANTSMadrid is home to around 3,100 eateries but only Santceloni, La Terraza del Casino, Sergi Arola Gastro and Ramón Freixa Madrid -with 2 stars- and Zalacaín, El Club Allard, La Broche, Diverxo, Kabuki Wellington and Kabuki -with one- are the chosen few by the Michelin Guide. Enjoy exquisite cuisine and fantastic service in these venues.

gASTRObARSThe culture of tapas, as seen by nouvelle cuisine and the most innovative design trends, finds a home in modern bars, where you can try out some truly creative recipes. These little dishes are brought up to date with the latest ingredients and techniques, and are served in venues that are just as modern, imaginative and chic. RESTAURANTS WHICH LOVE ARTAt the Thyssen Bornemisza Museum, the Teatro Real (Opera House), the Museo del Traje and the Reina Sofía Museum, visitors can enjoy more than the artistic collections, since they can also discover another type of art: gastronomy.

SAINT MICHAELS MARkETBuilt in 1916, this market is the finest example of cast-iron architecture in Madrid. Today it is a temple to gastronomy, home to 33 stalls selling mouth-watering products and select ingredients, offering food to take home or to consume right there on the premises.

RESTAURANTES CON ESTRELLASDe los 3.100 establecimientos madrileños, sólo Santceloni, La Terraza del Casino y Sergi Arola Gastro, con dos estrellas, y Zalacaín, El Club Allard, La Broche, Diverxo, Kabuki Wellington y Ramón Freixa Madrid, con una, son los elegidos por la Guía Michelín. Disfrute de una exquisita cocina y de un servicio excepcional en estos lugares.

gASTROBARESEl tapeo, visto por el ojo de la nueva cocina y el diseño más innovador, presenta unos modernos bares donde degustar las propuestas más creativas. Esta ‘pequeña cocina’ también se impregna de las últimas tendencias en ingredientes y técnicas, y se ofrece en locales acordes con su nueva imagen, imaginativa y chic.

RESTAURANTES CON MUCHO ARTEEl Museo Thyssen Bornemisza, el Teatro Real, el Museo del Traje y el Museo Reina Sofía ofrecen la posibilidad de disfrutar, no sólo de sus colecciones artísticas, sino también de descubrir otro tipo de arte: la gastronomía.

MERCADO DE SAN MIgUELEl mejor ejemplo de la arquitectura del hierro en Madrid se encuentra en este mercado de 1916, que actualmente es todo un templo de la gastronomía, formado por un conjunto de 33 puestos de exquisitos productos y escogidas materias primas, tanto de venta como de restauración.

© E

:M: P

rom

oció

n de

Mad

rid, S

.A. |

Tab

erna


NIgHTLIfELA NOCHE DE MADRID

RESTAURANTES CENTENARIOSDurante más de un siglo llevan cocinando guisos típicos de la gastronomía madrileña del mismo modo que se hacía antaño. Cocido servido en puchero de barro, cochinillo y cordero asados en horno de leña, callos o pepitoria de gallina son algunos de las opciones que proponen estos restaurantes, presentes en muchas etapas de la historia de la ciudad.

CENTENNIAL RESTAURANTSThese restaurants, for over a century have been cooking stews which are typical of Madrid cuisine in the same tradition from years ago. Stews served in clay pots, pork and lamb roasted in a wooden oven, tripe and chicken fricassee are some of the dishes offered by these restaurants, which are very present throughout the various historical stages of the city.

MADRID fOR yOU: NIgHTLIfEThe nightlife in Madrid is undoubtedly one of the city’s main attractions. Tapas bars, cocktail bars, clubs, jazz lounges, live music venues, flamenco theatres and establishments of all kinds cater for all tastes and ages.

A DESIgNER’S NIgHT OUTMadrid has always been a meeting point for very different people. New venues are continuously opening up with new offers to spice up the night. Live music, elaborate décor and lighting, signature cocktails or resident DJs are some of the proposals servedbythemost‘chic’venuesinthecapital.

MADRID PARA USTED: LA NOCHELa noche es uno de los principales atractivos de la ciudad. Bares de tapas, locales de copas, discotecas, salas de jazz, cafés musicales, tablaos flamencos y establecimientos de todo tipo satisfacen a un público de todos los gustos y edades.

UNA NOCHE DE DISEñOMadrid ha sido siempre un punto de encuentro para gente muy dispar. Por este motivo, nuevos locales abren sus puertas continuamente con ofertas inéditas para saborear la noche. Música en directo, elaborada decoración e iluminación, cócteles propios o djs residentes son algunas de las propuestas más ‘chic’.

© E

:M: P

rom

oció

n de

Mad

rid, S

.A. |

La

noch

e de

Mad

rid


fLAMENCO IN MADRID One thing is for sure: Madrid is the world capital of Flamenco. So that you can see for yourself, we suggest a tour to get a taste of the most authentic atmosphere. Tablaos and bars with live performances in which you can enjoy the best dance and the best music while sampling some delicious tapas.

LIVE MUSICEvery night, venues pertaining to the Live Music Venues Association La Noche en Vivo, host a wide range of live music shows. Everything from acclaimed to up-and-coming artists, singer-songwriters to rock bands, jazz concerts or electronic music sessions to enjoy music at its best.

EL MADRID MáS fLAMENCOSi hay algo que nadie pone en duda es que Madrid es la capital mundial del flamenco. Para que lo confirme, le proponemos una ruta en la que disfrutar del ambiente más puro. Tablaos y bares con actuaciones en directo en los que puedes degustar el mejor baile y la mejor música tomándote unas ricas tapas.

MúSICA EN vIvOLos locales de la Asociación de Salas de Música en Directo La Noche en Vivo albergan todas las noches una amplia oferta de actuaciones musicales. Artistas consagrados y nuevos talentos, cantautores y grupos de rock, conciertos de jazz o de música electrónica para disfrutar de la música en estado puro.

SHOPPINgCOMPRAS

MADRID SHOP The Tourism Information Centre at Casa de la Panadería in Plaza Mayor sells items related to the city under the brand ¡Madrid!. It features books on the history of the city, its architecture and museums as well as t-shirts and CD’s with tunes inspired by the capital.

MADRID SHOPEl Centro de Turismo de la Casa de la Panadería en la Plaza Mayor comercializa en su tienda artículos relacionados con la ciudad bajo la marca ¡Madrid! Se trata de libros sobre la historia de la ciudad, su arquitectura, museos; camisetas y cd´s con melodías inspiradas en la capital.

© D

avid

Val

dez

| Bal

let


COMMERCIAL LINESThe Madrid Shop, the museum shops, markets and malls, antique stores, historical stores, fairs and, of course, the various shopping areas of the city… Anywhere in the city you will be able to find the perfect gift: classic, old, new, old, modern, alternative, independent, luxurious, elegant… In Madrid there are no limits.

TRADITIONAL SHOPS AND TAVERNSThe streets of Madrid city centre hide some stores which have been there for more than a century. These are chemist’s, taverns, patisseries and other establishments which form part of the capital’s history, and still continue to run their business in the 21st century Madrid. You can experience these traditional shops and taverns for yourself.

LAS SALESAS DISTRICTSince the 1970s, the area surrounding the old Salesas Reales has been accommodating original and unique shops, art galleries, restaurants and cafés. They are chic and trendy, elegant and fun; and Las Salesas has become one of the most exclusive areas in the city.

EJES COMERCIALESLa Madrid Shop, las tiendas de los museos, los mercados y centros comerciales, las tiendas de antigüedades, los comercios centenarios, las ferias y, por supuesto, las zonas de compras de la ciudad… En cualquier sitio de Madrid puede descubrir el regalo perfecto: clásico, antiguo, nuevo, viejo, moderno, alternativo, independiente, lujoso o elegante… En Madrid no hay límites.

COMERCIOS CENTENARIOSLas calles del centro de Madrid esconden comercios que cuentan con más de un siglo de vida. Son farmacias, tabernas, pastelerías y otros establecimientos que se han mimetizado con el Madrid del siglo XXI y continúan desarrollando su actividad. Conozca de cerca el sabor añejo de esos comercios y tabernas tradicionales.

BARRIO DE LAS SALESASDesde los años 70, alrededor de las antiguas Salesas Reales, se han instalado tiendas, galerías de arte, restaurantes y cafeterías que apuestan por un estilo particular. Es chic y es trendy. Es elegante y divertida, seguramente una de las zonas más exclusivas de la ciudad.

© E

:M: P

rom

oció

n de

Mad

rid, S

.A. |

Mer

cado

de

Fuen

carra

l


EL RETIRO PARkWatch a puppet show, receive a soothing massage using millenary techniques from the Far East, listen to live music, play some sport, row a boat or, simply, relax under a tree reading your favourite book. Everything is possible in the centre of Madrid, in El Retiro park, a favourite of Madrid’s citizens and tourists.

ROyAL bOTANICAL gARDENDesigned 250 years ago, this garden invites visitors to enjoy a pleasant stroll surrounded by thousands of live plant species. Among its collections there is a herbarium with over one million specimens, a library and an archive with almost 10,000 drawings, as well as an exhibition of 5,000 live plant species. It’s greenhouse keeps plants from other latitudes, from foreign orchids to carnivorous plants.

EL CAPRICHO PARk With a romantic air and a slight French flavour, the gardens El Capricho were, in past times, owned by the Duchess of Osuna. A labyrinth, a palace or a pond are some of the most surprising and unexpected spots of the park.The perfect place for a walk on weekends and public holidays, the only days it opens.

SECRET gARDENSRarely visited by locals, these gardens are the city’s best kept secret. Discover the Garden of the Príncipe de Anglona, the old wall or the cemetery of St. Sebastian.

EL RETIRODisfrutar de un espectáculo de marionetas, recibir un masaje relajante con técnicas milenarias del Lejano Oriente, escuchar música en vivo, practicar deporte, montar en barca o simplemente, descansar bajo un árbol leyendo su libro favorito. Todo es posible en pleno centro de Madrid, en El Parque del Retiro, uno de los favoritos de los madrileños y los turistas.

REAL JARDíN BOTáNICOCreado hace 250 años, este jardín invita a disfrutar de un agradable paseo rodeado de miles de especies de plantas vivas. Entre sus colecciones destacan un herbario con más de un millón de ejemplares, una biblioteca y un archivo con cerca de 10.000 dibujos, así como una exposición de 5.000 especies de plantas vivas. Su invernadero conserva plantas de otras latitudes, desde extrañas orquídeas a plantas carnívoras.

PARQUE EL CAPRICHODe aire romántico y con cierto sabor francés, estos jardines invitan a agradables paseos los fines de semana. Un laberinto, un palacio o un estanque son algunos de los lugares más sorprendentes y caprichosos del parque. Es el lugar perfecto para pasear los fines de semana y los días festivos, los únicos días que abre.

JARDINES SECRETOSEstos rincones, poco frecuentados por los ciudadanos de Madrid, son el secreto mejor guardado de la ciudad. Descubra el Jardín del Príncipe de Anglona, la antigua muralla o el cementerio de San Sebastián.

PARkS AND gARDENS PARQUES y JARDINES

© E

:M: P

rom

oció

n de

Mad

rid, S

.A. |

Par

que

El R

etiro


CASA DE CAMPORide a bike, go canoeing, free fall, meet a panda, observe the city from up high, treat yourself to rice with lobster, see an exhibition or stroll along the Merques Stream, are some of the options this park has to offer. One thing you will never do there is get bored.

CASA DE CAMPOMontar en bici, practicar piragüismo, descender en caída libre, conocer un oso panda, observar la ciudad desde las alturas, comer arroz con bogavante, ver una exposición o pasear por la vega del arroyo de Merques, son algunas de las múltiples opciones que ofrece este parque. Lo que no hará ahí, será aburrirse.

ONE-DAy TRIPS EXCURSIONES

WORLD HERITAgE SITESThere are nine UNESCO World Heritage locations situatedjusttwohoursawayfromthecity:AlcaládeHenares, Toledo, Cuenca, Segovia, Ávila, Salamanca, Córdoba, the Monastery and Site of San Lorenzo de El Escorial and the Aranjuez Cultural Landscape.

MONTE DEL PARDOThis place is just about 8 kilometers from the Puerta del Sol and is one of the best preserved Mediterranean forests in Europe. El Palacio Real del Pardo, La Casita del Príncipe and the Quinta del Duque de Arco are located within the heart of the forest, which was utilized by kings for their hunting expeditions.

MEDIEVAL TRAINMadrid offers a special service called the Medieval Train, which can transport you to a city as wonderful as Sigüenza, and also can to take you on a journey back in time to the Middle Ages.

ENCLAvES PATRIMONIO DE LA HUMANIDADA tan sólo dos horas de distancia, Madrid tiene nueve enclaves catalogados por la UNESCO como Patrimonio de la Humanidad: Alcalá de Henares, Toledo, Cuenca, Segovia, Ávila, Salamanca, Córdoba, el Monasterio y Real Sitio de San Lorenzo de El Escorial y el Paisaje Cultural de Aranjuez.

MONTE DEL PARDOEste paraje, a 8 kilómetros de la Puerta del Sol, es uno de los bosques mediterráneos mejor conservados de Europa. El Palacio Real del Pardo, La Casita del PríncipeylaQuintadelDuquedeArcoseencuentranen el corazón de este bosque, frecuentado por los reyes para practicar la caza.

EL TREN MEDIEvALMadrid pone a su disposición un servicio especial denominado el Tren Medieval, capaz de transportarle a una ciudad tan maravillosa como Sigüenza y asimismo, capaz de llevarle en un viaje por el tiempo hasta la Edad Media de los trovadores.

© E

:M: P

rom

oció

n de

Mad

rid, S

.A. |

Seg

ovia

142

pARTNERSHIpS AND SpONSORSHIpSCOLABORACIONES y pATROCIOS

SPONSORS Of SOME SATELLITE WORkSHOPS EMPRESA ASOCIADA

OTHER COLLAbORATIONS OTHER COLLABORATIONS / OTRAS

You will find more information in the respective insert included into your bag

Annual Meeting 9th HTAi BILBAO 2012Health Technology Assessment International

An International Society for the Promotion of Health Technology Assessment

Advancing ThepapeuticsImproving Lives.

143

MAIN SUPPORTINg INSTITUTIONS PRINCIPALES INSTITUCIONES DE APOyO

OTHER SUPPORTINg INSTITUTIONS OTRAS INSTITUCIONES DE APOyO

PARTNEREMPRESA ASOCIADA

NETWORkS REDES

RED/EIBEROAMERICANAGPC

144

EXHIbITORSEXPOSITORES

The Cochrane Exchange is The Cochrane Collaboration’s dedicated exhibition space at this year’s Colloquium, hosting the Cochrane Editorial Unit, Secretariat, IMS and Web Teams, Methods Co-ordinator, Cochrane Training, Cochrane Consumer Network, and Evidence Aid. It’s the place to learn about the Collaboration’s latest news and current projects, find information on how to participate in Cochrane activities, ask questions and post comments about any aspect of the organisation, and meet members of our various teams and committees.

Visit the Cochrane Exchange to:

• Learn about the latest developments in RevMan, and Archie

• Discuss your Cochrane group’s website with a member of the Web Team

• Watch presentations on current Cochrane projects

• Arrange one-to-one meetings with members of the Collaboration’s core teams

• Get to know more about Cochrane Methods and their ongoing development

• Meet the Training Co-ordinator to discuss the latest available resources, your training needs, or the training programmes you provide

• Find out about how we are helping consumers access the best evidence in healthcare

• Learn about the developments to the Evidence Aid project, hear the feedback from the inaugural Evidence Aid conference (held on26September2011),andfindouthowyourentity can be involved in the project

• Post questions and comments in our dedicated ‘commentsbox’

For 175 years Wolters Kluwer has provided professionals with necessary information in the fields of legal, business, tax, accounting, finance, audit, risk, compliance, and healthcare.

Cochrane Exchange’ es el espacio de exposición que la Colaboración Cochrane tendrá en el Colloquium de este año. Este espacio albergará diferentes entidades como la Unidad Editorial Cochrane, el Secretariado, IMS y el equipo responsable del mantenimiento de la Web, los Coordinadores del Grupo de Métodos y de Formación, la Red Cochrane de Consumidores, y el equipo del Evidence Aid. Es el lugar para conocer las novedades sobre la Colaboración y sus proyectos actuales, obtener información sobre cómo participar en sus actividades, discutir sobre cualquier aspecto de la organización, y conocer a los miembros de las entidades mencionadas.

Visite ‘Cochrane Exchange’ para:

• Conocer las últimas novedades sobre RevMan y Archie.

• Discutir con los responsables del mantenimiento de la Web sobre el sitio web de su grupo Cochrane.

• Ver presentaciones sobre proyectos actuales Cochrane.

• Organizar una reunión con los miembros de alguna de las principales entidades Cochrane.

• Saber más sobre la metodología Cochrane y su desarrollo.

• Reunirse con el Coordinador del Grupo de Formación para discutir sobre los recursos disponibles, sus necesidades formativas o sobre las actividades de formación que imparte.

• Informarse acerca de cómo estamos contribuyendo a que los ciudadanos accedan a la mejor evidencia en asistencia sanitaria.

• Conocer el proyecto Evidence Aid y las reacciones derivadas de su conferencia inaugural celebrada el 26 de septiembre de 2011, y descubrir cómo su entidad puede participar en el proyecto.

• Publicar preguntas y comentarios en nuestro espacio dedicado a tal efecto.

Durante 175 años Wolters Kluwer ha proporcionado información profesional a abogados, contables, financieros, asesores, directivos de empresas, auditores, profesionales de la salud y a administraciones públicas.

145

You will find more information in the Wolters Kluwer stand and in the insert into your bag.

Datix is the leading supplier of patient safety software for healthcare risk management, incident reporting software and adverse event reporting.

You will find more information in the Datix stand.

Wiley’s Scientific, Technical, Medical, and Scholarly business, also known as Wiley-Blackwell, serves the world’s research and scholarly communities, and is the largest publisher for professional and scholarly societies.

Wiley-Blackwell is contributing to the simultaneous translation of the Colloquium allowing both English-speaking and non English-speaking people to attend all the sessions. They also designed and printed the abstracts book and provided the lanyards and badge holders. Finally they supported the singing festival (“Sing On The Wiley Side”) at the Farewell Party.

You will find more information in the Wiley-Blackwell stand and in the insert into your bag.

The Evidence for Policy and Practice Information and Co-ordinating Centre (EPPI-Centre) is part of the Social Science Research Unit at the Institute of Education, University of London. They have been at the forefront of carrying out systematic reviews and developing review methods in social science and public policy.

You will find more information in the ePPI Centre stand and in the insert into your bag.

Usted encontrará más información en el expositor de Wolters Kluwer y en un folleto en la bolsa.

Datix es el proveedor líder de software relacionado con la seguridad de los pacientes y para la gestión de riesgos de salud, así como de software de notificación de casos incidentes y el reporte de eventos adversos.

Encontrará más información en el expositor de Datix.

Las áreas de negocio científica, técnica, médica y académica de Wiley, también conocidas como Wiley-Blackwell, sirve a las comunidades escolares y de investigación en todo el mundo, y es el mayor editor de las sociedades profesionales y académicas.

Wiley-Blackwell contribuye a la traducción simultánea del Coloquio que permite tanto a las personas de habla inglesa como de habla no inglesa, asistir a todas las sesiones. También diseñó e imprimió el libro de resúmenes y facilitó los colgantes de identificación personal. Por último, ha dado soporte al festival de música (“SingOnTheWileySide”) en la fiesta dedespedida.

Usted encontrará más información en el expositor de Wiley-Blackwell y en un folleto en la bolsa.

El Evidence for Policy and Practice Information and Co-ordinating Centre (EPPI-Centre) es parte de la Unidad de Investigación en Ciencias Sociales en el Instituto de Educación de la Universidad de Londres. Ha estado a la vanguardia de la realización de revisiones sistemáticas y el desarrollo de métodos de revisión de las ciencias sociales y las políticas públicas de salud.

Encontrará más información en el expositor del Centro EPPI y en un folleto en la bolsa.

146

The Pan American Health Organization (PAHO) is an international public health agency with more than 100 years of experience in working to improve health and living standards of the countries of the Americas.

You will find a PAHO/WHO pictures exhibition at the main lobby.

“Art for Research” illustrates how health research generates wealth in the countries contributing to economic and social development, and to equity in health. This project includes two complementary shows:

• “Molding the World”, a collection of characters and their stories illustrated with portraits by renowned British artist Theo Chalmers.

• “Research in Movement”, a collection of photographs of the Australian Jane Dempster who traveled through Latin America documenting transforming histories of health research.

See: www.paho.org/arteparalainvestigacion

La Organización Panamericana de la Salud (OPS) es un organismo internacional de salud pública con 100 años de experiencia dedicados a mejorar la salud y las condiciones de vida de los pueblos de las Américas.

Usted encontrará una exposición de fotos de la OPS / OMS en el vestíbulo principal.

“Arte para la Investigación” ilustra cómo lainvestigación para la salud genera riqueza en los países contribuyendo al desarrollo económico y social, y a la equidad en salud. Este proyecto contempla dos exhibiciones complementarias:

• Moldeando el Mundo, una colección de personajes y sus historias, ilustrada con retratos del artista británico Theo Chalmers.

• Investigación en Movimiento, una colección de la fotografías de la australiana Jane Dempster quien viajó por América Latina documentando historias transformadoras de investigación para la salud.

Ver: www.paho.org/arteparalainvestigacion

EXHIbITION: “ART fOR RESEARCH” EXPOSICIóN: “ARTE PARA LA INvESTIgACIóN”

Photo by / Imagen de: Theo Chalmers. © PAHO 2011.

Photo by / Imagen de: Jane Dempster. © PAHO 2011

147

fUTURE COLLOQUIAfUTUROS COLLOQUIA

2012 NANNIG COLLOQUIUM...COLLOQUIUM NANNIG 2012...

148

AND... 2013 QUEBEC COLLOQUIUMy... 2013 COLLOQUIUM QUEBEC

El programa de un vistazo

Miércoles 1907:30 h15:00 h Reuniones

Jueves 20 Viernes 21 Sábado 22

09:00 h13:30 h

16:00 h17:30 h

Talleres

Inauguración Oficial17:30 h18:00 h

18:00 h19:30 h

Reuniones

20:30 h

Plenaria conjunta

CaféSesión de pósteres

PlenariaConferenciaSeguridad

Sesiones orales

07:30 h08:55 h

09:00 h10:30 h

10:30 h11:15 h

11:00 h12:30 h

Almuerzo


Almuerzo


Almuerzo12:30 h14:00 h

07:30 h08:55 h

09:00 h10:30 h

10:30 h11:15 h

11:15 h12:45 h

12:45 h14:00 h

07:30 h08:55 h

09:00 h10:30 h

10:30 h11:15 h

11:15 h12:45 h

12:45 h14:00 h

Talleres14:00 h15:30 h

14:00 h15:30 h

14:00 h15:30 h

16:00 h17:30 h

Acto social21:00 h

Reuniones

Sesión Plenaria Colloquium

Sesionesorales

Café15:30 h16:00 h Café15:30 h

16:00 h


Talleres16:00 h17:30 h

Noche libre

Reuniones


Talleres


Sesión Clausura Cochrane

Reuniones

Cena de gala y Fiesta de despedida

15:45 h17:00 h

17:00 h17:45 h

18:00 h19:30 h

21:00 h

Desde08:30 h Inscripciones

11:15 h12:45 h

Talleres

Reunión OPS

Reuniones


12:45 h14:00 h

ReuniónAnual

Generalde la

ColaboraciónCochrane


TalleresREDIBAM-GPC Reuniones

Sesión Plenaria de ClausuraConferencia Seguridad

17:30 h18:30 h

17:45 h19:30 h Reuniones Talleres

especiales

TalleresSatélite

15:00 h16:00 h Sesión Plenaria Colloquium

Plenaria conjuntaColloquium Cochrane-Conferencia Seguridad


Reuniones Talleres

Recepción de bienvenida

Talleres

17:45 h19:30 h TalleresReuniones

Talleres

Sesionesorales Talleres

OctubreCOLLOQUIUM

14:00 h14:45 h Sesión introductoria

Documents

XIX Colloquium Programa 20110914